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ABSTRACT 
Shotgun proteomic experiments provide qualitative and quantitative analytical information 
from biological samples ranging in complexity from simple bacterial isolates to higher 
eukaryotes such as plants and humans and even to communities of microbial organisms. 
Improvements to instrument performance, sample preparation, and informatic tools are 
increasing the scope and volume of data that can be analyzed by mass spectrometry (MS). To 
accommodate for these advances, it is becoming increasingly essential to choose and/or 
create tools that can not only scale well but also those that make more informed decisions 
using additional features within the data. Incorporating novel and existing tools into a 
scalable, modular workflow not only provides more accurate, contextualized perspectives of 
processed data, but it also generates detailed, standardized outputs that can be used for future 
studies dedicated to mining general analytical or biological features, anomalies, and trends. 
 
This research developed cyber-infrastructure that would allow a user to seamlessly run 
multiple analyses, store the results, and share processed data with other users. The work 
represented in this dissertation demonstrates successful implementation of an enhanced 
bioinformatics workflow designed to analyze raw data directly generated from MS 
instruments and to create fully-annotated reports of qualitative and quantitative protein 
information for large-scale proteomics experiments.  
 
Answering these questions requires several points of engagement between informatics and 
analytical understanding of the underlying biochemistry of the system under observation. 
Deriving meaningful information from analytical data can be achieved through linking 
together the concerted efforts of more focused, logistical questions. This study focuses on the 
following aspects of proteomics experiments: spectra to peptide matching, peptide to protein 
mapping, and protein quantification and differential expression. The interaction and usability 
of these analyses and other existing tools are also described. By constructing a workflow that 
allows high-throughput processing of massive datasets, data collected within the past decade 
can be standardized and updated with the most recent analyses. 
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CHAPTER 1:  The Role of Informatics in Shotgun Proteomics 
Experiments 
1.1 The Role of Proteomics in the Era of Systems Biology 
1.1.1. Systems Biology: The Ultimate Data Integration Challenge  
 
Answers are limited by the scope of the questions asked and the technology employed for 
the investigation. This is particularly true of experimental conclusions generated by the 
specific hypotheses put forth by today’s increasingly higher-resolution analytical 
platforms. As the questions become more specific, so do the answers. Consequently, 
there is a dichotomy of efforts simultaneously pushing both extremes of the spectrum: 
demands for highly accurate and precise data points collected within tightly controlled 
environments, as well as demands for highly reproducible, diagnostic, and deterministic 
characterizations of interactions between systems and their exceedingly complicated 
backgrounds. In the spirit of describing “systems biology,” researchers are ambitiously 
pursuing the goal of creating a scalable perspective of biology. This endeavor encourages 
collecting, analyzing, and integrating multi-dimensional data points at all levels of 
observable science, from the microscopic to the cosmologic, while preserving appropriate 
and accurate degrees of resolution in order to propose models that explain, predict, and 
describe the world around us.
1-3
 Although this grandiose aim graciously includes the 
indulgence of every scientist, allowing him to investigate his desired biological, physical, 
or chemical topic of interest at whatever level of depth or connectedness he desires, the 
grand achievement of putting the pieces together in a meaningful, lossless analysis 
remains a major challenge. 
 
Significant strides have been made in characterizing groups and pieces of related data, 
resulting in the designation of a myriad of meta- and sub-categories of systems. In 
attempt to adopt a consistent nomenclature that captures the hierarchical nature of the 
data, biological researchers have started cataloguing all of the data related to a system 
under an umbrella term suffixed with -ome. Terms such as biome, describing the smallest 
unit of complete characterization of a plant and animal community
4
, and genome
5
, 
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describing the entire sequence of deoxyribonucleic acid (DNA) that encodes an 
organism’s hereditary information, had existed since the beginning of the 20th century, 
but the “omics” revolution within molecular biology starting exploding in early 21st 
century when genomics, proteomics, transcriptomics, and metabolomics were joined by 
cytomics, epigenomics, glycomics, kinomics, metallomics, secretomics, and many more.
6
 
With the adoption of each new category, the existing categories had to be re-defined as to 
how they were different from and related to each other. For example, while genomic 
information for an organism may give insight as to what genes are possibly encoded in a 
cell and transcriptomic information reveals what genes are actually translated from 
ribonucleic acid (RNA), proteomic information sheds light on what proteins are encoded, 
translated, and ultimately expressed
7, 8
 (Figure 1.1). More concisely phrased, “DNA 
makes RNA makes proteins,” is known as the “central dogma of molecular biology.” 
This statement’s oversimplification of the transfer of information by molecular biology 
leads to a common misconception that measurements on each type of downstream data 
should agree with its biological predecessor and that any discrepancy between the 
profiles indicates one to be wrong. However, much like the three proverbial blind men 
describing an elephant, the different types of measurements have limited perspectives on 
the behavior of subcellular components at a given, time, location, or condition; they are 
only snapshots of a much larger dynamic picture. Until appropriate methods are devised 
to successfully integrate all of the contributing pieces of information, each individual 
“omics” is more than sufficiently complicated to merit focused investigation into its 
unique properties, biases, and limitations.  
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Figure 1.1. Central dogma of molecular biology. 
Genomics, proteomics, and metabolomics are three of the most common “omic” fields of 
study. (Figure adapted from Patti, et al., Nat Rev Mol Cell Biol, 2012.
9
) 
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1.1.2. Complementary “Omics” Technologies  
 
In the 1970s, molecular biology techniques heavily relied on laborious biochemical 
protocols to sequence the genome of small bacterial organisms, and completing a single 
virus genome in 1977
10
 was a major accomplishment. In the next two decades, these 
techniques underwent a paradigm shift in their approaches, increasing the throughput of 
each analysis and reducing the cost by more than 6-fold.
11
 By 1995, researchers had 
successfully implemented a “shotgun sequencing approach” that deciphered the genome 
of Haemophilus influenza using analytical and computational processes.12 This approach 
involves physically shearing the DNA into smaller pieces (reads) that are more amenable 
to quick analytical analysis and then using computational analyses to stitch the sequences 
back together. The success of this strategy relies on the fragments of DNA containing 
overlapping regions of sufficient length to allow the reads to be assembled together into 
contiguous regions and ultimately, the full genome sequence. 
 
Assembling a genome is not necessarily a straightforward computational process, 
especially if the process is only using information from the collected reads. De novo 
approaches are particularly problematic for organisms in which there are large regions of 
highly-repetitive DNA. Instead of the overlap-layout-consensus model,
13
 a more common 
informatics approach is to use a genome of a closely-related organism as a scaffold or 
template for the new organism.
14
 In order to map millions of collected reads against a 
reference genome, researchers must not only have sequence alignment software that they 
trust to correctly distinguish discrepancies between the reference and new genome, but 
also, more fundamentally, they need access to sequenced genomes. As the number of 
sequenced genomes continues to climb, online data repositories have become invaluable 
to creating accessible electronic catalogues of genomic information. For example, 
GenBank, a national genetic sequence database maintained by the National Institute of 
Health (NIH), collects all publicly available DNA sequences so that the scientific 
community has access to a single, centralized warehouse that includes the most 
comprehensive, up-to-date listing of genomic sequences.
15
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Although publication of the human genome sequence in 2001
16, 17
 has been perhaps the 
most notable achievement, as of early 2013, 2,417 species have had their genomes 
completely sequenced, including 2,125 species of bacteria and 149 eukaryotic species.
18
 
Developments of additional, “next-generation” sequencing methods, including 
pyrosequencing
19
 and massively parallel signature sequencing,
20
 are continuing to add to 
the number of sequenced genomes.
18
   
 
In contrast to the relatively static nature of a genome, gene expression in the form of 
RNA (i.e., transcripts) yields highly dynamic messages that are designed to be quick-
responding indicators that anticipate and adjust to changes in environmental conditions. 
Determining transcript sequences is therefore much more specific to the state of a 
particular cell at a given time and requires a complementary method to genome 
sequencing. Detecting transcript sequences are important from two points of view: their 
presence or absence provides evidence for genes (and whether they are being turned on or 
off), and their relative abundance taken between two time points signifies their level of 
gene expression. Technologies for gene expression profiling are typically variants of 
DNA microarrays, in which all possible mRNA sequences for an organism are 
specifically arranged on a single chip such that the fluorescent intensity signal of a 
particular spot on the chip corresponds to the abundance of that particular mRNA within 
the sample.
21-23
 More recently, a technology called “RNA-seq” or “Whole Transcriptome 
Shotgun Sequencing,” exploits the advancements made by next generation genomic 
sequencing to read cDNA or RNA just as easily as DNA.
24, 25
 The deep coverage and 
base-level resolution provides faster, less expensive measures of differential gene 
expression compared to microarray analysis, primarily because it does not rely on the 
manufacture of an organism-specific chip to perform measurements. Replicating the 
measurements is particularly helpful when the gene expression profiles are used in 
comparative studies that observe the change in expression levels between multiple 
biological conditions. These studies heavily rely on the powers of statistical tests to 
determine whether expression levels are significantly different between conditions. One 
of the major limitations to these studies is that the extraction and stabilization of mRNA 
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from environmental samples is not trivial and not all samples collected meet the stringent 
quality control criteria. Therefore, this process is still under development. 
 
Just as the number of words in a dictionary does not dictate how many books can be 
written, the number of protein-coding regions in a genome does not necessarily indicate 
the number of proteins that can be expressed by a cell. In fact, the human genome 
contains 20-25,000 protein-coding genes,
26
 but it has been suggested that these genes 
code for up to 1,000,000 distinct proteins,
27
 resulting in a large discrepancy between 
genes and proteins (1:40 ratio, respectively). The seeming disagreement is likely due to 
factors such as alternative splicing and post-translational modifications of proteins. In 
light of this, it is not surprising that the identifications from many gene expression assays 
do not always align with protein expression assays.
28-30
 Furthermore, transcripts may be 
degraded or modified after translation at a much different rate than protein turnover or 
modification rates. Therefore, it is also unlikely that the abundances of a transcriptomics 
experiment would demonstrate the same trends as a proteomics experiment. These 
measurements are, however, part of the same biological story, and integrating 
transcriptomic and proteomic measurements is becoming an increasingly popular goal.  
 
Proteomics,
31
 as the complete suite of proteins being expressed by a cell at a given time, 
captures information that is more of a “final product” than its biological predecessor, 
transcriptomics. Although recent studies have shown that transcripts can enact functions 
outside of carrying information about which proteins should be expressed,
32-35
 proteins 
are responsible for most of the longer-lasting, more complex machinery. Consequently, 
proteins are most often the targets of biological studies investigating phenotypes, the 
observable characteristics of an individual that result from interactions between a genome 
and the environment. Other studies may seek to characterize what factors are responsible 
for particular molecular mechanisms, such as motility, signal transduction, transporting 
or secreting molecules, forming or destroying complexes. Still other proteomic 
experiments may seek to identify constituent members of a complex community of 
organisms whose species can be readily identified by expression of certain proteins. 
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Depending on the goal of the research, it may be reasonable to take a targeted approach 
(focusing on one or a few proteins at a time) or a discovery-based approach (attempting 
to describe as many expressed proteins as possible).  
 
Early proteomic studies took targeted approaches because that was what the technology 
permitted. Previous techniques for determining what proteins were in a simple mixture 
primarily favored using electrophoretic gels.
36, 37
 By admitting proteins into the well of a 
polyacrylamide gel, a voltage could be applied that would cause the proteins to move 
down the gel and separate by size. The smaller proteins move slower and get caught up in 
the fibers of the polyacrylamide, whereas the larger proteins barrel down the gel without 
as much difficulty. Then, the distance the proteins traveled can be compared to the 
distance traveled by a selection of known proteins that are injected in a nearby well. The 
protein mixture is generally mixed with a stain, which facilitates protein detection from 
the gel background, as well as a denaturant such as sodium dodecyl sulfide (SDS), which 
unfolds the proteins and allows them to move more predictably. If the mixture is of a few, 
pure proteins, then the position of the protein results in a tightly concentrated band of dye 
moving according to the input voltage. However, if the mixture is complex or not purely 
proteins, the band could be very large and more closely resemble a smear or the band 
could be very faint. In either case, this technique is not very amenable to high resolution 
(small, clean bands), high sensitivity (sufficient distances between two bands), nor high 
selectivity (the concentration of proteins could not be determined by the opacity of the 
band and a protein would not always be visible with the dye). 2D gels that separate 
proteins based on two-dimensions, size and hydrophobicity, can improve the 
fractionation of proteins and these analytical figures of merit. In fact, 2D gels are 
common separation techniques employed in Western blots, methods that use gels to 
select proteins and then nitrocellulose membranes to hybridize targeted proteins with 
antibodies. In general, Western blots are limited to detecting a handful of proteins in each 
experiment and cannot provide information about their identifications beyond observing 
co-alignment with a ladder or standard. If a study calls for more proteins to be identified, 
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or more specific quantitative comparisons, other analytical techniques should be 
employed. 
 
Over the past two decades, mass spectrometry (MS) has arisen as a promising analytical 
technique for targeted and discovery-based proteomics approaches. Although allusions to 
mass spectrometry are often made without extensive detail, “mass spectrometry” actually 
refers to an entire family of techniques rather than a single method or type of 
instrument.
38-40
 Essentially these techniques can provide information about the mass of 
entire proteins, their sequences, and/or higher-order structural detail. Variations of the 
three main components (ion sources, analyzers, and detectors) are generally compared 
based on their resolution, mass accuracy, detection specificity, speed, and cost of the 
analysis. The different tools also have strengths and weaknesses according to a sample’s 
purity and available amount/concentration, but in general, compared to gel techniques, 
mass spectrometry has a much lower limit of detection, higher sensitivity, better 
resolution, and improved mass accuracy. Tandem mass spectrometry (MS/MS) exploits 
the dissociations of ions to give the nucleotide or amino acid sequences. In addition to 
determining the primary structural information, mass spectrometry can reveal secondary 
structure information, such as the number and location of disulfide bonds or details about 
alpha helices and beta sheets. Tertiary and quaternary structural information, such as how 
the molecule is folded and how the protein interacts with DNA or other proteins, can also 
be gained through coupling other techniques with mass spectrometry. All of these 
inferences are achieved through the interrogation of the number and behavior of ions, 
molecules with mass and charge. In fact, the two most important pieces of raw output 
generated by mass spectrometry instruments are simply the defining characteristic of the 
ion (its ratio of mass to charge or m/z) and how many times that ion was observed.
41, 42
 
Consideration of the ions’ charges with respect to their mass is one of the pivotal aspects 
contributing to the precision of mass spectrometry instruments. Although some scientists 
have a tendency to deprecate the usefulness of mass spectrometry analysis as a routine 
analysis or mere formality in confirming the identity of their protein, many mass 
spectrometry methods are becoming increasingly crucial to research and development 
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efforts tasked with confidently analyzing the identity and quantity of a single protein 
amidst complicated biological background or characterizing a broad swath of proteins 
within complex organisms and microbial communities. 
 
 
1.2 Mass Spectrometry and Shotgun Proteomics 
1.2.1. Shotgun Proteomics  
 
There are two fundamental approaches to mass spectrometry: the measurement of intact 
proteins (“top-down” proteomics) or the measurement of peptides from a complex 
protein mixture (“bottom-up” or shotgun proteomics). Although both can be used for 
large-scale proteomics experiments,
43
 top-down proteomics
44, 45
 is far less developed than 
bottom-up proteomics. One of the primary challenges to top-down proteomics is figuring 
out a way to analyze proteins across a wide mass range. The size of an intact protein 
under analysis may range from 10 kDa to 300 kDa, but the mass range constraints for 
instruments designed for multiply charged ions (200 to 1700 m/z) may advocate the use 
of analyzers that can sacrifice resolution to accommodate a wider mass range. For intact 
proteins, which are more likely to be highly multiply charged, charge states often merge 
together, making it difficult to deconvolute the peaks without ultra-high resolution 
instrumentation, such as that afforded by FTMS.
46
 In addition, intact proteins tend to be 
stickier on columns and unless the columns are hydrophilic enough, it is difficult to push 
them off. Also, since proteins maintain their higher-order structure, their retention time 
may be very different and not necessarily time-dependent. A last challenge faced by top-
down proteomics is that the fragmentation tends to be spottier. Logistically, identification 
through intact proteins is more of a “hit-or-miss” approach when compared to bottom-up 
proteomics, in which there are numerous peptides for each protein. With intact proteins, 
there are fewer chances of getting the right measurements. There could also be a number 
of modifications, including PTMs, truncations, and metal ion adductions, which would 
alter the molecular mass.
47
 In total, there are several unresolved challenges in the sample 
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preparation, instrumentation, and informatics interpretations that are currently limiting 
the use of top-down proteomics for high-throughput characterization studies. 
 
In comparison, shotgun proteomics has seen tremendous strides in the past two decades. 
The analogous “shotgun” strategy employed in genomics and transcriptomics relies on 
the fact that the sample is rendered more tractable for the experimental measurement, but 
the subsequent success relies on informatic processes to identify the constituents of the 
sample based on the reconstruction of the measured fragments. In shotgun proteomics 
using mass spectrometry, proteins from a complex mixture are denatured, reduced, and 
enzymatically digested into peptides before they are analyzed. These peptides are more 
similar in size, composition, and the number of charges they carry compared to the more 
complicated array of intact proteins. However, it is common to separate the peptides into 
even more similar fractions to achieve more comprehensive inclusion of the various types 
of peptides generated from the protein mixture. In fact, there are a number of nuances 
within protocols to prepare samples for the best coverage achievable by mass 
spectrometry analysis. 
 
Oftentimes it is helpful to first perform a series of ultracentrifugation steps in order to 
separate the extracellular, the cellular, and the membrane-bound proteins. Acquiring the 
extracellular components is easiest to do first. Sample preparation for this initial 
separation requires a round of washes of the intact microbial cells for simultaneous 
collection of the supernatant. Lysing the cells by sonication followed by a centrifugation 
step separates the cellular content into the supernatant. Additional centrifugation enriches 
the supernatant for better collection of the soluble proteins out of the whole cellular 
fraction. For membrane proteins, however, a slightly more rigorous protocol is in order. 
Maximizing protein solubility and therefore enriching the extraction of membrane 
proteins is best be achieved by the addition of a detergent like sodium dodecyl sulfide 
(SDS), but this reagent can cause significant analyte suppression in electrospray mass 
spectrometry. A number of variant protocols have been developed in order to improve the 
comprehensive solubilization of proteins, but each change or optimization in the sample 
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preparation needs to be taken into consideration in downstream informatics processing as 
these details can affect the expected and observed behavior of spectra. Proteins can then 
be precipitated and purified via TCA precipitation. Proteins are then denatured (typically 
by 8M urea) and reduced (by 10 mM DTT) so that they no longer have higher order 
structure or disulfide bonds that could obscure their surface area and minimize efficiency 
of the enzymatic digestion. Clean up with Sep-Pak and a small amount (0.1%) of formic 
acid in water is often needed to remove contamination as unanticipated adducts will 
severely lower the resolution of the spectra. 
 
Digesting proteins into peptides is one of the key elements of shotgun proteomics, but for 
the approach to be the most effective, peptides should ideally have similar lengths, 
ionization properties, and MS-compatibility. Trypsin is the most common protease used 
for such digestions, primarily because it cuts at the carboxyl side of arginine and lysine 
residues and generates peptides approximately 10 amino acids long. These frequencies 
are general rules, but for membrane proteins trypsin may not be able to generate peptides 
between 5 and 50 amino acids long. Nevertheless, the ultimate goal in choosing the right 
protease is to generate peptides that provide the most sequence coverage for the most 
number of proteins. More specifically, the only sequence coverage that will contribute to 
the protein’s identification will be those peptides that ionize well. This is another reason 
why trypsin is most commonly used: in addition to the frequency at which it cuts 
proteins, the basic residues yield well-defined paired with high charge states that tend to 
be readily identifiable with collision-induced dissociation (CID or collision-activated 
dissociation, CAD). Despite the general preference for trypsin, many other proteases 
(Table 1.1) have been chosen for specific experimental designs. Ultimately, the 
selectivity, pH range, optimum temperature, denaturing conditions, and digestion time all 
play critical roles in the number and types of peptides generated from proteins.  
 
Although the goal of digesting proteins into peptides is to reduce the variability among 
the measurements, the next critical component of the shotgun proteomics experiments is 
to fractionate the sample to maximize the depth and breadth of peptides identified by the   
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Table 1.1. Common proteolytic enzymes used for digestion step in shotgun proteomics 
experiments. 
(Table adapted from Sigma-Aldrich “Protease Profiler.” www.sigmaaldrich.com/life-
science/proteomics/mass-spectrometry/protease-profiler.html) 
 
Enzyme  Specificity  Optimal pH  
Trypsin, Proteomics Grade  Carboxyl side of Arg and 
Lys  
pH 8.0  
Asp-N  Amine side of Asp and Cys  pH 6.0 - 8.5  
Glu-C  Carboxyl side of Glu and 
Asp  
pH 4.0 – 7.8  
Lys-C  Carboxyl side of Lys  pH 8.5  
Arg-C  Carboxyl side of Arg  pH 7.5 – 8.5  
Chymotrypsin  Carboxyl side of Tyr, Trp, 
Phe, Leu  
pH 7.0 - 9.0  
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MS instrument. One of the more commonly used approaches for the next dimension of 
separation is an online liquid chromatography (LC) system incorporating strong cation 
exchange (SCX) and reverse-phase (RP) columns, also known as MudPIT 
(multidimensional protein identification technology, Figure 1.2).
48-50
 In general, the first 
phase, SCX, incorporates a negatively charged stationary phase that tightly grabs the 
positive molecules and allows the negative molecules to elute first. Eleven consecutive 
pulses of increasing ammonium acetate salt concentration (0-500 mM) achieve charge-
based separation. Each salt pulse is followed by a 2-hour RP gradient elution that 
separates peptides by their hydrophobicity, allowing the less hydrophobic peptides to 
elute off early before the more hydrophobic, sticky peptides requiring higher 
concentrations of organic solvent.  
 
More specifically, these two orthogonal separation techniques can be easily incorporated 
into the middle of the three main steps in a liquid chromatography experiment: sample 
injection, sample elution and detection, and column re-equilibration. There are two main 
ways to load samples for an LC experiment: using a six-way valve and a pressure cell 
column. Although using the six-way valve is the most common method, the volume is 
limited by the column size and flow rate as the sample is loaded on to the internal or 
external loop. Packing and loading the sample with a pressure cell allows for a much 
larger range of volumes to be added. Before the elution process begins, 100% of the 
starting solvent should be added to the sample. Depending on the type of elution chosen, 
the elution composition may be constant or marked by gradual or discrete changes. If the 
mobile phase remains constant, the chromatographic separation is known as an isocratic 
elution. If solvents are added gradually over time, then the elution composition, too, will 
change gradually over time; this is known as a gradient elution. Step gradient elution is a 
modification of gradient elution that involves changing the solvents in a discrete step-
wise fashion. After a certain point, however, the column reaches equilibrium and the 
eluents do not change regardless of the increasing solvent. Historically, detection 
techniques have included UV, electrochemical, and fluorescent methods,
51-54
 but now  
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Figure 1.2 The MudPIT strategy involves 2 chromatographic components: strong cation 
exchange (SCX) followed by reverse-phase (RP) separation of peptides. 
 
 (A) Changing the solvents in a discrete step-wise fashion generates salt pulses that push 
the peptides off the columns according to their hydrophobicity. (B) Chromatograms 
graph the total ion currents (TIC; y-axis) collected across time (x-axis). 
 
(B) 
(A) 
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many HPLC experiments can be directly coupled to electrospray mass spectrometry 
(more details in Section 1.2.3). 
Confidence in the detections relies heavily on the assumption that the column was 
equilibrated before the elutions began. Therefore, after every LC run it is important to re-
equilibrate the column by adding incremental amounts of salts to remove any excess 
proteins and to “clear the slate” for the next separation. A highly organic solvent is often 
used to re-equilibrate SCX columns. 
Both strong cation exchange and reverse phase chromatography involve a form of 
separation that works best with analytes that are charged or polar. SCX incorporates a 
negatively charged stationary phase so that it grabs those molecules that are positive. This 
tight binding allows the negative molecules to elute first followed by the positive ones. 
Strong salt solutions are added to help separate the charges and facilitate the elutions. In 
adsorption chromatography, the stationary or solid phase often consists of beads 
decorated with compounds whose properties determine which molecules are retained. 
Reverse phase chromatography involves a non-polar stationary phase that generally 
incorporates hydrophobic alkyl chains of C4, C8, or C18. Smaller alkyl chains such as C4 
are more amenable to proteins because the shorter chains are less hydrophobic. C18 
chains are better suited for hydrophilic peptides because they have to be pulled a little 
harder. The non-polar components elute more easily, but in general, bead size, column 
lengths, pressure, and temperature are factors that affect the absolute elution times of 
each peptide. 
 
The effectiveness of these coupled separations can be measured by how well one can 
characterize and resolve the resulting elution peaks. In the extracted ion chromatogram, 
these peaks represent total ion currents (TIC; y-axis) collected across time (x-axis). Ideal 
chromatograms have discernible, highly resolved chromatographic peaks- not 
overlapping peaks that are either too close to each other to be resolved, nor more subtly, a 
collection of peaks that are sitting on top of each other due to co-elution. Determining an 
appropriate sample load can greatly affect the chromatographic performance. Insufficient 
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sample may be below the instrument’s sensitivity limits, whereas too much sample might 
overload the column and dramatically impact the possible number of peptide 
identifications. Changing between an online and offline LC method could also impact the 
relationship between chromatography and initial peak observations. Offline techniques 
tend to clean better than online, but online chromatography touches fewer surfaces so 
there is less sample loss. Indications of too much salt, column bleed from a previous salt 
pulse not completely eluting all of the peptides, or decrease in sensitivity due to sample 
loss are other visual clues that may inform the researcher that the separation protocol may 
need to be adjusted for the particular sample under investigation. 
 
While the 2-D separation techniques separate peptides based on charge and 
hydrophobicity, the success of the MudPIT strategy heavily relies on the merits of the 
accompanying MS instruments to provide sufficient sensitivity, resolution, high mass 
accuracy, and analytical dynamic range to adequately capture the range of peptides 
present in each fraction. Recently, sequencing speeds have dramatically improved such 
that more scans with high-resolution data can be collected. The new LTQ Velos (Thermo 
Scientific, Waltham, MA) not only has a greater speed of spectral acquisition, but it also 
achieves a greater analytical dynamic range and sensitivity than its predecessors. In other 
words, it can analyze data points from peptides that exist in the sample across a wide 
range of abundances, including those that may be low abundant and those that may not 
ionize very well (resulting in low signal-to-noise ratios).  
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1.2.2.  Mass Spectrometry Instruments 
 
The three basic components of a generic mass spectrometer are the ion source, analyzer, 
and detector, whose respective main functions are to generate, sort, and identify ions.  
 
Ion sources, such as Electron Ionization (EI), Chemical Ionization (CI), Matrix-Absorbed 
Laser Dissociation Ionization (MALDI) or Electrospray Ionization (ESI), generate ions 
from molecules in a sample that may be from solution, surfaces, or solids, so that the ions 
can be separated by their mass-to-charge (m/z) ratios. Among a number of additional 
distinctions, ionization methods can differ by how much sample is required as input, what 
pressure level is ideal, whether they generate ions continuously or pulsed, whether they 
produce singly or multiply-charged ions, and the harshness of their fragmentation. 
Because of the wide variety of types of samples and the strengths and weaknesses 
inherent to each ionization method, there is no ion source that is ideal for all applications. 
Similarly, there is no mass analyzer that is ideal for every possible experiment. Sorting 
ions in the mass analyzers falls into two types of processes, defined by their type of 
fields: static fields, such as those found in sector, time-of-flight, or ion cyclotron 
resonance mass spectrometers; or dynamic electric fields, such as those found in linear 
quadrupoles or quadrupole ion traps.
38-40
 All of these analyzers exploit the charge of ions 
as a handle to steer and manipulate their positions. Whether in response to electric, 
magnetic, or a combination of both fields, the charged properties of ions allow them to be 
filtered or trapped so that detectors can distinguish the molecular components of the 
sample. The detectors feed their input into data systems that process the information and 
output the signal intensities in a human-readable fashion. Finally, one or more database 
searches are typically performed in order to produce a list of identifications and 
descriptions corresponding to the significant peaks. 
 
Matrix-assisted laser desorption ionization (MALDI) is an ion source that is often 
coupled with a time of flight (TOF) analyzer to separate the singly-charged ions. 
MALDI, a softer ionization technique, involves forming a crystal with the sample and a 
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UV-absorbing matrix, pulsing a laser beam at the crystal, and lifting the ions out. The 
matrix helps soften the high energy of the laser, leaving craters in the crystal where 
desorption occurred and the analytes were lifted out into the gas phase. The ions steal 
protons from the matrix, typically only a single hydrogen at a time. 
55
 
 
Electrospray Ionization (ESI) is a type of ion source that captures ions by converting 
them from the liquid phase to the gas phase.
41, 56
 The samples are first protonated in 
solution either by adding 0.1% acetic acid to a 50:50 mixture of water and acetonitrile. 
The solution is then injected into the instruments (by direct infusion or from HPLC 
attachment) and continuously pushed through a highly charged (3-6 kV) metal needle at a 
rate of approximately 1 µL/minute. 
 
“Ideal” solvent conditions for ESI-MS often differ from “typical” solvent conditions 
employed in biology labs for protein studies.
57, 58
 Typical biological solution phase 
conditions are not very amenable to clear identification of proteins of interest by ESI-MS 
ionization. Electrospray ionization operates on the principle that anything that is charged 
will be seen- including unwanted detection of solvents and buffers. Many buffers that are 
used in HPLC separations, such as TFA, are such good ion-pairing reagents that they 
create unstable sprays. Other adducts from separation techniques, such as salts with 
sodium or potassium ions, can give undesired peaks that contaminate the mass 
spectrometry profile. The presence of carrier proteins, such as bovine serum albumin 
(BSA), as well as denaturants like guanidine and urea, show peaks that may also 
overwhelm the protein of interest, or at least increase the noise level. In fact, typical MS 
requirements are fairly stringent for solvents, pH levels, salts, protein co-factors, and 
sample amounts. Ideally, MS instruments work better with pure water as a solvent, but 
some small amount of acetonitrile is acceptable. Because ESI-MS relies on pre-formed 
ions, buffers that are slightly acidic tend to produce better results. Salts and co-factors are 
considered contaminants and should not be present at all. Therefore, as a compromise 
between biological and MS preferences, solvents are generally composed of both water 
and acetonitrile (50:50 by volume). Their pH ranges from 3 to 7 for most proteins. 
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Buffers are typically low concentrations, 1-100 mM ammonium acetate. For macro-ESI, 
protein concentrations are uM in solution volumes of 100 to 1000 uL, but macrospray 
does not tolerate 100% water. Nanospray, electrospray with flow rates ~ 25 nL/min, is 
more tolerant to salt. Processes to ensure purity include removal of molecules that can be 
charged, including protease inhibitors like EDTA, cleanup by dialysis or reverse-phase 
C4 Zip-Tips, and desalting columns before eluting into MS. 
 
Some samples are better-suited to ESI than others; those that are charged in solution, 
including inorganic anions and cations, organic acids and bases, and synthetic polymers 
and biopolymers, are particularly amenable because they form ions more quickly. 
Because ESI is a soft ionization technique that can produce multiply charged ions, special 
care should be taken when the mass spectra are interpreted. Mixtures can be difficult to 
analyze because each compound could give a number of peaks for each component with a 
different charge. This may result either in overlaps of signals or hiding less abundant 
peaks. The monoisotopic mass, which should be the peak with the smallest m/z ratio, 
may not be visible if there is a particularly large abundance of highly charged molecules 
skewing the scale of the relative intensity. However, this capability of detecting ions with 
multiple charges increases the range of the mass of proteins that can be detected. In fact, 
ESI instruments can measure proteins up to 100,000 Da. Despite the inclusiveness of 
large molecules, ESI can be used for samples that have very low concentrations, from 
250 fmol to 10pmol, and are generally very accurate in their mass determinations. The 
accuracy greatly depends on the purity of the sample, as inclusions of salts, buffers, 
detergents, and other contaminates that carry charges cannot be discriminated from the 
molecules of interest. 
 
Analyzers, the components of the mass spectrometry instruments responsible for sorting 
ions, generally fall into two categories that are defined by the type of fields they use to 
manipulate ion motion: static fields, such as those found in sector, time-of-flight, or ion 
cyclotron resonance mass spectrometers; or dynamic electric fields, such as those found 
in linear quadrupoles or quadrupole ion traps.  
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Selecting the most appropriate analyzer for a given analytical experiment is generally 
weighed by a common list of figures of merit including input limitations, quality of the 
measurements, and performance metrics. Mass resolution and mass accuracy are the 
figures of merit most often used to describe analyzer specifications, but they are also the 
most commonly confused. Simply put, mass resolution is the sharpness of the peaks, and 
accuracy is whether the peaks of mass/charge ratios are in the right place. The general 
formula for resolving power, 
 
Rm= m / Δ mresolution  
 
can be used to determine the resolving power of a mass analyzer where m is the 
mass/charge of the ion and Δ mresolution can be estimated by measuring the peak’s full 
width at half-maximum (FWHM). Sharper peaks, which have narrower FWHM and 
smaller Δmresolution, result in larger numbers for the unit-less measure Rm.  
 
Accuracy, which is only concerned with the lateral placement of the determined peaks 
from their true values, is typically described in terms of parts per million or Daltons: 
 
10
6
 × Δmaccuracy/Δmmeasured, where  
Δmaccuracy = Δmtrue - Δmmeasured 
 
It is important to keep in mind that the lower the number, such as 0.0001 Da, the better 
the mass accuracy. 
59, 60
 
 
While the higher resolution instruments also tend to follow the same trend in terms of 
their relative accuracies, it is possible for spectral interference to affect the measurements 
and cause larger deviations from the true mass/charge calculations. Using normal scan 
rates, the mass resolution of analyzers typically follows the general trend: linear time-of-
flight (500-1.000), quadrupoles (1,000-2,000), ion traps (1,000-2,000), reflection time-of-
flight (2,000-10,000), sectors (5,000-100,000), and Fourier transformations (5,000-
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1,000,000). These last three analyzers offer high sensitivity and therefore more accurate 
mass determinations as well.  
 
Due to the softer ionization of electrospray, ESI is most often employed in tandem mass 
spectrometry approaches with linear quadrupoles and ion traps to draw more information 
out of the fragmented the ions. Linear quadrupoles derive their name from applying 
alternating radio frequency (rf) and direct current (dc) voltages to four linear rods 
arranged symmetrically to direct ions from the source to the detector. These instruments, 
therefore, lend themselves to both targeted approaches in which a very narrow m/z 
window (down to a single m/z) is permitted or an extremely large m/z range is allowed to 
pass.
39
 
40
 
Quadrupole ion traps (LTQs) are essentially 3-dimensional versions of linear quadrupoles 
in which the z direction is exploited as yet another motion that can be used for further 
separation. The electrodes supplying rf and dc voltages take the form of a ring and 2 end-
caps. Although the principles operating in the mass filtering process between quadrupoles 
and traps are somewhat similar, the ion traps have many more favorable characteristics 
that extend their functionality and performance. Ion traps are high performance devices 
that achieve higher sensitivity, resolution, and m/z values.
39, 61
  
Many of these features were preserved and improved in the recent adaptation of the 
quadrupole ion trap to produce the orbitrap. An orbitrap separates ions of different m/zs 
by monitoring their axial oscillations and rotations around a central electrode, but the 
most notable difference between the quadrupole ion trap is that the orbitrap assumes the 
ions travel along a spindle-shaped central electrode in a constrained z direction. 
Measured frequencies of ions moving in the angular, orbiting motion around the central 
electrode and the oscillations along the z-axis can then be selective while detecting the 
composition of m/z ratios collected. One of the most valuable attributes of both linear ion 
traps and orbitraps are their ability to easily facilitate multi-stage mass spectrometry 
(MS
n
) for selected ions. 
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Multi-stage mass spectrometry, which is used to interrogate higher order protein 
structures as well as provide sequences of proteins and peptides, is most commonly 
termed as tandem mass spectrometry (MS/MS). MS/MS employs two sequential stages of 
mass spectrometry to achieve greater fragmentation detail: the first scan provides a 
general idea of what is in the sample, and the second selectively filters and fragments the 
precursor or parent ions of interest based on their m/z ratios. One might assume that it is 
always preferable to use the highest resolution and mass accuracy possible for analyzing 
every scan (both the precursor MS scans and following MS/MS scans), or at least to use 
the same type of analyzer for both, but it is becoming increasingly popular to use hybrid 
instruments that have quadrupole and TOF analyzers, or two different types of ion traps. 
In fact, using high mass accuracy for the precursor ion and low mass accuracy for the 
fragment ions from linear ion trap-Orbitrap instruments (LTQ-Orbitrap) is a widely 
applied instrumental configuration. Because low-resolution scans are much faster than 
high-resolution, the “high-low” strategy afforded by these instruments can increase the 
overall identification and quantification of peptides over “high-high” strategies. Aside 
from the sacrifice in resolution using LTQ for fragmentation, small fragment ions (~ 30% 
of the precursor ion mass) are typically difficult to detect. However, in the newer LTQ-
Orbitrap instruments, precursor ions can be dissociated in different compartments: within 
the linear ion trap, or in a “high energy” octopole collision cell. Whereas ion activation is 
usually performed in the linear ion trap, the new addition of an octopole collision cell 
allows an additional activation technique of higher energy to fragment ions in the far side 
of the instrument and then transfer them back to the C-trap for analysis.  
Even these new high-performance instruments cannot measure all peptides presented to 
the mass spectrometer. Data-dependent settings are needed to handle the hundreds of co-
eluting peptides so that the MS can make “smarter,” more-informed decisions about 
which analytes should be targeted for MS-sequencing. For example, it would not be a 
good use of MS time to repeat analyses of the same ions over and over again. Therefore, 
once a precursor ion is selected for sequencing, its m/z value is put on a dynamic 
exclusion list. If an ion is on this list, it will not be selected for fragmentation, at least for 
a specified period of time during the LC run. This enables the MS to measure ions across 
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a wider abundance range rather than constantly resampling the most abundant ions. 
Typical settings require an ion to stay on this list for 1 minute before it is automatically 
taken off and allowed to be considered for selection. Alternatively, a maximum list size 
can be specified in which case, if a sufficient number of ions have been added to the 
exclusion list, ions are popped off the list in first-in, last-out order until the list size meets 
the size requirements.  
 
Another variable in setting the dynamic exclusion list is to also parameterize the isolation 
window to determine whether two ions are essentially the same. Depending on the 
analyzer, one may be able to resolve a difference of 0.001 Da or 0.01 Da. Therefore, 
setting an isolation window involves a tradeoff between specificity and sensitivity. It is 
advantageous to have a wide isolation window to go through as many species as possible 
(maximizing sensitivity), but if the window dimensions are small enough to allow two 
peptides, the fragmentation spectra will be very messy and difficult to assign. 
1.2.3. Ion Activation & MS/MS Fragmentation 
 
One of the more popular forms of fragmentation, collision-induced dissociation (CID, or 
collision-activated dissociation, CAD), uses energetic collisions to cause an immediate, 
single fragmentation. Briefly, the precursor ions selected in the MS1 phase are 
accelerated by electrostatic pulses and forced to collide with a large neutral target gas, 
such as helium or argon. When the precursor ions hit these curtain gasses, the weakest 
bond in the peptide breaks and creates smaller, fragmented ions. The amount of energy 
transferred is a function of the energy of the ion (Eion), the mass of the collision gas 
(mgas), and the mass of the ion (mion). For a single collision, the center of mass collision 
energy (Ecom) is represented by the following equation: 
 
Ecom = Eion × (mgas / (mgas + mion)) 
 
As Ecom increases, the number of fragmentations increases because the internal ion energy 
increases. These spectra created by peptide fragments are usually visualized by plotting 
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each ion’s mass-to-charge ratio (m/z; x-axis) against the relative ion intensity (y-axis) 
62
(Figure 1.3). 
 
For protein analysis, one can expect MS/MS fragmentation to break peptides in 
predictable ways. In fact, there are a limited number of types of ions that one would 
expect to see. A common nomenclature for the types of ions from peptide fragmentation 
is described below (Figure 1.4).  
 
The notation of an a, b, or c ion indicates that during the cleavage, the charge was on the 
fragment with the N-terminus. Conversely, the notation of an x, y, or z ion indicates that 
the charge was on the fragment with the C-terminus. The most common types of ions, b 
and y, represent a cleavage between the carboxyl and amide group. For each amino acid 
at position i within a peptide sequence of length L, the N-terminus ions can be thought of 
having a relationship with a paired C-terminus ion using the equation:  
 
C(i) = L + 1 – N(i) 
 
where N(i) represents the position of the N-terminus ion, defined by N(i) = i, and C(i) is 
the complementary C-terminus ion for a given amino acid position i. 
 
Depending on the type of fragmentation method used, one is more likely to see different 
types of N- or C-terminus ions. 
 
The mass difference between each peptide’s adjacent fragment ions represents a single 
amino acid, so one could manually take the differences between all of the peaks in the 
MS/MS scan, compare the mass differences to the masses of amino acids, and stitch the 
peptide sequence back together. Some complications in this process may arise due to the 
presence of different ion types, or additional peaks that represent noise or chemical 
additions that are not from the peptide fragmentation. Several computational algorithms 
have been developed to avoid these noise peaks and determine the best peptide-spectrum 
match (PSM).  
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Chromatogram 
 
 
 
 
 
Survey Scan (MS1) 
 
 
 
 
 
 
Fragmentation Scan (MS/MS) 
 
 
 
Figure 1.3. Illustration of data collected in a tandem mass spectrometry run. 
(A) The chromatogram reflects the separation of peptides by liquid chromatography, 
graphing the total collected intensity (TIC; y-axis) by time (minutes; x-axis). (B) The 
survey scan details which individual ions (m/z values) are observed. Their most abundant 
peaks are selected for fragmentation (MS/MS). (C) The fragment ions in an MS/MS scan 
can be used to sequence the peptide. 
(A) 
(B) 
(C) 
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Figure 1.4. Illustration of collision induced fragmentation of a polypeptide. 
A peptide backbone with four amino acid residues (R) and the types of fragment ions generated in a CID MS/MS spectrum. If the 
charge is retained on the N-terminal side, the fragment ion is classified as either a, b, or c. If the charge is retained on the C-
terminal side, the ion type is x, y, or z.  
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To aid in this process, most algorithms do not work from spectral information to infer peptide 
sequences, but actually work in the opposite order. That is, because peptides fragment in 
predictable ways, in silico fragmentation can generate the ion series that is expected to be 
found in the MS/MS spectra from each peptide sequence. In CID, peptides generally 
fragment along the peptide bonds (as opposed to backbone bond cleavages) to generate b and 
y ions. Figure 1.5 illustrates the b and y ion series predicted from the peptide sequence and 
which peaks in the spectra correspond to the expected m/z values, thus contributing to the 
peptide’s identification.  
 
Energetic collisions often cleave off amino acids’ post-translational modifications, so one 
would not typically expect to see the addition of a phosphoryl group in the masses of the ions 
generated from CID. This “invisibility” of modifications is not strictly true for electron 
transfer dissociation (ETD or electron capture dissociation, ECD). ETD is similar in concept 
to CID except that it typically causes more cleavages than CID and different backbone 
cleavages. It requires low energy electrons and long reaction times, fragmenting at the most 
labile bonds. Because of the low-energy added, modifications typically stay on the amino 
acids so one can expect to see their addition to the m/z values for the ions. For example, if a 
peptide had a phosphorylated serine, one would expect the masses of the ETD ions that 
include the modified residue to be shifted at least the mass of a phosphorylation (79.979 Da), 
and thus greater than the corresponding ions CID would generate for the same peptide. 
However, even for unmodified peptides, one might not expect to see the same types of ions 
present for CID and ETD fragmentations. Whereas CID favors b and y ions, ETD more 
commonly produces c and z ions for certain peptides. Thus, the two techniques are 
complementary to each other. In fact, recent studies have favored the implementation of a 
decision-tree instrument setting that makes a decision about which fragmentation technique 
to use for a particular MS scan based on the charge and m/z ratio of the ion, whether CID or 
ETD is most likely to yield a better distribution of ions. 
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b b(+2) 
   
y y(+2) 
187.087 94.047 1 W 15 1779.848 890.428 
288.134 144.571 2 T 14 1593.769 797.388 
359.171 180.089 3 A 13 1492.721 746.864 
472.255 236.631 4 L 12 1421.684 711.346 
529.277 265.142 5 G 11 1308.6 654.804 
660.317 330.662 6 M 10 1251.579 626.293 
773.401 387.204 7 L 9 1120.538 560.773 
870.454 435.731 8 P 8 1007.454 504.231 
1007.513 504.26 9 H 7 910.401 455.704 
1136.556 568.782 10 E 6 773.342 387.175 
1251.583 626.295 11 D 5 644.3 322.654 
1348.635 674.821 12 P 4 529.273 265.14 
1476.694 738.851 13 Q 3 432.22 216.614 
1605.737 803.372 14 E 2 304.162 152.584 
1761.838 881.422 15 R 1 175.119 88.063 
 
Figure 1.5. A peptide-spectrum match. 
(A) Peptide WTALGMLPHEDPQER (+2) matches 24 peaks in the MS/MS spectrum. 
Observed peaks that match the peptide’s b and y ions are highlighted in purple and blue. 
(B) The observed m/z values from the spectrum that matched the expected m/z values for 
the peptide are listed in the table in bold. 
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The most recently adopted fragmentation technique, higher energy collision dissociation 
(HCD), is most noteworthy for overcoming the limitation of CID fragmentation known as 
the “one-third rule,” that is, the loss of mass ions less than 1/3 the parent ion mass. 
Whereas CID converts kinetic energy to internal, mostly vibrational energy that affect the 
weakest bonds, HCD uses a beam-type energy that results in fragment ions with higher 
levels of energy, allowing for not only more primary, but also secondary dissociation to 
occur. The increased energy also reduces rearrangement reactions and increases the 
reproducibility of HCD fragmentation spectra of the same peptide. Furthermore, HCD 
and CID differ in where they physically occur within the instrument. HCD activates ions 
in the collision cell at the far side of the instrument, requiring ions to pass through the C-
trap before they are analyzed by the orbitrap. In total, then, HCD is able to achieve high 
resolution and high accuracy for both the precursor and fragment scans. The tradeoff for 
these desirable figures of merit result in diminished sensitivity compared to CID as well 
as slower duty cycle. However, instruments that have this extra HCD collision cell also 
include a new device, termed an S-lens, that is touted to improve total ion current by 10-
fold, arguably minimizing the disadvantages to HCD fragmentation. In tandem mass 
spectrometry analyses using HCD for fragmentation, one could either send the ions to the 
orbitrap or LTQ for measurements. Detection of an LTQ measurement requires the ions 
to be accelerated towards the curved surface of a dynode cup which then directs the ions 
to an electron multiplier, which amplifies the signal so that the ion current leaving the 
detector is an amplified intensity or signal. On the other hand, detection of ions in an 
orbitrap involves a broadband image current detection and fast Fourier transformation 
algorithm, which converts the frequency of each orbiting ion into a m/z signal. Because 
the orbitrap is much closer, sending ions there would take a shorter transmission time and 
would most likely result in a higher yield, not to mention very high resolution (~100k) 
and highly accurate mass measurements (<1 part per million). However, the MS/MS 
scans themselves would be much slower than if the ions were sent to the LTQ. 
Depending on the goal of the experiment, one analytical strategy may be more 
appropriate than the other. 
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1.2.4. Spectral Interpretation 
 
Data from a mass spectrometer are generally very simple in their format: measurements 
are reported as x, y values indicating the m/z ratio and intensity value for each peak 
observed, whether it was for a precursor scan or MS/MS scan. Translating these results 
into peptide sequences is the researcher’s responsibility. For the past two decades, 
computer software has rescued researchers from tedious manual inspection of each 
collected spectrum, but much effort and debate has been put forward in order to reconcile 
simulating a person’s logic in deconvoluting spectra with computational modeling 
probabilistic expectations of likely measurements.
63, 64
  
 
One of the foremost recognitions that an interpreter must note is that calculations of an 
expected peptide mass must consider the isotopic abundances of each element within 
each amino acid. Within the periodic table of elements, the average mass is almost 
always represented. This means that it takes into consideration the distribution of all of 
the possible isotopes’ masses for each element. The average mass is somewhat limited to 
the calculations of “typical” relative abundances for the isotopes. Similarly, one may 
commonly find peptide masses are calculated as the sum of the monoisotopic masses of 
amino acids, using the most abundant isotopic mass for each element, but this, too, has 
limitations. When thousands to millions of ions are collected for a given amino acid, one 
must consider the distribution of isotopic abundances. In fact, the mass of a detected 
peptide may be up to a tenth of a Dalton off of the calculated, typical peptide mass.  
 
Another factor that complicates interpretation of spectra is the inclusion of noise peaks. 
Not every peak that is recorded in a MS/MS scan belongs to a peptide. Although 
abundant peaks in a fragmentation scan are more likely to be “true” ions compared to less 
abundant peaks, the sensitivity and specificity of the mass analyzer needs to be taken into 
account when defining the noise level.  
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1.3 Informatic Analogues of Analytical Processes in Shotgun 
Proteomic Studies 
 
1.3.1. Spectrum to Peptide Matching 
 
Each dissociation method fragments peptide sequences in a predictable way. If one 
knows the peptide sequence and charge state, all of the analyte’s possible fragment ions 
(m/z values) can be calculated. This property of fragment scans allows interpretation of a 
peptide from a spectrum by scoring how well a sequence’s expected list of m/z values 
align with the observed m/z peaks within the scan. The interpretation of a peptide from a 
spectrum is called a peptide-spectrum match (PSM). Although all PSM algorithms count 
how many observed m/z positions are within certain tolerances of the expected m/z’s, 
many algorithms also take into consideration one or more other spectral features, such as 
the intensities of the matching peaks, to score a PSM. Scoring the PSM has traditionally 
been assessed through static measurements, such as a score of 3 is always “good” on a 
scale where lower numbers indicate better matches. However, it is becoming increasingly 
popular to give dynamic scores that are accompanied by probabilistic likelihoods. Using 
these newer algorithms, the same score of a 3 may be “good” in one search and “bad” in 
another search because their respective probabilities indicate the scores are 5% and 25% 
likely due to error. How different computational tools calculate these scores is discussed 
later in Section 2.1.1, but commonalities between these algorithms are most 
fundamentally based on whether the algorithms implement a database search or de novo 
method. 
 
Database searching is one of the most popular methods for identifying peptide-derived 
MS/MS spectra, perhaps because the software provides answers that fall within a list of 
expected identifications. Database-searching algorithms operate on the assumption that 
the researcher has a complete list of all of the proteins expected to be present in the 
sample (e.g., a fasta file of protein sequences translated directly from the genome 
sequence of the organism or organisms). Each of the proteins within this list undergoes 
  32 
an in silico digestion to generate a completely list of possible peptides and each peptide 
in turn undergoes an in silico fragmentation to generate a theoretical, “expected” 
spectrum against which each spectrum within the collected dataset can be compared. 
Since this entire process heavily relies on the comprehensiveness of the input (given as a 
protein FASTA file), an ideal list of proteins would be based on a complete genome with 
reliable gene calls, including all potential alternative splice variants or isoforms, as well 
as the addition of all possible types of post-translational modifications (single and 
multiple) that could be found on expressed proteins. Including all of these biological 
intricacies can cause a huge expansion in the search space for finding potential peptide-
spectrum matches. This problem is only partially optimized by the implementation of a 
greedy algorithm that assumes the best short-term matches represent optimized long-term 
matches. There are a number of different scoring schemes with various parameters for 
thresholds, error rates, and other empirically-dependent metrics that provide additional 
suggestions for true identifications of peptides. Despite the number of possible ways one 
can arrive at the “true” identification of a peptide, database searching cannot identify all 
possible peptides from a tandem mass spectrum. The primary advantage of database 
searching also serves as its greatest disadvantage: one needs to know what he is looking 
for before performing a search. In other words, if the scientist does not make the 
searching software “aware” of all potential methylations, truncations, adducts, and other 
such biological contributors to shifts of masses, the software will not even consider those 
as possible sequences. In addition, the researcher is responsible for setting appropriate 
parameters for significant signal to noise ratios, standard deviations of analyzer 
resolutions, and other pertinent values to ensure that the scores returned by the peptide-
spectrum matches are calibrated correctly and do not exceed or underestimate the 
capabilities of the instrument. Although one would conclude that all possible known 
modifications or additions should be included in the search and that the filtering should 
be less stringent to ensure all observed masses correspond to a theoretical mass, one 
important caveat is that not only are such searches computationally expensive, larger 
search spaces can dramatically increase the likelihood of false positives (incorrect 
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identifications). Thus, only pertinent modifications with reasonably small allowances for 
error are generally included as search parameters. 
 
In response to the increasingly high-throughput of analytical technologies and informatics 
packages, a slightly different approach to database-searching has recently been proposed. 
Assuming that reproducible measurements are collected with very high mass accuracy 
and high precision, researchers have investigated the construction of spectral libraries as 
an optimization or alternative input to database-searching algorithms. Spectral libraries 
are collections of experimental data that have been confidently assigned to particular 
peptides within a proteome. It has been suggested that such spectra can take the place of 
the computationally-derived “expected” fragmentation spectra for all of the peptides 
observed in a proteome, ensuring a better, more realistic experimental-to-experimental 
comparison for scoring the newly generated datasets. Scores evaluating how well each 
spectrum from the spectral library matches against the experimentally observed spectrum 
still consider similar features (m/z fidelity, intensities, etc) as traditional peptide-spectrum 
matches, but additional meta-information can be easily acquired. For example, if the 
same database is to be queried repeatedly, the confident peptide-spectrum matches can be 
tracked and used both as diagnostic indicators of internal consistency in terms of 
instrument performance and sample quality as well as consistency of PSM assignments 
among the entire scientific community. These direct comparisons, of course, have a 
number of caveats, primarily involving the determination of whether the data is generated 
by the same types of experimental protocols for sample preparation, analytical strategies, 
and types of instruments. Another factor in evaluating identifications from spectral 
libraries is that one can only identify peptides that have been previously identified. 
Similar to deciding what proteins should be included in a database search, when 
considering if using a spectral library is appropriate, one must carefully consider whether 
the experiment could potentially provide evidence for sequences that were previously 
unsubstantiated or undetected. 
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De novo sequencing is a complementary method to database searching. This method 
requires finding a stretch of 3 or more amino acids described by the peaks in an MS/MS 
spectrum, and then submitting this sequence to BLAST to see whether the residue 
sequence matches any known proteins. The approach has merit when there is not any 
previous information available. Because it does not make any assumptions about the data, 
it can be helpful for identifying proteins that may not be in one’s database, either because 
of post-translational modifications or single nucleotide polymorphisms. Coupling de novo 
sequencing to database searching can greatly optimize the efficiency and accuracy of 
searches through the database alone. One can either use de novo sequencing before 
database searching in order to limit how many sequences the algorithm has to search or 
after database searching, when there are only a few unidentified sequences remaining. 
Alternatively, new hybrid methods of integrated de novo and database-searching 
approaches have been proposed as a compromise between achieving confident 
identifications and allowing for flexibility in discovering novel or unexpected variants 
and modifications.  
 
1.3.2. Peptide to Protein Mapping 
 
Interestingly, most shotgun proteomics analysis tools have separate peptide-spectrum 
matching software and protein inference programs. The peptide-spectrum matching 
algorithms generally output an exhaustive list of the top 5-10 candidate peptide sequences 
and charge states that could potentially have generated each MS2 spectrum. Then, a 
distinct program uses one or more scores to check whether any of the peptides pass a 
certain score threshold indicating a confident match, and then it determines which peptide 
candidate is the best and which protein identification(s) are inferred from the peptide 
sequence.  
 
In the most straightforward scenario, a single peptide suggests the identification of a 
single protein within the expected proteome. This unique identification is considered a 
confident piece of evidence, especially when compared to a shared or degenerate peptide, 
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which may map to multiple proteins. As Figure 1.6 illustrates, ambiguous protein 
inferences can cause discrepancies in reporting the number of proteins identified in a 
sample- should one report all proteins that have at least one detected peptide (maximal 
list) or should one only include those proteins that have at least one unique peptide 
(minimal list)? Some researchers among the scientific community have decided that it 
largely depends on the biological system in question. Especially for higher eukaryotes 
and microbial communities, the protein inference problem causes much controversy as 
neither of the proposed solutions is desirable. The maximal list may overinflate protein 
counts as well as complicate quantitative measurements, while the minimal list may 
under-represent protein identifications and result in throwing away more than half of 
quality peptide-spectrum matches.  
 
Nomenclature has been developed to qualify different levels of ambiguous protein 
inferences, primarily characterized by the number of unique or shared peptides 
contributing to a protein’s identification. Distinct proteins are those that are identified by 
only unique peptides, while differentiable proteins are those that are identified by both 
unique and shared peptides. The most ambiguous identifications, indistinguishable 
proteins, are identified by only shared peptides. More specifically, an equivalent protein 
is one that is identified by an identical group of shared peptides with another protein. As 
a subtle difference, a subset protein is one in which it is identified by peptides common to 
another set of peptides corresponding to a larger protein. A more extreme example, a 
subsumed protein is one that is identified by peptides that are subsets of two or more 
larger proteins. 
 
Depending on the software, a false discovery rate (FDR) is calculated at the peptide-
spectrum level or protein level and may also influence whether a peptide is assigned to a 
spectrum and whether the peptide is included in the protein call. Some of the most 
debated filtering criteria for compiling a final protein list include the minimal number of 
unique and/or non-unique peptides to substantiate a protein call and the minimal number 
of spectral counts to provide evidence for a protein.   
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Figure 1.6. Graphical illustration of the protein inference problem. 
Oftentimes a single peptide identification may map to multiple proteins, adding 
ambiguity to the final protein list. Proteins supported by unique peptide evidence, such as 
Proteins A, B, and E are considered more confident identifications. Because Protein D 
and E share a peptide and D does not have any unique peptides detected, we cannot be 
sure whether both D and E are present in the sample or just Protein E.  
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1.3.3. Differential Protein Expression 
 
Initially inspired by more traditional biochemical techniques, common analytical methods 
for comparing protein abundances involve collecting data on a known entity and 
systematically comparing its information to that generated by an unknown entity. The 
absolute quantification of each protein identified in a proteomics run can be calculated by 
normalizing its abundance to the measurement of a spiked internal standard, that is, a 
protein with known sequence and quantity added to a protein mixture. To calculate the 
most accurate comparisons, the selection of standard peptides should reflect the 
abundances as close to the sample peptides as possible (a 1:1 ratio). In the past several 
years, researchers have developed a number of high-throughput techniques to generate a 
standard peptide for every sample peptide, including methods that allow for multiplexing 
up to six or eight samples in a single run. Large scale chemical labeling techniques, such 
as AQUA,
65, 66
 TMT,
67
 iTRAQ,
68
 and iCAT,
69
 use stable isotope amino acids or add 
small isobaric tags to peptides so that the overall physiochemical responses of the labeled 
peptides mimic those of the sample peptides. In such methods, the only detectable 
difference between a standard peptide and a sample peptide’s elution profile, 
electrophoretic properties, and mass is a distinguishable increase in mass in the heavy 
isotope’s MS2 spectra. The two main disadvantages to these approaches are the unknown 
percentages of incomplete heavy amino acid replacements and the limited number of 
samples that can be compared in a single mass spectrometric run. An alternative group of 
isotopic labeling methods, metabolic labeling, requires the organisms to be grown in 
media with only heavy isotopes (such as 
15
N, 
18
O, and 
13
C) as well as grown in separate 
cultures of normal minimal media. While this process circumvents most of the 
shortcomings associated with chemical labeling methods, it is largely limited to use on 
organisms that can be cultured (i.e., bacteria and archaea). Mammals can be fed nutrients 
that have heavy 
13
C, but these SILAC methods
70
 are much less widely adopted. Common 
to all of the labeling methods is the addition of biologically cumbersome methods and 
expensive synthesis and/or incorporation of isotopically-labeled amino acids. Also 
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ubiquitous to each of the labeling methods is an underlying dependency on one or more 
metrics of protein abundance. 
 
Metrics of protein abundance are inherent characteristics associated with fragment scans 
or spectra measurements, including but not limited to tandem spectral counts, spectral 
intensities, peak area, and peak width. Spectral intensities are an intuitive measure of 
abundance but they may not fairly represent the peptide’s abundance because the 
fragmentation scan may not pick the spectra at the height of its eluting peak, especially if 
the peak is very wide and spans several consecutive scans. It therefore might be logical to 
determine peaks by their width, but it is sometimes difficult to determine where one peak 
ends and another begins, particularly if there are co-eluting peptides or high signal-to-
noise ratios. Peak widths would most likely also need to be normalized against peak 
height, because a peak that has low intensity but is very close to the noise-threshold may 
have the same area as that of a peak that is very intense but only is captured for a scan or 
two. Peak areas, then, are a popular combination of peak intensity and peak width, but 
their measurements suffer a common problem: peak identification and disambiguation. 
Another possible shortcoming to looking at peak shape is the effect of ion suppression. If 
an isotopic packet comes from a peptide that happens to ionize very well and co-elutes 
with precursor ions that do not ionize as well, the physiochemical properties of the 
dominant packet can mask or suppress the features of the secondary packets. Spectral 
count, the number of times a peptide is seen in a MS/MS scan, is less sensitive to these 
issues and has been one of the more commonly used metrics of protein abundance, 
primarily for its simple calculation and what it represents.  
 
One or more of these metrics can be used with or without the labeling methods. However, 
if relative abundance metrics are chosen, it is important to choose effective means of 
normalizing the measurements. Normalization is the process of standardizing 
measurements so that a comparison of measurements maintains biological and statistical 
integrity. Most important to the normalization process is having an idea of what to 
expect, i.e. the general type of distribution that the numbers follow. Typical 
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normalization methods account for the total assigned spectral counts within a run as well 
as eliminate biases of protein lengths. Such methods do not mean the adjusted 
measurements then follow a normal distribution, but once the log10 is taken of the 
normalized values, it is common practice to observe a normal distribution.  
 
Achieving a somewhat normal distribution is helpful for performing statistical tests of 
differential protein expression. Analysis of Variances (ANOVA) is the most powerful test 
that can discern whether two values are different given the context of their related 
measurements, but it assumes that the measurements are independent and taken from a 
normal distribution. ANOVA tests, therefore, are useful in comparing whether Protein A 
has a significantly different relative abundance value in Condition 1 compared to its 
relative abundance value in Condition 2. Those proteins that demonstrate evidence of 
significant differences are generally considered the most interesting and suggested as 
implicated in the cell’s response to the different biological conditions. One would expect 
that technical replicates may show minor discrepancies within an expected variance, but 
biological replicates are helpful in determining whether differences observed between 
samples are more likely attributable to biological or external factors. 
 
1.3.4. Functional Analysis and Data Visualization 
 
Throughout mass spectrometry experiments, visualizing the collected data is a helpful 
way to quickly perform quality checks, diagnose problems, and capture general behavior 
of the measurements. In fact, software plays a key role in calibrating the instruments, 
ensuring that they are running properly as scans are collected, and interpreting the results. 
When validating a peptide-spectrum match, researchers often find it useful to visualize 
the matched peaks within the scan as a bar chart of m/z ratios graphed by their relative 
intensities. Similarly, when looking for evidence of a protein identification based on 
peptide calls, overlaying the peptide sequences on top of the amino acids belonging to the 
protein provides a more easily comprehensible understanding of sequence coverage than 
a mere percentage. More importantly, after a list of proteins have been identified from a 
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sample, it is common to investigate the functions of the proteins and determine whether 
any noticeable trends or anomalies stand out. While a list of protein names might not be 
particularly informative to a researcher, a report or graph summarizing the presence, 
absence, or change in abundance of a group of proteins may be more meaningful and 
reinforce confidence in the significance of the findings. Differential protein expression is 
typically depicted as a heat map colored on a dichromatic scale to represent relatively 
high and low expression levels within the collected samples. Hierarchical clustering of 
the proteins arranges the identifications in blocks of identifications that have similar 
trends of abundance so that one can visually track the magnitude and agreement of the 
variations in measurements. Upon inspection of clustered proteins that have similar 
behaviors in abundances, researchers generally inquire as to the functional categories (as 
defined by euKarytoic Orthologous Groups, KOG or Clusters of Orthologous Groups, 
COG) or pathways common to a subset of proteins. This functional analysis is typically 
illustrated as a bar chart graphing normalized abundances per category or as a super-
imposed KEGG (Kyoto Encyclopedia of Genes and Genomes) map of identifications 
within metabolic and regulatory pathways.  
 
1.4 Conclusions 
 
With the rising popularity of mass spectrometry for proteomic studies and the general 
interest in “omic” and other large-scale endeavors, there are ever-increasing needs for 
scientists who handle data in a way that is consistent with the current understanding of 
the biological system of interest, understand the biases and advantages of the analytical 
measurements, and the apply or develop the informatics components that transform 
measurements into value. There are, however, numerous tools available for each of the 
main informatics processes critical to mass spectrometry interpretation, each asserting 
that their method identifies limitations in a previous study and their new project performs 
comparably or overcomes these hurdles. Critical evaluation of existing tools that attempt 
to solve the same or similar problem is an absolutely necessary step in the development 
or integration of any bioinformatic workflow. Therefore, while keeping in mind that there 
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are computational bottlenecks in the existing informatic analyses, this dissertation 
attempts to survey the current state of the field and identify where there are areas for 
improvement or adding novel features, with particular focus on methods that match 
peptides to scans, infer protein identifications, and quantify relative protein abundances.  
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CHAPTER 2:  Current Tools & Workflows Employed for Analysis 
of Large-Scale Shotgun Proteomics Experiments 
2.1 Evaluation of Existing Proteomic Informatic Tools and 
Approaches 
 
2.1.1. Database Searching Algorithms 
 
Most current tools in use today can trace their ancestries to software written 10-15 years 
ago, but they have adopted new computational strategies, analytical philosophies, and 
interpretational considerations. Before using a new software package, it is important to 
have not only a fundamental understanding of the new features it affords, but also an 
appreciation of the differences with respect to its precursor. The following discussion 
briefly highlights similarities and differences between 2 workflows currently employed 
by our lab: SEQUEST
63
 (v 0.27) and DTASelect
71
 (v1.9) compared to Myrimatch
72
 
(v2.1) and IDPicker
73
 (v3.463). 
 
SEQUEST is one of the most popular choices for database searching algorithms, not only 
because it was one of the first tools to match raw spectra to peptide sequences, but also 
because it has inspired a number of adaptations and optimizations. The original 
SEQUEST algorithm was written by Jimmy Eng, Ashley McCormack, and John Yates in 
1994. It is comprised of 4 major steps: data reduction, search method, scoring method, 
and cross-correlation analysis (Figure 2.1). 
 
SEQUEST’s data reduction step involves retaining only the 200 most abundant ions in 
each scan (ranked by intensity) and renormalizing their intensities to 100. All peaks 
within +/-1 Da window are equalized to the intensity of the higher value, and peaks that 
fall within 10 Da of the precursor ion are removed. 
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Figure 2.1. Primary methods of SEQUEST and Myrimatch for generating the peptide-
spectrum  matches (PSMs). 
 (A) SEQUEST scores PSMs by comparing the m/z ratios of theoretical spectra generated 
from all possible peptides in the proteome. (B) Myrimatch scores PSMs by calculating 
the probabilities of observed m/z ratios and their intensities matching a peptide’s 
expected m/z ratios and their intensities.  
(B) 
(A) 
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The search method within SEQUEST involves scanning each protein sequence in the 
given fasta file and finding all combinations of consecutive amino acids that fall within 
the observed mass range of the precursor. Then, the program predicts the mass-to-charge 
ratio values of b and y series ions for the candidate list of peptides. Any chemical 
modifications to amino acids that were specified in the search parameters can be 
specified as “static,” that is, they are assumed to affect every occurrence in the sequence, 
or “dynamic,” indicating that the algorithm should test the fit of the amino acid with and 
without the modification. These mass shifts are taken into consideration for the b and y 
ion calculations. Additional parameters can be specified in the required sequest.params 
configuration file. 
 
When computing the scoring method, SEQUEST first renormalizes each spectrum’s 
observed peaks into 3 intensity classes based on how well they match the predicted b and 
y ions: “Class A”: observed peaks matching b and y ions; “Class B”: observed peaks 
matching +/- 1 Da of b and y ions; “Class C”: observed peaks that match to a neutral ion 
loss of water and ammonia and a ions. The number of class A and B ions are summed 
and additional weight is given for consecutive fragment ions and immonium ions. This 
preliminary score (Sp) provides a quick preview of peptide-spectrum match scores, but 
has biases towards longer peptides. 
 
SEQUEST then employs a cross-correlation analysis score to compare the top 500 
candidate amino acid sequences with a reconstructed (theoretical) spectrum based on the 
m/z ratios of predicted b and y ion series, and relative intensities are assigned one of three 
intensity values using the classes described above. (Class A ions are predicted to be twice 
as intense as Class B ions, and Class B ions are predicted to be 2.5 times as intense as 
Class C ions.) The correlation score (Cn, more commonly called xcorr) is an average 
distance of differences between the observed and reconstructed spectra. To accommodate 
for the increased number of ions expected to be produced by sequences with higher 
charge states (and therefore more opportunities for deviations from theoretical spectra), 
there are different standard thresholds for what is considered a “good” score based on the 
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sequence’s charge state. Typically, we accept xcorr values > 1.8 for +1 sequences, > 2.5 
for +2 sequences, and >3.5 for +3 sequences. The scoring thresholds are higher as the 
charge state increases in order to reflect the additional numbers of fragment peaks 
generated by multiply charged ions, which should act as supporting evidence for the 
peptide identification. An additional score, the deltCN, is the difference between the 2 
highest xcorr values within a spectrum, and gives an indication of how well SEQUEST 
could distinguish the top peptide-spectrum match compared to the second-best peptide-
spectrum match.  
 
The output from SEQUEST, sqt files, records all of the top 500 candidate sequences, 
their xcorrs, and the deltCN for each spectrum. Typical SEQUEST v0.27 searches take 3-
4 hours for microbial isolates, 7-10 hours for complex eukaryotes like plants, and 2 
weeks to a few months for metaproteome databases even on large clusters. One of the 
primary drawbacks to this software is the intense input and output requirements for each 
search. After each spectrum is compared to all of the peptides within the database, a 
small temporary file is created, which is only deleted once all spectra have been searched 
and aggregated into a single output file. Later versions of the software, including the 
similar algorithms that have since been developed based on the same underlying 
principles but with modern optimizations to improve speed and accuracy, are indeed 
consistently faster. Many labs today rely on the improved algorithmic and software 
engineering techniques found in TurboSequest, Crux, and Tide for high throughput, 
large-scale proteomic studies. 
 
Over the years, SEQUEST and its accompanying protein assembly software, DTASelect, 
have inspired many suites of novel algorithms and software packages. New software is 
being constantly developed to keep pace with the evolving metrics of instrument 
capabilities, including improvements in their precision, accuracy, and throughput. One 
such set of tools, Myrimatch and IDPicker, facilitates rapid protein identification in a 
seamless workflow of database searching and filtering processes. Written 5 years ago by 
David Tabb, Christopher Fernando, and Matthew Chambers, Myrimatch is a database 
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searching algorithm that primarily differs from SEQUEST’s analysis by including a 
probabilistic measurement for each peptide-spectrum match (PSM) and thus allowing a 
more dynamic scoring platform in which each PSM is considered independently and with 
respect to random chance. It is comprised of 3 major steps: data reduction, search 
method, and scoring method (Figure 2.1). 
 
The data reduction step involves reading from mzML files (converted from RAW files) 
and retaining only the top X% of ions in each scan (ranked by intensity). This percentage 
can be defined by the user, but by default 98% of the TIC is kept. Additional peaks are 
removed that do not have the minimum number of peaks to fill each intensity class. 
Integral to Myrimatch’s functionality, the intensity classes are characterized by the 
number of peaks grouped into each class compared to the class below it. For example, 
under the default setting of three intensity classes, “Class A” peaks have half as many 
peaks as “Class B” peaks, which in turn has half as many peaks as “Class C” peaks. 
Under such circumstances, scans must have at least 7 peaks (1 A + 2 B + 4 C peaks) to be 
considered for sequence matching; otherwise, they are removed from the analysis. 
 
The search method incorporates a novel fragmentation model for defining b and y ions. 
While the series of b and y ions follow conventional calculations for singly and doubly 
charged sequences, triply charged sequences employ a different method. For each amino 
acid in a predicted peptide, a three-tiered weighting system is used based on the residue’s 
basicity (its ability to hold an extra proton). More specifically, Arginine, Histidine, and 
Lysine are given a weight of 5, Glutamine and Asparagine are given a weight of 3, and 
other residues are given a weight of 1. Depending on where the fragmentation occurs, the 
side of the peptide that has the larger summed score is given 2 protons and the other side 
is given a single charge. If the “duplicate spectra” option is selected, Myrimatch will 
attempt to assign a sequence with a +2 and +3 charge if it cannot determine the charge 
state of the scan and both sequences will be reported in the output. This is a rare 
occurrence in high mass accuracy data, but for LTQ searches, the option is strongly 
recommended. 
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The scoring method first involves calculating whether a predicted m/z peak falls within 
the expected fragment tolerance and then it determines the intensity class of the matched 
peak. If there are multiple peaks that fall within the fragment tolerance, the closest peak 
is chosen. The distance from the expected m/z and the intensity class is incorporated into 
an initial mzFidelity score. Once all of the peaks are matched for a peptide, the number of 
missing peaks and the number of expected peaks for each intensity class are calculated 
for the PSM. These numbers are then used in a probability calculation to determine how 
likely this match could happen by chance. Because there are probabilities associated with 
each intensity class, Myrimatch uses a multivariate hypergeometric distribution in the 
calculation of this mvh score. Whereas SEQUEST reported the top 500 candidates for 
each scan, Myrimatch ranks and reports the top 5 peptide hits for each scan based on the 
mvh score. To accommodate users who are accustomed to SEQUEST’s scoring, 
Myrimatch can also report its version of the xcorr for each PSM. 
 
One of the most attractive features of Myrimatch is its inclusion of many parameters that 
the user can define or choose to leave as the default configuration. The range of options 
available include different data reduction parameters (SpectrumListFilters, 
TicCutoffPercentage, MaxPeakCount), precursor and fragment scan filtering criteria 
(AvgPrecursorMzTolerance, MonoPrecursorMzTolerance, and FragmentMzTolerance), 
fragmentation settings (FragmentationRule, FragmentationAutoRule), modification 
considerations (MaxDynamicMods, DynamicMods, StaticMods), digestion information 
(CleavageRules, MaxMissedCleavages, MinPeptideLength, MaxPeptideLength), and 
many more. Some of the unique settings that are helpful but also confusing to those 
unfamiliar with the algorithm are the “PrecursorMzToleranceRule” and the 
“UseSmartPlusThreeModel” option. The PrecursorMzToleranceRule option is an 
acknowledgement that sometimes the mass spectrometer will pick the wrong isotope as 
the monoisotope of an eluting peptide (exacerbated in our new data-dependent settings). 
When using narrow tolerances for monoisotopic precursors, this can cause identifiable 
spectra to be missed. Myrimatch can be instructed to adjust the observed precursor m/z to 
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the expected monoisotopic precursor m/z. Additionally, Myrimatch can customize the 
number of fragment ions compared to each candidate peptide within the database using 
the Smart Plus Three Model. In most search algorithms, each peptide sequence of the 
same length generate the same number of fragment ions: a sequence of 10 amino acids 
will always have theoretical +1 y5, +2 y5, +1 b5, and +2 b5 ions. However, Myrimatch 
gives the user the option of interrogating the amino acid composition of the sequence and 
by retrieving the number and position of basic residues (those likely to carry a charge), 
the expected fragment ions can be generated in a sequence-specific manner. Parameters 
like this highlight how many algorithms can be developed on the same basic principles 
but additional nuances afforded by each program can provide valuable contributions to 
advance specific projects. 
 
A myriad of other protein identification software exists, but most of the more recently 
developed tools are incorporating probabilities at one or more of the PSM, peptide, or 
protein levels. Many of these, like PeptideProphet
74
 and ProteinProphet,
75
 build on 
SEQUEST scores to compute probabilities and error rates for each identification. 
PeptideProphet, software developed by Keller in 2002, also uses a SEQUEST xcorr score 
and deltCN score, peptide length, the logarithm of rank of Sp score and mass accuracy, to 
calculate a Bayesian posterior probability for each peptide identification, which is 
combined and re-evaluated at the protein level within ProteinProphet. Others, like 
Mascot,
76
 OMSSA,
77
 and X!Tandem,
78
 use their own PSM scores to compute 
probabilities and e-values. Some emerging algorithms are even specifically tailored to 
analyze labeling methods, such as Sipros’ identification of peptide sequences and 
estimation of 15N atom% from stable isotope probing methods.
79
 Studies have shown 
that direct comparisons of different algorithms chosen for peptide and protein 
identification consistently demonstrate ~ 70-80% overlap in the results for a given 
dataset.  
 
Although database-searching algorithms are extremely useful in identifying expected 
peptide sequences from a dataset, many of the more recent studies are challenging the 
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primary prerequisite (namely, that one has a comprehensive list of expected protein 
sequences). Whether the problem is due to a static reference proteome used to analyze a 
dataset collected from a slightly different genus, or the proteome does not include all 
possible single amino acid polymorphisms or isoforms, or the list of expected post-
translational modifications is ill-defined, there is an increasing need for sequencing 
proteins whose exact sequence and mass may not be known. Only recently have 
instrument resolutions and computational resources been able to achieve exhaustive 
database searching for amino acid mutations.
80
 With a peptide-sequence tagging 
approach, such as that afforded by the combination of DirectTag
81
 and TagRecon,
82
 one 
can exploit many of the advantages of database searching algorithms while also 
incorporating a degree of flexibility in order to identify unanticipated sequence variants.  
 
DirectTag is a tool that infers partial sequences (“tags” that are typically 3 amino acids 
long) from 4 peaks within a spectrum that match a peptide’s expected consecutive ion 
series. For each collected spectrum, these tags are scored based on intensity, m/z fidelity, 
and complementarity, and each subscore is converted to a p-value. The intensity subscore 
is a sum of the ranks of the 4 matching ions among all the spectrum’s observed ions 
sorted by intensity, and its associated p-value denotes whether their summed rank is 
representative of the entire spectrum. On the other hand, the m/z fidelity score is a 
summed square error (SSE) of the 4 estimates of m/z values for the first amino acid in the 
tag, inferred from the position of each of the other matching peaks. The p-value 
associated with this score conveys the probability of the SSE occurring by chance. The 
last subscore, complementarity, has two components that factor into its p-value: one to 
account for the number of peaks in the spectrum that are complementary (paired b and y 
ions), and the second to account for the agreement of the peptide mass estimated by the 
complementary peaks. For each tag in each spectrum, Fisher’s Method is used to 
combine the p-values from the 3 subscores. Multiplying each joint p-value by the number 
of tags matched with each spectrum yields an “expectation value” metric that can be used 
to filter high-ranking, quality tag matches. These tags can then be input into another 
software tool, TagRecon, which uses the tags as a scaffold to infer longer peptide 
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sequences that may contain up to one or two amino acid mutations or mass shift 
modifications.  
 
TagRecon, software designed to enhance peptide-sequence matches by allowing the 
comparison of specific or best-fit mass shifts to account for mutations or post-
translational modifications of proteins within the expected proteome. Using the tags 
created by DirecTag as input, TagRecon compiles a list of extended “flanking” sequences 
around each tag and compares whether the calculated masses of the flanking sequence 
matches can be explained within the spectrum. The comparison between the flanking 
sequence and the rest of the spectrum can be allowed up to one or two mass mismatches. 
If the researcher anticipates oxidations on methionine residues, for example, a flanking 
peptide sequence that contains a methionine may try to match a spectrum using a mass 
shift (+16 Da) on the methionine and its downstream amino acids. If the researcher is 
interested in mutation analysis, the BLOSUM62 matrix is used to determine which amino 
acid substitutions are permitted in reconciling the mass mismatches. Parameters similar to 
Myrimatch’s scoring criteria are used to determine the best peptide-spectrum match. 
 
Compared to other mutation and modification identification software, TagRecon provides 
a fast, flexible platform for confidently identifying peptides that have mass shifts altering 
their expected mass based on a static proteome. Despite the advantages afforded by 
TagRecon, localizing mass shifts, constraining the number and type of expected mass 
shifts, and evaluating the biological interpretation of its results are still challenges that 
have yet to be conclusively resolved. Filtering these results and finding an appropriate 
false discovery rate and/or false positive rate for each of the identifications is an 
especially difficult but important hurdle to overcome before confidently identifying 
modified or unmodified peptide sequences. 
2.1.2. Filtering Criteria and FDR Calculations 
 
The standardization of datasets using False Positive Rates (FPRs) and False Discovery 
Rates (FDRs) are a hot topic of debate among mass spectrometrists. False Positive Rate 
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(FPR) is a property of an individual spectrum as opposed to the False Discovery Rate 
(FDR), the property of multiple spectra. More specifically, FDR is the proportion of 
incorrect identifications among all identifications judged correct.  
 
 
FDRs have many advantages and are the most pervasive form of reporting the quality of 
a filtered dataset. Typically, an FDR is calculated at the protein level, although it may 
also be reported for peptides as well. When a database-searching algorithm is adopted, it 
is common practice to append a decoy database to the list of possible identifications. The 
FDR is calculated by multiplying the number of identifications from the decoy database 
times 2 and dividing by the total number of identifications. Doubling the counts of decoy 
identifications assumes that the numbers of unidentified false positives (those that were 
identified as target identifications, but are not real) are as likely as the number of known 
false positives.  
 
Ideally, this decoy database should resemble the target protein identifications as closely 
as possible so as to measure the selectivity of an algorithm as it makes peptide-spectrum 
matches (PSM). This approach assumes that each spectrum should be given an equal 
opportunity to match a target peptide and a decoy peptide so that a direct competition of 
their scores reflects not only how well the peptide sequence matches the spectrum, but 
also allows for the possibility of the PSM being a false positive. Previous studies have 
systematically explored whether it is most profitable for the decoy database to be 
comprised of shuffled sequences from the target database, reversed sequences of the 
target database, or sequences from the proteome of a completely different organism than 
the one under investigation. Proponents of a shuffled decoy database preserve the amino 
acid composition of the target database while simulating a random sequence by simply 
rearranging the order of the residues. More widely accepted, the reverse decoy databases 
not only maintain the composition of the target database but also the projected size of the 
contributing proteins. Oftentimes both of these decoy database strategies include 
additional distracting proteins or common contaminants, such as human keratin, BSA, or 
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trypsin, but including an entire separate proteome is not always deemed appropriate. 
While the additional proteome serves as a comparison of a true biological distribution of 
peptides, it is considered more likely that the different size and composition of the 
distracter proteome would introduce biases rather than providing truly equal chances of 
detecting target and decoy peptides. 
83-85
 
 
Most broadly, FDRs consider the context of the entire dataset; the entire collection of 
PSMs is taken into account when estimating an FDR. Not only do FDRs estimate 
observed false positives, but they make an effort to estimate hidden false positives as 
well. Practically, FDRs measure false positives according to the scoring algorithm, not a 
theoretical model, so the false positives are as specific to the dataset and method of 
identification as possible. If the target-decoy approach is executed correctly, overlap 
between target and decoy databases should be an exceedingly rare event. Therefore, a hit 
to the decoy database represents the error rate of the scoring algorithm regardless of the 
quality of the match. Whether the match was at the tail end of the likely distribution or 
near the average, all false positives are weighted the same. However, robust PSM scores 
can easily differentiate between decoy false positives and target peptides, even if they 
have equal likelihoods. Elias and Gygi demonstrated that the distributions of considered 
peptides were practically the same between target and decoy peptides, regardless of mass 
tolerance. Their study also provided evidence that top-ranked peptides showed a strong 
bias towards target database hits, unlike lower-ranked matches.
85
 Relatively high-scoring 
decoy searches rarely outscore correct identifications in composite databases so 
researchers will not be misled to set inappropriately high scoring criteria. Therefore, if a 
PSM passes an FDR threshold, attributes can be investigated to distinguish features of 
true identifications. 
 
Despite their widespread use, FDRs have many disadvantages as well. Antagonists to 
FDRs posit that assigning the same “blanket” FPR to a set of identifications with 
identical scores is a dangerous oversimplification since the scoring functions of existing 
MS/MS tools are not based on rigorous probabilistic models and are often inaccurate. In 
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addition, the target-decoy approach gains criticism for only looking at scores assigned by 
the search tool but not at the false positive rate of individual identifications. As such, it 
becomes possible for bogus identifications to be included in the results as long as the 
overall FDR among all identifications is acceptable. From a cynical perspective, scoring 
algorithms that identify few or no decoy hits (which seems like an analytically ideal 
situation) cause problems for FDR calculations, which assume equal likelihood of 
matching target and decoy peptides. For example, for a given spectrum, the number of 
matches between the spectrum and a typical decoy database of size n (where n is the 
same as the size of the target database) is usually zero. To obtain a reliable FPR for an 
individual spectrum, n could be increased to make a giant decoy database that is much 
larger than the target database, but this is impractical. Furthermore, FDRs are considered 
poor approximations of the non-exact solution. It is argued that a decoy database is 
simply a time-consuming way to evaluate the sum of all probabilities of a spectrum 
matching a random database over all spectra in the dataset, but not a good way to 
estimate individual probabilities. Given a database of all possible peptides with a certain 
length, it is possible to compute the precise number of the identified peptides and thus 
evaluate the error rate; however, the time required to search this entire database is 
unfeasible. One of the greatest proposed strengths of FDRs can also be considered a 
weakness: FDRs assume a virtual coin flip in the likelihood of a target or decoy 
identification. Ideally, the target-decoy approach assumes that the distribution of scores 
of incorrect identifications in the target database is the same as the distribution of scores 
in the decoy database, but in practice, a bogus peptide may get a higher score than a true 
peptide. Another principle that some consider advantageous and others find disconcerting 
is that FDRs are based on relative scores that are database-dependent. Searches against a 
composite target-decoy database yield relative scores that can differ from searches 
against separate target or decoy databases. Yet another prong that upsets dissenters of the 
target-decoy approach is that FDRs integrate raw and combined peptide scores. In other 
words, the algorithms make decisions using both raw PSM scores (like Xcorr) with other 
data-dependent information that takes into consideration the distribution of scores of all 
peptides in the database. To summarize, the aggregate measure of a blanket FDR is the 
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source of much controversy that some see as a beneficial, encompassing description and 
other see as a diluted approximation.
83, 84
 
 
Those who dismiss using a False Discovery Rate (FDR) propose that False Positive Rates 
(FPRs) based on peptide-spectrum match (PSM) probabilities have many preferable 
advantages. The most notable difference in this approach is that FPRs do not require 
decoy databases, so the entire debate about how to simulate random distracters is 
completely eliminated. Instead, raw scores generated by PSM-based algorithms typically 
rely on generator-like functions that assign probabilities of individual PSM matches. This 
principle of computing FPR probabilities for individual spectra is the second point of 
contention. FPR proponents assert that by accurately computing probabilities for the 
individual spectra, the validity of MS/MS “one-hit-wonders” (a single spectrum provides 
the sole evidence for a protein’s identification) is not a debate.86 The lack of support from 
other identifications is irrelevant in the FPR philosophy so if probabilities deem the 
PSMs to be unlikely by chance, these otherwise questionable pieces of information can 
be retained. Researchers advocating FPRs tout that an exhaustive set of potential matches 
can be calculated with their approach. By calculating the difference between the best de 
novo spectral interpretation and the best database spectral interpretation, a spectral energy 
score represents the quality of the match between the chosen peptide sequence against 
any other possible peptide. In an effort to assure FDR supporters that the FPR approach is 
not missing or misrepresenting information, researchers still estimate overall numbers of 
false positive hits within their search even without reporting actual false positive 
identifications. The spectral probability metric represents the total probability of all 
peptides with scores exceeding a given threshold. In a recent study comparing the target-
decoy and PSM probability approaches, the number of spectra that were matched in a 
search with a decoy database was very close to the expected number of matches 
computed by the generating function’s spectral probability. In closing remarks in his 
systematic comparison of the two approaches, Pevzner et al. demonstrated that their 
algorithm had better sensitivity-specificity than other algorithms’ combined scores, 
especially at very small error rates. 
83
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While FPRs contest the FDR approach, using FPRs also has its disadvantages. Some 
degree of ambiguity is usually associated with each peptide identification, but inspection 
of which PSMs are correct or incorrect usually does not consider the context of the PSM 
within the dataset. Thus, the dependence or independence of PSM identifications based 
on the other identifications in the dataset is the most fundamental point of debate between 
the two approaches. FDR advocates often find fault in FPR studies over-valuing their 
statistics because the touted accuracy of the calculated probabilities may not be preserved 
all the way to the extreme tails of the expected distribution of scores. As one researcher 
snidely observed against FPRs, “Theory is needed because simulations rarely cover the 
extreme tails of a distribution.” Additionally, while the FPR focuses on PSM-level 
probabilities, there is not provision for protein-level confidence values. On a final note of 
discrepancies between FPR and FDRs, some of the models used in estimating likelihoods 
for PSMs disagree or use different parameters according to the platform or expected 
distribution of false-positive matches, so the probabilities are not entirely absolute 
measurements. 
 
Also, measurements from mass spectrometry can only report what was detected, and it is 
dangerous to extrapolate that the absence of a peptide or protein identification means that 
it is not present in the sample. However, given an identification, metrics can be applied to 
describe the likelihood that it is the correct identification. For example, the detection limit 
is the smallest signal to noise ratio that can be differentiated at a given concentration. 
Identifications with high signal to noise ratios are more confident than those that are 
closer to random observations that could be due to chemical or instrumental noise. 
However, if a protein is only identified by a single peptide, regardless of its spectra’s 
signal-to-noise ratios, this protein identification is typically considered untrustworthy and 
removed from the analysis. Moreover, if a protein is not identified by any unique 
peptides, it is also considered ambiguous and typically filtered out of the analysis. One 
assumes that proteins with more spectra and more peptides are more likely to be the 
abundant proteins. The low abundant proteins, identified only by spectra that are close to 
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or under the signal-to-noise threshold, are commonly filtered out. When multiple runs are 
compared, there is increased variation caused by the lack of consistency in detection of 
low-abundant proteins. To improve the reproducibility of the reported results, the 
proteins with few spectra counts may be eliminated from the overall analyses. Pearson 
correlations can be used to measure the overall reproducibility of identified proteins 
between replicates and sample types. 
 
2.1.3. Protein Inference Approaches 
 
While SEQUEST is an effective tool for automated identification and scoring of peptide-
spectrum matches (PSMs), a complementary program is required to filter the results so 
that only “quality” PSMs are retained and mapped into the context of protein 
identifications. DTASelect,
71
 written by David Tabb, Jimmy Eng, and John Yates in 
2002, performs this function for SEQUEST outputs. DTASelect has 3 primary 
components: summarization, evaluation, and reporting. 
 
DTASelect’s summarization step first extracts the xcorr, deltCN, Sp rank, sequence, 
precursor m/z, protein name, intensity, and percentage of matched fragment ions for each 
PSM and sorts them by locus. If a peptide belongs to more than one protein, the PSM 
information is reported for each shared protein. This information is stored as a 
DTASelect.txt file so that it doesn’t need to be re-extracted each time a new filter is 
applied. The evaluation step in DTASelect applies the PSM-level and protein-level 
filtering criteria. The PSM-level filtering criteria keep PSMs that are above the charge-
specific thresholds (as described above). The protein-level criteria only retains proteins 
that have a sufficient number of different peptides (“-p 2” for 2-peptide/protein minimum 
or “-p 1” for 1-peptide/protein minimum). After filtering, the program stacks protein 
identifications that have the exact same sequence coverage for a group of peptides. The 
reporting step formats the filtered DTASelect file into an HTML file and allows for more 
interactive exploration. Typically we do not use the more advanced features of this part 
of the program except the plain text and html files. 
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After DTASelect, there are a number of additional manipulations that must be performed 
before a dataset is publication-ready. Some of these processes include ppm filtering, 
enforcement of protein evidence from a minimum of 2 peptides (at least 1 of which must 
be unique to the database), FDR calculations, and removal of redundant PSMs for more 
accurate spectral counts.  
 
Just as SEQUEST required DTASelect to refine its search results, Myrimatch’s 
complementary program is IDPicker. IDPicker,
87
 initially written in 2007, by Bing 
Zhang, Matthew Chambers, and David Tabb, is a GUI wrapper program that has 
undergone a number of changes since its first release. The latest (IDPicker v3.0) is a user-
friendly program that essentially incorporates 3 modules: FDR calculation (idpQonvert), 
protein assembly and filtering (IdpAssemble), and reporting (idpReportFDR). 
 
IDPicker’s PSM-level FDR calculation first extracts peptide, sequence, scan, and scoring 
information from Myrimatch output files (in .pepXML format). By comparing how many 
forward and reverse hits are allowed at each ranked PSM in the scan, the FDR is 
calculated for each PSM. PSM-level filters remove any scans that match below the user-
defined FDR level. Typically, 5% is the recommended maximum PSM-level FDR, 
although situations may warrant using 1% or 2% for additional confidence. The next step 
in IDPicker, protein assembly, involves first creating peptide groups and protein groups 
through a “minimal list” approach to parsimony. Peptide groups provide evidence for the 
exact same set of proteins and protein groups share the exact same set of observed 
peptides. User-defined PSM-level and protein-level filters are then applied. This includes 
minimum spectra per peptide, minimum spectra per match, maximum protein groups, 
maximum distinct peptides, minimum additional peptides, and minimum spectra per 
protein. In the context of IDPicker, a distinct peptide is a peptide that is not only unique 
to the database, but that also has a unique mass. In other words, charge states and 
modifications to unique sequences increase the number of distinct peptides. Additional 
peptides provide evidence for proteins that would not be identified if only distinct 
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peptides were required. For most cases, a protein level between 5 and 10% is acceptable. 
Also key to this protein assembly step is the formation of peptide groups, protein groups, 
and clusters. Peptide groups gather peptides that identify a common set of proteins, and 
protein groups include proteins whose peptide evidence all overlap. These groups 
therefore represent levels of ambiguity in both directions of protein inference. One 
property of these peptide and protein groups is that adding evidence from additional MS 
runs may change the constituents of the groups. Other researchers have suggested caution 
in relying on this type of clustering, citing that its volatility and data-dependence are not 
sufficiently biologically relevant for unaided interpretation.  
 
Finally, IDPicker’s reporting step basically transforms the filtered information into user-
friendly viewing panes for detailed exploration as well as facilitates exporting the 
information into Excel. IDPicker’s initial release had a number of limitations that have 
since been mitigated to a certain extent, but a few properties that are inherent to its design 
still remain contentious drawbacks. IDPicker was primarily designed to be a browsing 
tool for exploring individual information contributing to a spectral identification as well 
as a means of clustering identifications at the peptide and protein level, based on the 
which pieces of supporting evidence were shared between two peptides or proteins. In the 
early versions of the software, an HTML page was created for each protein so that one 
could open the main page of the project, choose filtering settings, and upon completion, 
click on a hyperlink on the protein’s name to see which proteins had similar information. 
Each of these HTML pages were re-created each time the user wanted to change the 
filtering settings, which took a fair amount of time. The layout also required a 
considerable number of mouse clicks in order to navigate around the dataset, with very 
little meta- information and limited spectrum-specific information. Newer versions of the 
software implement a sqlite database file that stores all of the identification information 
collected during the run, so that when the user is changing filtering settings, he is simply 
querying the database and generating a different report. The software has an option to 
export peptide, protein, or spectral level information to Excel, which helps users easily 
sort, transform, and summarize information. One of the remaining challenges of using 
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IDPicker for large-scale proteomic studies, however, is its dependence on a Windows-
based platform that demands user interaction. Although the GUI is user-friendly, it does 
not allow the researcher to filter or query a number of runs at a time. Therefore, for 
complex experimental designs, one is limited to running a single instance at a time and 
clicking through the settings to arrive at a filtered, summarized dataset. Another 
debatable feature of IDPicker is not a logistical problem, but an analytical restraint: 
IDPicker’s filtering and FDR calculations require the assignment of protein and peptide 
groups. IDPicker assigns proteins to a group if they share at least one peptide, which is 
beneficial for a researcher to have a perspective on the analytical overlap between 
identifications, but it does not necessarily reflect biological association. More detail about 
the implications of this feature is discussed in Chapter 4. 
 
Other software packages handle protein inference by reporting all possible proteins that 
could be identified, choosing one representative protein, or assigning a rank or 
probability to each protein identification. For example, ProteinProphet
75
 ranks proteins 
according to probabilities computed from the number of peptides, confidence in the 
peptide sequence, and degree to which proteins are shared between multiple proteins. 
DBParser,
88
 on the other hand, simply ranks proteins according to those with the most 
peptides. Yet another software, Phenyx,
89
 ranks proteins by the number of peptides 
identified and the protein sequence coverages, but chooses only one representative 
protein for shared peptides. Despite the abundance of these naming conventions and 
software solutions, there is yet consensus among researchers about a biologically-
meaningful compromise to unambiguously infer protein identifications from shared 
peptides. 
 
2.1.4. Differential Protein Expression Algorithms 
 
Among the advocates of label-free relative quantification, most prefer to use spectral 
counts for evaluating protein abundances. Most of the efforts in analyzing differential 
protein expression, then, have focused on significance tests for determining whether two 
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spectral count measurements for a protein are statistically different from each other. One 
of the primary premises of all of these statistical tests demands knowledge or estimation 
of an expected distribution of spectral counts within the dataset. Despite the widespread 
adoption of spectral counts as the metric of choice for these tests, there is a substantial 
disparity within the community about what kind of distribution spectral counts do and 
should follow, or whether Bayesian probabilities should estimate likelihoods rather than 
cumulative distribution functions. Consequently, the number of normalization methods 
attempting to adjust spectral count distributions is as numerous as the suggestions for 
statistically-robust measures for evaluating differences among values. Of the more 
noteworthy methods to date, the beta-binomial method, generalized linear mixed effects 
models, quasi-Poisson method, and normal distributions have been most commonly 
compared. 
 
In 2008, Choi et al from Nesiviskhi’s lab proposed the implementation of QSpec, 
90
quantitation software using spectral counting to measure protein expression differences 
between two datasets. From their perspective, one of the biggest disadvantages in 
previous quantitative efforts was that the statistics relied too heavily on signal-to-noise 
ratios to adjust spectral count distributions within a run, causing biases that favored large 
differences in highly abundant proteins. They assert that signal-to-noise methods lose 
power because they are performed on a per protein basis, rather than taking into account 
all of the proteins within a replicate. While they admit that most other algorithms focus 
on the highly abundant proteins because they are the most reproducibly present across 
replicates or across samples, a primary aim of QSpec is to include a model that is robust 
enough to handle the absence of replicate samples. In short, QSpec uses hierarchical 
Bayes estimation of generalized linear mixed effects model (GLMM) where the spectral 
counts are considered random numbers from a Poisson distribution, described by a large 
population of proteins (those identified within a replicate). Therefore, regression 
parameters are modeled for each protein as random effects, and if replicate information is 
available for the protein, the coefficients are “shared” by each instance of the protein so 
that intrasubject variation is preserved and consistent across the dataset. Random effects 
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are also contextualized by every sample and for every treatment or condition. Model 
parameters are estimated using a Markov chain Monte Carlo method, and the number of 
iterations can be specified by the researcher. In particular, the treatment term, which is 
described as a random variable from a Gaussian distribution with inverse gamma-
distributed variance parameters, is tested for significance, and if it is found not to be 
contributing to the description of the data, the model is “reduced.” For each protein, a 
significance test is performed to determine whether there is more evidence for the “full” 
or “reduced” model. Proteins that have more evidence for the full model are considered 
statistically differentially expressed.
90
 One of the primary disadvantages to this approach 
is that it requires pooling statistical information across all identified proteins. Another 
contentious decision is how they handle “missing” data: QSpec randomly generates a 
count from a Poisson distribution using its replicate’s mean. While this ensures that the 
protein will not be considered significantly different, its meaning is slightly different 
from a true-negative. 
 
Much like the debate between single aggregate descriptive metrics versus individual, 
specific scores as discussed in the context of False Discovery Rates and False Positive 
Rates (Section 2.1.4), a similar debate exists in the context of protein quantitation. In 
2009, Pham et al. proposed a beta-binomial method to describe spectral count data 
collected from label-free tandem mass spectrometry-based proteomics, citing their 
primary contribution as distinguishing between within- and between-sample variation.
91
 
Therefore, instead of pooling statistical information for each protein like QSpec, this 
software attempts to identify the variation resulting from the random sampling process of 
each biological sample and the variation of random biological samples in a sample group. 
The two types of variation are modeled by the beta-binomial distribution, in which the 
parameters to estimate within-sample variation (binomial distribution) and between-
sample variation (beta distribution) are based on a likelihood ratio test (G-test). Using the 
beta-binomial distribution, one can achieve comparable true detection rates of the 
differential expression of proteins when compared to the LPE test, t-test (with log-
transformed data), and the G-test,
91, 92
 as well as estimate a false positive rate, which is 
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not possible with the LPE or t-test. An important consideration, however, is the 
performance of the test with multiple replicates. The beta-binomial distribution can be 
used if there are one-replicate comparisons, but it outperforms QSpec and performs 
comparably with one-way ANOVA with multi-replicate experiments.
91
 
 
As a default option, most researchers prefer to use ANOVA as a test of significance in 
differential protein expression. Although many computational groups have suggested 
various other methods of testing label-free data (spectral counts in particular), ANOVA is 
a very straight-forward test that is not only well-understood, but it can be easily 
implemented through a variety of pre-existing software packages, including Excel, R, and 
Matlab. ANOVA tests whether the between-group variation of collected data overlaps 
with the expected variation within a group. ANOVA is therefore more powerful when 
replicates are available and more powerful when the collected data is comprised of 
independent measurements from a normal distribution. A log transformation of spectral 
counts can approximate a normal distribution, especially if the filtering criteria is high 
enough to retain only the most abundant (and therefore more reproducible) protein 
measurements. Setting the minimum spectral count and reproducibility too high may 
result in undesirably significant data loss. Currently there is no “gold standard” for 
determining which proteins pass an appropriate cutoff for identification purposes and 
whether an additional stringent filter needs to be used before quantifying proteins. Even if 
ANOVA is performed on a well-filtered dataset, the test considers a repeated 
measurement of 0 (no spectral counts) to be highly consistent as well as a repeated 
measurement of 3 to be highly consistent. A comparison of a protein that is consistently 
not detected in sample 1 and consistently detected as 100 spectral counts in sample 2 may 
not pass through filtering criteria that require a protein to be detected in each sample, 
eliminating this otherwise striking change in protein expression from the final report. 
Additional considerations are needed to ensure that the measure of protein abundance is 
in accord with the chosen normalization method as well as the filtering criteria employed 
to generate final datasets. 
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2.1.5. Toolboxes and Software Packages 
 
Concomitant with the rise in popularity with mass spectrometry for shotgun proteomic 
analysis and the continuous advances of instrumentation resolution, speed, and 
throughput, it is not surprising that the last two decades have witnessed an explosion of 
informatics tools to facilitate the researcher’s ability to aggregate, visualize, compare, and 
analyze the generated data. Many specific software tools have been generated to help 
model or predict information, such as outputting all possible peptides that could be 
generated from a protein subjected to a certain proteolytic enzyme, or calculating entire 
fragment ion series theoretically from a peptide sequence at a given charge state, or 
estimating the relative intensities of fragment ions generated by a peptide sequence. A 
common feature of most of such scripts is that they are generally designed for handling a 
single input at a time. Especially since most of these tools are web applications, it is 
sometimes difficult to find the tools as well as apply their calculations to an entire 
proteome, which is becoming an increasingly necessary step. Some websites, such as 
ExPasy
93
 and PROWL,
94
 contain links to many of these small tools developed 
exclusively for descriptive mass spectrometry questions. Notably, these tools do not 
attempt the computationally-intensive tasks of identifying and quantifying analytes 
measured within the experiments. Such processes are generally designed for personal 
desktops or, more recently, in cloud computing environments. In the past decade, there 
has been a major push to make this type of software user-friendly with graphics, selection 
boxes and drop-down menus, and configurable settings so that the peptide sequencing 
algorithms, protein assembly processing, and quantitative comparisons not only generate 
quality results, but also are easily understood and navigable. Many commercial software 
companies have spent a considerable amount of time and effort in creating a user 
experience designed to help the user feel more comfortable using the software as well as 
instill confidence in the results. A major deterrent to using such tools is the cost 
associated with purchasing a license as well as the proprietary algorithms that are not 
easily nor sometimes legally accessible. Other software that come from universities and 
research facilities tend to be more transparent, but other than typically having a less jazzy 
look and feel compared to the commercial software, they suffer from a major common 
  64 
issue: inconsistent file formats. These tools primarily arise out of meeting an immediate 
need within a mass spectrometry lab and are designed to work with their specific 
bioinformatics workflow. Oftentimes this means that they require obscure file formats or 
extracted information from more standardized data and the additional work to pipe one 
tool’s input to another’s output is not generally within the scope of time or skillset 
available to a typical researcher wanting to analyze his mass spectrometry results. There 
has therefore been a push to build large software packages, groups of tools that 
seamlessly communicate with each other and internally handle the integration of multiple 
informatic processes. Some desktop packages such as Bumbershoot offered by 
Vanderbilt University, include a number of options to perform the same task (peptide 
sequencing) using a variety of different approaches. Bumbershoot allows the user to run 
Myrimatch, DirectTag, TagRecon, and Pepitome in preparation for analysis by a 
complementary software package, IdPicker, which filters and assembles protein 
identifications. Other software packages, such as the TransProteomicPipeline (TPP),
95
 
have the option of downloading a desktop component that communicates with their web 
server or using their software in a cloud account. TPP contains a number of tools that 
perform various tasks along the informatics pipeline transforming raw data into 
biologically meaningful reports and displays. However, installing the desktop software is 
quite complicated and using cloud services requires registration and payment for storage 
space and compute time. Many other software bundles have been proposed but few offer 
transparent algorithms that can handle multiple large datasets and report information in 
an easily understandable, portable format. 
 
 
2.2 Challenges of Integrating and Developing Workflows for 
Analyzing Large Experimental Datasets 
 
2.2.1. Standardization of Data Formats 
 
The goal of proteomics is to identify and quantify proteins, but as data complexity 
increases, accurately determining high- and low-confidence identifications and high- and 
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low-abundant abundances becomes non-trivial. For the past decade, MS-analysis has 
been centrally-processed in a workflow with primary emphasis on converting raw 
instrumental data (*.RAW files) to summarized reports  (DTASelect files
1
) with basic 
spectral, peptide, and protein information. As new instruments collect approximately 
28,000 spectra per fraction and a typical run consists of 12 fractions, over 308,000 scans 
are collected for every MS run- which translates into approximately 10 GB. For a single 
experiment on the newer instruments, between 120,000 and 180,000 spectra are assigned. 
Some experiments have been known to incorporate up to 60 MS runs, resulting in a 
deluge of highly dimensional high mass accuracy raw data that requires matching to 
peptide sequences, mapping to protein sequences, filtering, quantification, and 
normalization before biological interpretation can begin.  
 
The Human Proteomics  Organization’s (HUPO) Proteomics Standard Initiative (PSI) is a 
group of researchers dedicated to standardizing data formats to improve cross-platform 
analyses, set standards of high quality data, and foster collaborations between 
institutions.
96
 Their organization is divided into three primary working groups: molecular 
interactions, mass spectrometry and proteomics informatics, and protein separations. 
Each year each working group hosts a meeting to discuss the emerging needs of the 
current technologies and experimental designs as well as evaluate how the existing data 
formats, controlled vocabularies, and responsibilities are faring. Currently, most of the 
recommended data formats are XML-compliant, ensuring a relational structure that can 
not only be easily enforced with strictly defined schema but also effectively compressed 
into manageable file sizes. Until 2008, PSI suggested that mzData and mzXML formats 
should be used to capture raw data generated by the instruments. Whereas mzData was 
intended to be more of an index file to aggregate and point to numerous types of raw file 
formats from instrument vendors and not intended to replace the original files, mzXML 
files were created to be used as open-source substitutes for the information stored in 
vendor files, which were locked in proprietary formats. While mzData format is now 
deprecated, mzXML is still in common use. However, PSI currently recommends mzML 
or TraML formats instead. mzML files are expected to be ubiquitous and applicable to all 
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mass spectrometry instrument configurations and experimental designs, although no 
vendor has yet released software supporting it. TraML is a more specifically-designed 
format, targeting selected reaction monitoring (SRM) experiments. Both of these data 
formats contain scanning information to be used as inputs to search algorithms, which 
are, in turn, recommended to output mzIdentML files. mzIdentML files are expected to 
report MS scans, their MS/MS scans, the peptide sequences matching the MS/MS scans, 
and peptide-spectrum match (PSM) scores. These files do not contain all of the original 
peak data, but they have the structure in place to allow for matching fragment peaks to 
supplement each PSM score. For software that does not generate mzIdentML files by 
default, there is free software available to convert the other formats, such as dtaselect 
(from SEQUEST) or pepXML (from Myrimatch or MASCOT). Notably, the mzIdentML 
file format is not the last stage of the post-processing analysis. There is yet another step 
of filtering PSMs, assembling peptides into proteins, and quantifying abundances. For 
such processed information, PSI is currently working on finishing mzQuantML. 
However, mzQuantML has yet to be widely adopted, most likely due to the numerous 
differences on the standard procedure for filtering, assembling, and quantifying proteins.  
 
2.2.2. Impediments to Integrating Systems Biology Data 
 
As technologies continue to improve in quality, throughput, and specialization, propelling 
the pursuit of scientific knowledge into new frontiers, it is not surprising that the newly 
acquired information does not immediately suggest clear-cut mathematical models, 
completely agree with all existing theories, or self-organize in a way that can easily be 
documented, stored, and accessed. In fact, there are three main impediments to 
integrating systems biology data. First, with each new discovery and accumulation of 
information, assimilation of theories, and unexpected breakthrough, the meaning and 
context of scientific ideas keep changing. Some of these revelations are truly 
revolutionary while others take a while to refine, become accepted, and incorporated into 
our understanding of how things work. Secondly, the progression of science requires 
work to provide context and details. A single discovery cannot stand on its own, but once 
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it has been recognized and adopted, the scientific community has to work together to 
understand the meaning and implications behind the discovery. Even from a purely 
technical point of view, the effort in integrating multiple analyses, services, storing 
information in a way that not only makes sense with the current architecture, but is 
amenable to extraction and adaptation in anticipation of future expansion. The 
instrumentation, file formats, and data recorded keeps changing faster than people can 
accommodate. Thirdly, people are motivated to further scientific research by a number of 
different drivers, including funding opportunities reward systems, popular science topics, 
or personal interests. Most of this work requires extensive collaborations across 
disciplines, institutions, and cultures, and figuring out how to seamlessly coordinate with 
others can be a challenge in itself. With the rise of the internet and cloud infrastructures 
improving data accessibility, computing resources, and methods of communication, some 
of these hurdles are easier to overcome than others. As we continue to move forward, it is 
becoming ever more important for computational biologists to keep analyzing data in its 
proper, albeit dynamic context and implement modular, scalable software solutions.  
 
2.3 Summary of Dissertation 
 
  
The objective of this dissertation is to develop and integrate tools that enhance the entire 
spectrum of proteomics analysis by mass spectrometry- from detection of raw data to 
interpretation of biological story. These tools alleviate computational bottlenecks at each 
step of analysis by providing statistically-sound software in order to deliver biologically-
relevant and meaningful output without distorting information, losing data, or adding 
artifacts. The intentionally modular design of this toolbox provides an environment for 
each tool to perform its individual function in response to specific bioinformatic queries, 
as well as sets the framework for all of the tools to interact in a seamless, holistic manner 
for a more comprehensive understanding of the biological questions under investigation. 
By looking through a computational biologists’ lens at a vast array of biological studies 
implementing mass spectrometry for proteomic analysis, a number of inter-related but 
functionally-distinct informatics processes present themselves. The development of a tool 
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for each process provides a mechanism of answering biological inquiries ranging from 
focused, hypothesis-driven questions, such as the increased ratio of a structural cellulase 
protein CipA in condition 1 compared to condition 2, to more global, discovery-based 
investigations, such as the identification of a core group of proteins expressed across a 
collection of plant tissues. 
 
Answering these questions requires several points of engagement between informatics 
and analytical understanding of the underlying biochemistry of the system under 
observation. Deriving meaningful information from analytical data can be achieved 
through linking together the concerted efforts of more focused, logistical questions. This 
study focuses on the following aspects of proteomics experiments: spectra to peptide 
matching (Chapter 3), peptide to protein mapping (Chapter 4), and protein quantification 
and differential expression (Chapter 5). The interaction and usability of these analyses are 
also described (Chapter 6). 
 
While it is important for informatic tools to be able to handle large datasets, it is 
becoming increasingly crucial for tools to also handle the biological complexity 
associated with more intricate experimental designs. Although some existing tools can 
scale computationally and maintain biological relevance, most of the time new tools need 
to be developed to appropriately address these concerns. The overwhelming volume and 
complexity of these experiments requires that the new and existing tools are not only 
optimized for speed and interpretation, but they also necessitate seamless communication 
with each other in an integrated workflow. By constructing a workflow that allows high-
throughput processing of massive datasets, data collected within the past decade can be 
standardized and updated with the most recent analyses. Once these analyses are 
complete, meta-analyses can identify global analytical and biological trends. 
 
Technological and informatic improvements are continuously accelerating the scope and 
complexity of biological investigations. As such, defining how a question is answered is 
becoming just as important as determining what both the question and answer should 
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look like. In fact, clearly identifying appropriate analytical and informatics methods is 
half of the work in solving these biological problems. Method optimization, versatility, 
and specialization become ends worthy of research in themselves. Although collections 
of measurements are motivated by biological enquiries and ultimately exist to reveal 
biological significance, the data points that act as intermediary, empirical evidence of 
interactions between genotypic and phenotypic information could arguably be considered 
more “real” and reproducible than their initial biological drivers and final interpreted 
conclusions. However, data cannot be useful until it is contextualized as information and 
interpreted as knowledge. In these processes, the truth or value of the data may be altered 
due to misinterpretations of newly annotated data, such as causal instead of correlative 
conclusions, or tendencies to over-fit, normalize, or filter results in an effort to arrive at 
pre-conceived outcomes. Therefore, in order to continue the iterative feedback loop of 
inspiring and answering biological questions, it is becoming ever more important to also 
ensure that the informatics validating, analyzing, and interpreting collected data preserve 
and reflect the integrity of the analytical measurements. 
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CHAPTER 3:  Spectrum to Peptide Matching 
 
Data presented in Section 3.1 has been adapted from the following journal article ready 
for submission to the Journal of Proteome Research: 
 
Rachel M. Adams, Richard J. Giannone, Paul Abraham, Robert L. Hettich. “Protease-
Optimized Spectral Indexing Enhances Protein Identification and Quantification in 
Shotgun Proteomics Datasets.” Sample preparation and experiments were performed by 
Richard J. Giannone. Data analysis was performed by Rachel M. Adams. 
 
Data presented in Section 3.2 has been adapted from the following journal article: 
 
Paul Abraham*, Rachel M. Adams*, Richard J. Giannone, Robert L. Hettich. “Defining 
the Boundaries and Characterizing the Landscape of Genome Expression in Vascular 
Tissues of Populus using Shotgun Proteomics.” * Authors contributed equally to this 
work. Sample preparation and mass spectrometry experiments were performed by Paul 
Abraham. The bioinformatic workflow for evaluating sequence redundancy was developed 
by Paul Abraham, Rachel Adams, Richard Giannone and implemented by Rachel Adams. 
The supplemental database for single nucleotide polymorphism detection was created by 
Rachel Adams. Quality of spectra was evaluated using software written by Brian Erickson. 
Biological data analysis was performed by Paul Abraham. 
 
Data presented in Section 3.3 has been adapted from the following journal article: 
 
Paul Abraham, Rachel Adams, Gerald Tuskan, Robert Hettich. “Moving Away from the 
Reference Genome: Evaluating Single Amino Acid Polymorphism Identifications from a 
Peptide Sequencing Tagging Approach for the Genus Populus”. Journal of Proteome 
Research  (In review). Sample preparation, mass spectrometry experiments, and 
manuscript preparation were lead by Paul Abraham. In-house scripts for matching ion 
intensity information and evaluating the site-determining ions of modified amino acids 
were developed by Rachel Adams. 
 
3.1 Matched Ion Intensities Increases Accuracy and 
Robustness of Peptide Identification 
 
3.1.1. Evaluating Spectral Counts and Matched Ion Intensities 
 
Proteomics, the characterization of the complete suite of proteins expressed in a cell, is 
commonly used as a discovery-based component to identify and quantify protein 
expression in an organism under a given condition. Considering that differing cell types 
produce different levels of complexity, the biological dynamic range of proteins analyzed 
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in a proteomics experiment can span up to 7 orders of magnitude and cover an equally 
large mass range. To reduce the complexity of this wide range of protein types and 
abundances, researchers commonly adopt the shotgun proteomics strategy, i.e., digesting 
proteins into peptides that have a smaller range of sizes, masses, and physiochemical 
properties. By sequencing the resulting peptides via mass spectrometry (MS), each 
experiment’s detected peptides can be computationally mapped back to their proteins. In 
fact, this dependence on informatics to reflect the analytical measurements and inform 
the biological interpretation is not a single requirement. Each of the experimental steps 
that simplify the set of analytes being measured at a given time requires an analogous 
informatics process that deconvolutes the measurements and reconstructs the 
identifications within their local and global context. Thus, in silico analyses must be 
performed in reverse order of their experimental counterparts and 
scored/evaluated/assessed according to the scope of the measurement before proceeding 
to a larger interpretation: 1) spectra are matched to peptides, 2) peptides are mapped to 
proteins, 3) proteins are quantified in the context of the run, 4) proteins are compared 
between technical replicates, and finally, 5) proteins are compared between experimental 
conditions. For this bottom-up strategy to accurately identify and quantify proteins, all 
variables and optimizations within the data collection processes must dictate which and 
how the data analysis methods should be applied. 
 
However, one does not want to over-fit or transform raw data in such a way that it loses 
analytical accuracy and biological relevance. As Occam’s Razor suggests, the most 
simple, straightforward metrics are generally considered the more confident methods for 
inferring protein identification and quantification.
75
 Label-free protein quantification, in 
fact, assumes that one can accurately compare relative protein abundances using inherent 
features of the collected data without introducing any additional analytes to the sample. 
The most common measure of label-free protein abundance, spectral count (SpC), is the 
number of MS/MS scans that match peptides belonging to a protein. While the simplicity 
of SpCs has merit, this single-dimensional measure relies on a number of assumptions 
and shifts the more complicated calculations to downstream analysis. For example, the 
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discrete property of spectral counts coupled with the stochastic nature of low-abundance 
protein identifications, diminishes the likelihood of SpC following a normal distribution 
and suggests a quasi-Poisson, modified binomial, or some other mixed model 
distribution. These more complicated distributions can limit the statistical powers of 
significance tests attempting to discern which proteins are differentially expressed in two 
samples. However, recent studies have suggested that instead of counting the MS/MS 
events that identify a protein, one can achieve greater analytical accuracy by summing the 
intensities of the individual fragment ions contributing to a peptide-spectrum match. The 
protein’s spectral index (SpIn) therefore inherently includes SpC information but also 
captures the chromatographic contexts of the identifications. This multidimensional 
measure embodies analytical nuances provided by the TIC, the number of total MS/MS 
peaks, and number of matching peaks but simplifies them as an aggregate data point. In 
other words, matched ion intensities preserve quantitative features that articulately reflect 
how well the peptides were separated, the degree of competition for charge, and each 
peptide’s specific ion contribution within ambiguous peptide-spectrum matches due to 
co-fragmentation or indiscernible charge states. In addition, the number and range of 
individual matched ion intensities contributing to protein identifications far exceeds that 
of spectral counts. Like all analytical measures relying on a sampling process rather than 
a fully comprehensive collection, there are inherent biases and advantages to both 
spectral counts and matched ion intensities. 
 
Although both spectral counts (SpC) and matched ion intensities (MIT) reflect a 
successful peptide identification, whether the peptide-spectrum match should be a digital 
or weighted measurement is the primary point of contention between SpC and MIT. It is 
highly intuitive that the more times the instrument detects a peptide within a set period of 
time, the more abundant that peptide must be among the group of peptides under analysis. 
However, the number of times a peptide is observed (SpC) is not just a function of 
abundance within the sample- it also dependent on instrument settings, the 
physiochemical properties of the peptide sequence, the number and types of peptides that 
are eluting around the same time, and the peptide-spectrum matching algorithm.  
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If the goal of an experiment is to identify the primary components of a sample, then the 
researcher may choose data-dependent settings on the instrument in that focus on 
acquiring deeper measurements of the more abundant analytes (more SpC per peptide) 
rather than achieving a broader survey of all possible constituents in the sample, 
including capturing those peptides that may be low-abundant. That is, in a discovery-
based experiment seeking to acquire comprehensive identifications, instruments may be 
instructed to skip over analytes that had previously been measured so that less-abundant 
peptides may get an opportunity to be detected. In such a scenario, all detected peptides 
would receive a spectral count of 1 and no quantitative information could be inferred at 
all (other than the presence of one or more peptides supporting each protein 
identification). For those types of experiments, however, the instruments more often 
implement a dynamic exclusion list, allowing an analyte to be temporarily ignored from 
additional measurements if it had been previously detected within a certain window of 
time or after it has been measured a certain number of times within the run. With these 
types of rules enforced, it is important to keep in mind that the peptides are following an 
elution peak (where the x axis is time and y axis is typically the precursor intensity) in 
response to a changing salt gradient and that at the time a peptide is put on an exclusion 
list, it may not be measured at its highest point. Under these circumstances, SpCs are 
robust measurements because they are not concerned with the intensities at which the 
peptides were analyzed- just whether or not the measurement was acquired. In general, a 
peptide that has a wide elution peak is more likely to be sampled (and therefore have a 
higher SpC) than one that has a very narrow elution peak. For experiments in which the 
biological dynamic range is relatively small or when deep, repetitive measurements are 
more important than the breadth of identifications, SpC are consistent metrics that can be 
reliably used for relative abundance measurements.  
 
In LC-MS experimental designs, however, the elution profile of a peptide is characterized 
not only by its width, but also its height. The intensity or height of a peak has been 
argued to be just as indicative of a peptide’s abundance compared to the peak’s width 
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(SpC). Whereas SpC is applauded for decoupling the individual measurements from the 
context in which their measurements were taken, proponents of intensity measurements 
boast of empirically incorporating the quality of the measurement with respect to the 
other analytes in the background. Across analytical platforms there is general agreement 
that observations may be useless, or at least statistically insignificant, if they are 
indistinguishable from noise measurements. Following this trend, the signal to noise ratio 
has often been used to filter SpC measurements by allowing only those spectra that were 
collected above a certain threshold to be used for quantitative measurements. From there, 
it is not difficult to imagine how one would extend these digital comparisons of “quality” 
or “poor” spectra to a more continuous scale by summing the precursor intensities of each 
peptide identification.  
 
To illustrate how interpretation based solely on raw SpC can be misleading, two 
examples are shown below. Figure 3.1A compares the MS/MS assignments of two 
proteins from each salt pulse collected from a single MS run analyzing the C. 
thermocellum proteome. These two proteins, Clo1313_0465 and Clo1313_0296 have 
very different SpC (20 and 113), ranking them in the 25
th
 and 75
th
 percentiles, 
respectively. When the TICs of their MS/MS scans are compared (6.07E7 and 6.12E7), 
the proteins both fall within the 40
th
 percentile. While it is not advisable to directly 
compare protein A against protein B within the same sample or between conditions, the 
relative percentage of SpC assigned to a protein is used in the most common form of 
protein abundance normalization (NSAF). It is assumed that two proteins of similar size 
and similar SpC have the same relative abundances within a sample. Figure 3.1B 
illustrates a scenario when this would not appear to be a fair assumption. Proteins 
Clo1313_0837 and Clo1313_0467, both 256 amino acids long, generated about the same 
number of peptides (6 and 7 peptides, respectively) and approximately the same SpC (26 
and 27). When their intensities were compared, however, Clo1313_0467 was almost half 
as intense as Clo1313_0837. As the picture illustrates, the less intense protein was 
sampled at very different parts in the chromatogram compared to the more intense 
protein. Many such proteins receive additional spectral counts from the low-complexity   
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Figure 3.1. Peptides representing proteins with different SpC but similar MIT. 
(A) High spectral counts may be over-inflated due to over-sampling in low-complexity 
regions. (B) Low spectral counts may be underrepresented due to competition in high-
complexity chromatographic regions.  
A. YAFMGGSNLVIFNSSK 
SpC: 45, MIT: 1.501 E7 
B. AHTIANLAGFEVPETTK  
SpC: 11, MIT: 1.393 E7 
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regions of the chromatogram, typically at the very end and beginning of each salt pulse. 
These spectra are generally low-intense peaks that are continuously re-sampled for lack 
of competition, but it is evident from visual comparison that the additional SpC collected 
during these times are not at all comparable to the SpC collected in regions of higher 
chromatographic complexity. Therefore, intensity measures can be highly indicative of 
the chromatographic background in which the identification was assigned and give a 
more sensitive abundance measurement. 
 
When using intensity measurements as a proxy for relative protein abundances, a weighty 
assumption is that the observed intensity truly affects the quality of the measurement and 
not just the ionizability of the peptide. However, depending on the physiochemical 
properties of a peptide sequence, a peptide may not be very compatible to ESI and 
therefore may not have the same opportunities to be detected as another peptide that is 
just as abundant (or less abundant) but is very amenable to enzymatic digestion, SCX-RP 
separation, and salt gradient elution. In fact, studies have shown that 2 peptides presented 
to the mass spectrometer at the same concentration can behave up to X-fold different in 
their intensities due to differences in their sequence’s hydrophobicity, length, and number 
of immonium ions. For these reasons, simply picking the most intense point of a 
peptide’s elution peak is not sufficient; taking multiple samples along the peak more 
accurately describes the behavior of a peptide compared to the other peptides it is 
competing against. For quantitative purposes, some researchers suggest that taking the 
sum of each intensity measurement sufficiently captures the shape of the peak, whereas 
others insist that taking the area under the curve of the elution peak is more accurate. 
Taking the area under the curve, a method commonly employed in labeling approaches 
even for absolute quantitative measurements, is indeed more accurate when one is 
comparing the two observations of two analytes that have the exact same chemical 
composition. However, deviations in peptide length, charge states, post-translational 
modifications of residues all significantly affect the ionizability of the analyte and 
therefore its elution peaks. 
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More recently, researchers have proposed that not only are precursor intensity 
measurements more descriptive than SpC, but that even more information can be gleaned 
by looking at the individual intensities of peaks within an MS/MS scan. More 
specifically, instead of using the intensity of the MS precursor or taking the sum of all of 
the peaks within an MS/MS scan, also called the total ion current (TIC), one could sum 
the intensities of each peak within a scan that matches a peptide’s expected fragment ion. 
These matched ion intensities (MIT) for each MS/MS scan can then be summed for each 
peptide and in turn, summed for each protein, to give an overall spectral index (SpIn) 
value. (See Chapter 5 for more details about the downstream calculations).  
 
One of the most practical advantages about this MIT approach to quantitation is that it is 
not an entirely new concept or measurement: a form of the method has already been 
essentially implemented into every automated peptide-spectrum matching algorithm over 
the past decade. That is, every search algorithm compares a list of observed and expected 
m/z’s and performs some type of scoring assessment, usually taking into consideration 
the corresponding intensity measurements of the matching fragment ion peaks. The 
choice of the best peptide identification for a given spectrum is not always clear and 
depending on the database-searching algorithm and its criteria for scoring peptide-
sequence matches, the list of which peaks contribute to the peptide identification may 
change. Although each algorithm constructs internal lists of matched observed and 
expected m/z values for each peptide and spectrum compared, none of the approaches 
provide explicit reports of which of those peaks are the matched ions. We were also 
interested in looking at the contribution of secondary fragment ions (in a case study with 
HCD), which most search algorithms currently do not take into account for 
identifications. Therefore, for this study, it was necessary to devise our own matching 
analysis that compared expected ion series and observed peaks within the spectrum.  
 
The goal of POSI is not to make any new peptide-spectrum matches, but rather work 
within the scope of the supplied information to make qualitative and quantitative calls 
about the identifications. In other words, this study’s implementation of a peak-matching 
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algorithm did not compare all possible peptides to all possible spectra. Instead, it was 
limited to the user-defined list of peptide-spectrum pairs and only compared the collected 
peaks of selected spectrum against the theoretical ion series of its associated peptide and 
charge state.  
 
One of the most relevant characteristics of matched ion intensities is their ability to span 
multiple orders of magnitude, compared to the limited number of spectral counts acquired 
during MS. The analytical dynamic range of matched ion intensities more accurately 
aligns with the biological dynamic ranges captured in an MS/MS sample, and even 
approaches the increased accuracy generally associated with absolute quantitative 
methods. However, the relative nature of these measurements necessitate normalization 
methods that accurately attribute precise abundance information to confident protein 
identifications, ensuring that each inference is interpreted within the analytical 
background in which the data was collected and the informatic context in which 
assignments were made. 
3.1.2. Calculating Matched Ion Intensities 
 
Removing Noise from Analysis 
Each spectrum has different distributions of peak intensities and therefore different noise 
peak cutoffs, so we looked for the inflexion points where the bottom-ranked peak 
intensities indicated strong linearity (R
2
 > 0.8). Additional R
2
 values were explored as 
well as comparison against the TIC, the number of total peaks in the spectrum, the 
number of matched peaks, keeping the most intense peaks that accounted for X% of the 
TIC, and retaining only the top X peaks per scan (see Figure 3.2). Also, for comparison to 
other existing methods, rather than simply removing all of the peaks determined to be in 
the noise (the “remove” method), the intensity of the highest peak determined to be in the 
noise was subtracted from all of the non-noise peaks (the baseline “subtract” method). 
Quality scores were calculated based on the sum of the matched ion intensities compared 
to the sum of the unmatched ion intensities.  
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Figure 3.2. Method for detecting noise.  
This approach goes through each spectrum, ranks all of its peaks by decreasing intensity, 
and looks for inflexion points where the intensities become linear, indicating a level of 
randomness in the data. Any peaks below the inflexion point are considered noise and 
removed from the analysis.  
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Matched Ion Intensity Calculations 
Only peaks that have intensities higher than the spectrum’s calculated noise level should 
be considered for matching ions. Matching ions are peaks within the spectrum that 
contribute to the peptide’s identification. Because peptides fragment in predictable 
patterns, each peptide’s theoretical ion series can be calculated in silico and then 
compared and scored against the observed peaks in approaches described above (see 
PSM scoring). For this study, it was necessary to devise our own matching analysis that 
compared expected ion series and observed peaks within the spectrum. It is important to 
note that the input to the overall POSI algorithm requires a list of filtered peptide-
spectrum matches that the researcher has confidently generated from a previous database-
searching algorithm.  
 
Matching Ions for PSMs 
The list of candidate expected ions for a given sequence was developed to be highly 
parameterizable. The researcher could define which ion series (“a”, “b”, “c”, “x”, “y”, or 
“z”), which losses (“-H20”,”-NH3”), as well as which static and dynamic modifications 
(“C+57”, “M+16”) should be considered. Parameters can also be set for secondary 
fragmentation ions (neutral fragment losses, see Section 3.2.3 for details). Each of the 
analyses performed for this study only used the b and y ion series, static cysteine 
carbidomethylation modification (+57), dynamic N-terminal modification (+43), and 
dynamic methionine oxidation modification (+16). For each sequence observed at a given 
charge state, each ion series was calculated with a charge of +1 to precursor – 1. Within 
each scan that identified a peptide, lists of matched fragment ions were generated by 
sorting the observed m/z’s by intensity and then assigning the sequence’s closest 
expected fragment ion within a user-defined tolerance (0.5 Da by default). The newly 
matched fragment ions were then removed from the candidate list for the rest of the scan. 
 
After matched ions were identified for each peptide-spectrum match, it was necessary to 
sum each peptide’s matched ion intensities for each of its scans. For 97% of the scans, 
summing the intensities of the matched ions for that peptide and scan was 
  81 
straightforward. The remaining scans had ambiguous peptide-spectrum matches primarily 
because the searching algorithm could not determine charge state and instead assigned 2 
peptide sequences to the scan, one for +2 and one for +3. To avoid double-counting the 
intensities of matched ions that were strong candidates for both peptides associated with 
the same scan, matched ion intensities that were assigned to two peptides were 
proportionally distributed among the peptides according to the number of matched ions 
assigned to each peptide. This careful summing of matched ion intensities was carried 
through for each peptide, and a summed matched ion intensity was calculated for each 
scan as well. We also explored additional aggregate functions including taking the mean, 
median, and selecting the top 3 scans’ intensities for each peptide. 
 
Generating Report with Protein Spectral Indexes 
Peptide matched ion intensities can be summed to generate protein spectral indexes. To 
account for peptides that are shared between multiple proteins, the matched ion 
intensities for the redundant peptides are apportioned among the shared proteins 
according to each protein’s number of unique peptides identified. The number of unique 
peptides that provide evidence for protein identification is proportional to the confidence 
we have in that particular protein call. Therefore, a weighted fraction of matched ion 
intensities are directed to each protein that has at least one unique peptide. After the 
matched ion intensities are balanced and summed into protein spectral indexes, the 
spectrum, peptide, and protein information is reported in a format similar to the common 
DTASelect –t0 output (an unfiltered tab-delimited format). In other words, the report 
includes details about every spectrum contributing to a peptide identification and a 
protein call. Most notably, the generated output from POSI also contains additional 
information about the number of matched ions, matched ion intensities for the peptide 
sequence, matched ion intensities for the scan, and how many times each peptide 
sequence appears in the protein. For portability purposes, this output can also be 
converted into an mzIdentML file format, a standardized report for database-searching 
algorithms.   
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3.1.3. Comparing PSM-level Intensities to Peptide-level Intensities 
 
Data reduction step 
When using intensities to estimate relative protein abundances, it is important to make 
sure that we are not inflating measurements with data from instrument or chemical noise. 
Just as the TIC varies dramatically from scan to scan, even within a single salt pulse, the 
intensity and number of noise peaks in each MS/MS scan also change. Each spectrum has 
different distributions of peak intensities and therefore different noise peak cutoffs, so we 
looked for the inflexion points where the bottom-ranked peak intensities indicated strong 
linearity. Due to the high variability of individual scans, these noise levels ranged widely 
in their absolute values (between 5-300 peaks and 1000-5000 summed intensities due to 
noise), On average, this noise-reducing method resulted in removing about 80% of the 
peaks and roughly 20% of the TIC, suggesting superior performance that neither intensity 
nor peak counts could individually achieve (
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Figure 3.3). However, further examination revealed that the data reduction step was not 
noticeably improving the matched ion intensities for a given peptide, so this method was 
not used in the final quantification analyses.  
 
Scan-based metrics 
Each scan averaged an MIT of 2.87e5 with a standard deviation of 1.34e6, accounting for 
22% (+/- 12%) of the TIC. Whereas the TICs ranged from 1.29e4 to 7.07e8, the MITs 
ranged from 1.95e3 to 2.64e8. MITs were not correlated with the TICs, so the matching 
process was demonstrated to be an informative calculation step. Similarly, the MITs were 
not correlated with the number of peaks (or quality peaks) in a scan, so they could not 
have been substituted by those quality metrics. Each salt pulse contributed a slightly 
different distribution of scans- as noted by the distribution of TICs and the average MITs. 
Figure 3.4 below also illustrates how the number and range of matched ion intensities of 
each salt pulse differed for a single run. Almost a 50:50 split between the number of b 
and y ions were observed. For each scan, an average of 11.78 and 11.99 b and y ions 
were matched, contributing an average of 4.8e4 and 1.25e5 to a scan’s MIT, respectively. 
On average, 24 peaks (+/- 9) matched within a scan, predominately reflecting the number 
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Figure 3.3. Validating the use of matched ion intensities instead of other simple features 
inherent to MS/MS scans. 
(A)  Each MS/MS scan’s TIC was compared to the number of fragment peaks within 
the scan to see if there was a correlation.  
(B)  For each peptide-spectrum match that passed the typical filtering criteria, the 
MS/MS scan’s TIC was compared to the matched ion intensity to see whether the 
matched ion intensity was a consistent fraction of the TIC. 
  
(B) 
(A) 
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of matched peaks from the most abundant charge states (+2 and +3), which matched 22.5 
and 23.45 peaks per scan. The +1 scans averaged 15 matching peaks and the +4 scans 
averaged 53.8 peaks, differing from the other scans’ metrics primarily due to their 
relatively increased and decreased number of possible peaks matched. 
 
Peptide-based metrics 
In keeping with the NSAF assumption that more opportunities to sample an analyte 
would increase its abundance, MIT measurements were compared to peptide length in 
order to assess whether there was a correlation. Similarly, peptides with a higher charge 
state have more opportunities to generate fragment ions, so the correlation between MITs 
and charge state (and number of possible fragment ions). PSM-level MITs grouped into 
peptide MITs were not biased for more opportunities based on any of these metrics. As 
Figure 3.5 suggests, peptide MITs were, however, different between charge states and 
salt pulses. The distribution of MITs for a highly abundant peptide, 
TVIEVLVENGNVSK (700 total SpC and 2.45e8 MIT) is illustrated in Figure 3.4. The 
average of the MITs collected for each salt pulse are slightly different for the exact same 
analyte. The shift downwards (smaller intensities) with each consecutive salt pulse 
reveals that the peptide is continuing to be measured even amidst growing competition 
for identification. Looking at any of these salt pulses individually would be a 
misrepresentation of the peptide’s behavior across the entire run. Even looking at the 
cumulative distribution of MITs observed for this analyte does not completely capture the 
behavior of this peptide sequence. As the graph in Figure 3.5 suggests, this peptide 
behaves like quite different analytes depending on its charge state- perhaps just as 
differently as two peptide sequences altogether. If one is trying to validate the distribution 
of the peptide’s MITs as a component of the protein’s abundance within a run, it is more 
accurate to compare the peptide’s distribution across technical replicates than it is to 
compare two peptides from the same protein within a single run.  
 
Figure 3.6A highlights the similarities in MIT distributions between the same peptide 
identified in two technical replicates. To determine whether the peptide distribution  
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Figure 3.4. The distributions of an abundant peptide’s matched ion intensity for each of 
the 11 salt pulses in a single run. 
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would behave the same across different loading amounts, the same sample was loaded on 
to a column in 2 different concentrations (25 μg and 67 μg). Figure 3.6B graphs how the 
peptide MIT distribution follows the same shape and general trend between the two 
concentrations and systematically reflects the expected shift in intensities between the 
two runs. Therefore, peptide MITs are considered reproducible across replicates and 
across loading amounts. However, not all peptides were identified in all replicate 
measurements. When the peptides are assembled into protein measurements, these 
inconsistencies in identification warrant careful consideration to either filter or normalize 
for the disparities. 
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Figure 3.5. Abundant peptide demonstrates different matched ion intensity distributions 
depending on its charge state. 
(A) The same peptide sequence was captured by vastly different SpC throughout a single 
run. The +2 species was observed over 700 times, compared to the 3-60 SpC detected by 
the other species. (B) An inset of the graph above to illustrate that the carbamylated (N-
terminus + 43) species of +1 and its non-modified form followed the same general trend, 
as did the +3 modified and non-modified species.  
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Figure 3.6. Peptide matched ion intensities are reproducible. 
(A) Peptide matched ion intensities are consistent across technical replicates. (B) Peptide 
matched ion intensities may reflect the relative differences in the amount of sample 
analyzed by MS.  
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3.2 Augmented and Refined Peptide Identifications from 
Otherwise Unassigned Spectra 
 
3.2.1.  Qualifying Peptide Assignments from Ambiguous Peptide-Spectrum 
Matches 
 
Intensity information not only helps identify which proteins are more abundantly detected 
within a sample, but it can also highlight which peptide-sequence matches (PSMs) are 
more confident than others. As database size and redundancy increases, there is an 
increased likelihood of several peptide sequences receiving sufficiently high XCorr 
values for the same observed MS/MS spectrum. To account for these occurrences, 
SEQUEST uses ‘DeltCn’ to measure how the lower ranked peptide scores differ from the 
XCorr of the best-matched peptide sequence. Therefore, a higher DeltCn score of the 
second ranked match means that the best-matched peptide sequence is most likely 
correct. Since prokaryotic and eukaryotic genomes can vastly differ in size and genetic 
redundancy, the abundance of peptide sequences, which are similar in sequence identity, 
dramatically increases in plants. The Populus genome is highly convoluted by genetic 
redundancy that has resulted in two-thirds of the genes that express proteins to have a 
high sequence similarity (~90% or higher sequence identity). To address how this 
phenomenon could impact spectral processing, we compared the DeltCn distribution of a 
24-hour MudPIT for E. coli and Populus. By plotting DeltCn values for the best-matched 
peptide sequence for every scan, the distributions for E. coli and Populus differ in both 
location and shape (Figure 3.7).In comparison to E. coli, the DeltCn distribution for 
Populus clearly shifts towards zero, indicating an increase in quality MS/MS spectra 
matching to more than one peptide sequence. This characteristic shift reflects the 
increased amount of genetic redundancy within the plant genome, which contains more 
indistinguishable peptide sequences. Previous studies show that a DeltCn threshold of 
0.08-0.1 provides the necessary FDR with an appropriate balance between false-positives 
and false-negatives. This study suggested that perhaps high mass accuracy should be 
incorporated in future studies to decrease ambiguity and allow the DeltCn filters to 
become more liberal.  
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Figure 3.7. Comparison of DeltCN scores between Populus and E. coli. 
SEQUEST’s DeltCN score is the percent difference between the top and second-best 
xcorr values assigned to an MS2 scan. If these two xcorr scores are very similar to each 
other, (indicated by a DeltCN value close to 0), the algorithm was not able to clearly 
choose one candidate peptide sequence over another. Overall, the DeltCN scores in the 
Populus dataset were systematically shifted towards 0 when compared to the E. coli 
dataset, suggesting that Populus has more ambiguous peptide-spectrum matches than E. 
coli. 
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An alternative approach, however, is to determine which peptide has the highest matched 
ion intensity or which matched ion intensity best falls in line with the other unambiguous 
intensity information assigned to the candidate peptides. In most scenarios, one would 
most likely attribute the scan to either the protein with the overall highest abundance, or 
the peptide with the most matching peaks. However, with matched ion intensity (MIT) 
information, we can distinguish which peaks matched which peptide and possibly give 
non-redundant intensity support to both proteins. Figure 3.8 below illustrates an example 
in which the scan 05.29208 matches both WEIEFFK (+2) and VVDLIVHMASVDAK 
(+3). The peptide WEIEFFK, which belongs to protein Clo1313_1808 (932 SpC, total 
MIT of 1.17e5) matched 12 peaks in the scan and received a Myrimatch MVH score of 
32.3, while peptide VVDLIVHMASVDAK, which belongs to protein Clo1313_2095 
(5911 SpC, total MIT of 9e5), matched 23 peaks and received an MVH score of 42.8. 
Based on the number of matched peaks, the mvh score, and the overall protein intensity, 
one would most likely attribute this scan’s intensity measurements to the second peptide, 
but it in fact matched 2% of the TIC, whereas the smaller peptide matched 23% of the 
TIC. Peptide WEIEFFK (+2) had an MIT of 6.50e5, which was an order of magnitude 
greater than the other peptide’s MIT (6.31e4). Upon examination of each peptide’s MIT 
distribution within its respective proteins, it is interesting to note that WEIEFFK had 2 
ambiguous scan assignments within the run and VVDLIVHMASVDAK had 33 
ambiguous scan assignments within the run. In total, Clo1313_2095 had 49 ambiguous 
scan assignments (whose MITs sum to 8.72e6, 0.2% of the protein’s total MIT). We 
suspect that these ambiguous scan assignments may be over-inflating protein 
Clo1313_2095’s SpC, but the impact of these incorrect or co-fragmentation 
identifications are more appropriately handled by the MIT measurements.  
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Figure 3.8. Comparison of 2 possible peptide-spectrum matches for an ambiguous scan. 
Because the precursor charge state could not be determined for this MS2 scan, the 
searching algorithm tried to assign a peptide-spectrum match as if the charge state was +2 
and +3. The candidate peptides for +2 (WEIEFFK, Fig A.) and +3 
(VVGLIVRMASFGAK, Fig B.) scored similarly and their matched ions contained no 
overlapping peaks (Fig C.).  
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3.2.2.  Supplementing Traditional Database Searching Approaches 
 
One of the greatest heuristics that contributes to the success of database-searching 
approaches also has a complementary limitation: regardless of the quality of peptide-
derived spectra, algorithms will only match spectra to peptides that exist within user-
defined sequence variations. Peptide sequencing by mass spectrometry is most commonly 
performed via collisional-induced dissociation (CID), in which peptide ions fragment in a 
predictable manner to produce dissociation products that yield sequence information. 
Though widely used for its simplicity and effectiveness, more than 50% of MS/MS 
spectra collected in a typical shotgun proteomic experiment do not result in high-
confidence peptide identifications when using automated search algorithms such as 
SEQUEST or MASCOT. Even though these low identification rates can be partially 
explained by the presence of spectra arising from concurrent fragmentation of multiple 
precursor ions, incomplete fragmentation of peptides, and chemical noise, a large fraction 
of peptide-derived spectra remain unassigned because of the quality and completeness of 
the proteome database
97, 98
. Neither prokaryotic nor eukaryotic protein databases typically 
include protein isoforms or alterations/modifications, and furthermore their omission has 
a more dramatic effect on higher eukaryotes in which sequence variations and unexpected 
splice variants are more prevalent. Thus, by not anticipating the presence of these 
peptides, database search algorithms are more likely to interpret fewer peptide-derived 
MS/MS spectra when analyzing proteomes of higher eukaryotes. Reanalysis of 
unassigned tandem mass spectra was performed to determine the magnitude of peptide-
derived spectra that remained unmatched to a sequence, thereby providing the proportion 
of “missing” peptide identifications in a run.  
 
To compare the rates of peptide-spectrum matching (PSM) between eukaryotes and 
prokaryotes, we contrasted MS/MS data from Populus with a simpler bacterium, 
Escherichia coli.
99
 In both cases, proteolytic peptides were measured on the same 
instrument using identical methods to minimize experimental biases. The instrumental 
acquisition and chromatographic distribution of all MS/MS spectra collected were similar 
for both organisms. However, the ability to successfully match experimental MS/MS 
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spectra to theoretical database sequences was superior in E. coli. A greater percentage 
(86%) of Populus MS/MS spectra remained unassigned, as compared to only 63% of the 
MS/MS spectra collected for E. coli. A closer look at the proportion of unassigned 
peptide-derived spectra was used to determine if the observed discrepancies in peptide 
identifications could be attributed to the incompleteness of the reference database. 
Spectral quality assessment was used to identify the number of unassigned high-quality 
spectra, i.e., a population of spectra that likely represents mutated, modified or novel 
peptides. A conservative set of criteria, based on previous implementations of spectral 
analysis was utilized in the assessment of MS/MS spectral quality.
100, 101
 A spectrum was 
considered high quality if the parent charge state was calculated to be greater than +1 and 
if the spectrum contained three or more peaks within 20% of the base peak intensity with 
a minimum intensity of 2,500 counts. Using this approach, we performed an assessment 
of MS/MS spectra quality to distinguish high-quality unassigned spectra from low-quality 
unassigned spectra in the representative MS runs from Populus and E. coli. Spectra 
analysis revealed that, of the total MS/MS spectra collected for Populus and E. coli, the 
percentage of high-quality MS/MS spectra (45%) within the representative MS run for 
Populus contained almost twice the percentage (24%) in the E. coli run. Nonetheless, the 
ability to successfully match the high-quality experimental MS/MS spectra to database 
sequences remained more common in E. coli. A greater percentage of Populus high-
quality MS/MS spectra (77%) remained unassigned, as compared to only 45% of the 
high-quality MS/MS spectra collected for E. coli. This suggests a critical need to evaluate 
bioinformatic approaches to rescue the lost, high-quality spectra. 
 
To explore the prevalence of single amino acid polymorphisms (SAAPs), a single MS run 
from within the 60 described above was searched against an expanded Populus database 
that included a list of tryptic peptides generated from predicted SAAP variants in the 
database. In brief, high-throughput single nucleotide polymorphism (SNP) discovery 
through deep (30X depth per genotype) resequencing of 19 trees yielded 16 million SNPs 
in the Populus genome (485 Mb) (unpublished results). For this analysis, a subset of 
these SNPs present in 2 P. trichocarpa and 2 P. deltoides genotypes were considered. Of 
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the 17 million amino acid positions found in P. trichocarpa's 45,778 protein-coding gene 
models, ~400,000 amino acid positions due to non-synonymous SNPs (SAAP) were 
investigated. All possible combinations of SNP-influenced peptides (SAAP peptides) 
were predicted and subjected to in silico tryptic cleavage using PeptideSieve
102
 software 
with the following parameters: maximum mass criterion of 5000, minimum sequence 
length of 6, maximum sequence length of 50 and allowing for 4 missed cleavages. Some 
of the non-synonymous amino acid changes resulted in new tryptic cleavage sites or 
resulted in disappearance of these sites. These were taken into consideration while 
predicting the peptides. To detect the expression of a SAAP peptide, experimental 
MS/MS spectra from one MS run were compared to theoretical tryptic peptide sequences 
generated from a target database consisting of the protein database of P. trichocarpa 
(v2.0) and all predicted SAAP peptides. Each SAAP peptide was concatenated to the 
target database as a new protein entry, in which ten tryptophan residues flanked both 
sides of the peptide sequences. For SAAP peptides that originated from the N-terminus of 
a protein, the tryptophan residues were excluded from the beginning of the SAAP 
peptide. Similarly, for each SAAP peptide that originated from the C-terminus of a 
protein, the tryptophan residues were excluded at the end of the SAAP peptide. With the 
high frequency of SAAPs in Populus, over 700,000 distinct SAAP positions and 
7,200,000 new peptides were included in our database. All MS/MS were searched with 
SEQUEST and filtered by DTASelect as described previously.
103
 Once peptide-spectrum 
matches were identified, filtering criteria were controlled to yield peptide FDRs less than 
1%. We found that Populus proteins on average contained 17 SAAPs. When identifying 
SAAPs from MS/MS spectra, it is important to differentiate these from post-translational 
modifications (PTMs) or peptide modifications generated during sample processing that 
result in mass shifts which are isobaric to several amino acid substitutions. For example, 
the covalent addition of a methyl group to a K, R, E, or Q produces a mass shift that is 
similar to the following amino acid changes: D to E, S to T, V to I/L, and G to A. 
Therefore, all spectra interpreted as both a PTM and a SAAP were discarded to lower the 
identification of false positives. To identify a targeted common set of PTMs, MS/MS 
spectra were analyzed by an automated software tool, InSpecT,
104
 at a peptide FDR of 
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2%. In total, 271 spectra that matched to both a PTM and a SAAP peptide were removed 
from the analysis. Using conservative search criteria, we were able to identify a total of 
1,354 peptides containing a SAAP and 201 peptides that become tryptic due to a K or R 
substitution. Although the new SAAP peptides account for 2% of high-quality unassigned 
spectra, these newly identified peptides correspond to 502 proteins. Among these, we 
identified 97 proteins that had not been previously identified. Interestingly, for those 
proteins containing a SAAP peptide, their overall peptide coverage increased by an 
average 25%. 
 
Due to the widespread distribution of SAAP peptides in the database, it seems probable 
that the detected SAAP peptides would map randomly across the proteome. However, our 
data suggests that the detected population of proteins containing a SAAP peptide map to 
specific and functionally similar groups. Grouping the SAAP proteins into KOGs, the 
vast majority of SAAP proteins belonged to the four specific functional categories: 
unknown function, signal transduction, post-translational modification, and carbohydrate 
transport and metabolism. Although these functional categories are among the most 
abundant categories in phloem and xylem, we note that other abundant functional 
categories, such as general function and translation, do not contain a large number of 
proteins containing SAAPs. Therefore, it appears that the overrepresentation of non-
synonymous substitutions for the aforementioned functional categories is not a result of 
their expression levels, but rather that these proteins are under low selective pressure. 
Although it is unclear how many of these proteins represent evolutionary novelties, future 
comparative proteomics studies may identify expression patterns that reveal the outcomes 
of such mutations. In some instances, the location of these mutations could compromise 
or benefit an enzyme: replacing catalytic, binding, or substrate determining residues with 
amino acids differing in size, polarity, or hydrophobicity can either disrupt or modulate 
the activity of an enzyme. 
 
For example, when looking at the monolignol biosynthesis pathway, we identified a 
SAAP within phenylalanine ammonia lyase (PAL), the entry enzyme into the 
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phenylproponoid pathway. As shown in Figure 3.9, a mass shift of +1 Da and the 
experimental b- and y- ion fragmentation pattern coincides with the predicted SAAP 
substitution of an asparagine (N) with an aspartic acid (D) at position 138. While the 
effect of the observed polymorphism is unknown, the localization of the substitution 
within a few amino acids of the substrate-binding site may impact the binding of 
coumarate to the substrate specificity residues.
105
 Because studies have shown that PAL 
serves as a regulatory control point for the entire pathway,
106
 any mutations 
compromising or altering the activity of the enzyme will, in fact, impact the overall lignin 
content. 
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Figure 3.9. SAAP-resolved peptide identification in PAL. 
(A) MS/MS spectra of the genomic peptide (FLNAGIFGNGTESSHTLPR) and the (B) 
SAAP peptide (FLNAGIFGDGTESSHTLPR). (C) A partial sequence alignment of P. 
trichocarpa (PtPAL) with other members of the phenylalanine ammonia-lyase family 
(PcPAL, P. Crisum and AtPAL, A. thaliana). The yellow box highlights the substrate 
specificity residues and the green box highlights the SAAP position.  
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3.2.3. Evaluating Amino Acid Polymorphisms by Proximal Matched Ion 
Intensities (AAPProxiMIT) 
 
In a later study, we sought an alternative approach to appending predicted protein 
sequence variations to the original database in order to detect novel protein forms. The 
main disadvantage of that approach is the requirement of a priori knowledge of SNPs. 
Moreover, it was preconditioned on both the coverage and quality of the predictions 
when they are available. Therefore, in a follow-up study, we argue that a more attractive 
approach considers unexpected single amino acid polymorphisms, relying on matched 
ion intensity information to help discriminate false positive identifications.  
 
The high-throughput discovery of protein sequence variants (truncations, post-
translational modifications, or mutations), has seen tremendous advancements in recent 
years, with the identification of unexpected variants particularly emerging as 
investigations of interest.
107
 Many database-searching algorithms have been recently 
designed to effectively identify unanticipated (blind) sequence variants at a global level. 
One class of such algorithms uses de novo sequencing in order to infer full-length peptide 
sequences from tandem mass spectra without requiring a sequence reference database.
104, 
108, 109
 A strength of this approach is that the concept of variant peptides is not relevant; 
each spectrum is given an equal opportunity to match any combination of amino acids, 
regardless of whether the researcher anticipated detecting the sequence or not. This 
technique, however, greatly increases the number of candidate peptides compared to each 
spectrum, consequently incurring not only significant costs to processing time but also 
unacceptable false discovery rates (FDR).
110
 In addition, mass spectrometrists have 
developed and routinely used a hybrid approach between traditional database searching 
and de novo approaches: here peptide sequence tagging (PST) algorithms can detect 
unexpected sequence variants as extensions of partial sequences identified from a 
database.
111-114
 In particular, the proteome informatics group led by David Tabb recently 
released a two-step methodology involving the DirecTag algorithm
81
 for highly accurate 
PST tag generation, followed by the TagRecon software
82
 for the detection of peptide 
sequence variants through tag reconciliation. In brief, short sequence “tags” are directly 
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inferred from a tandem mass spectrum and then tags are automatically reconciled against 
representative peptides from a protein database while making allowances for unexpected 
mass shifts (i.e., mutations and post-translational modifications). PSTs serve as a filter to 
effectively reduce the number peptide-spectrum matches being scored, which in turn 
improves costs in processing time, sensitivity, and specificity.
64
  
 
To evaluate a peptide sequence tagging approach for Populus with the ultimate goal of 
globally identifying unknown SAAPs, we employed DirecTag and TagRecon software. 
Using the state-of-the-art LTQ-Orbitrap-Pro platform, we profiled and compared two 
genotypes of P. trichocarpa and revealed a large number of unexpected SAAPs that 
would have otherwise been missed by a traditional database search. The sequence 
variants leveraged from TagRecon demonstrates the value of using peptide sequence 
tagging algorithms to interrogate proteomics data sets, provided that a SAAP location 
could be confidently identified. Therefore, while our initial aim was to comprehensively 
identify SAAPs, we focused on our most abundant sequence variant to show that 
confident site localization remains an important yet challenging task. Since others have 
shown that HCD fragmentation improves the coverage of peptide sequences overall, in 
particular for tryptic peptides up to 15 amino acids in length, we exploited HCD 
fragmentation to further refine a subset of the dataset. 
 
The procedure described above identified a total of 76 types of sequence variants (each 
type denoting an amino acid with a mass shift corresponding to a mutation). Noticeably, 
the occurrence of variants in both genotypes is similar (Pearson correlation = 0.99). 
Peptides and fragment ions containing an oxidation mass shift (+15.99 Da) were the most 
prevalent variant type, representing ~38% of the total assigned spectra for variant 
peptides. While this observation may suggest the two most prominent SAAPs are 
Ala→Ser and Phe→Tyr, we critically evaluated the results by validating each variant 
through manual verification of the MS/MS spectra. In the course of this inspection, we 
observed that the site of +16 Da mass shifts were often in close proximity to a methionine 
residue (see Figure 3.10), which is frequently oxidized during sample processing.  
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Figure 3.10. Identifying the level of ambiguity between adjacent mass shift sites. 
When MS/MS spectra were collected using a high-high (blue) and high-low (red) 
strategy, some spectra that matched to the same peptide sequence but differed in the 
placement of the modification (i.e., at alanine or methionine). (A) The frequency 
distribution of CS illustrates that level of ambiguity is strongly dependent on the 
distances between two potential modifications sites. (B) A matched ion intensity (MIT) 
was calculated for the two site positions and the difference between the matched ion 
intensity values was calculated for each CS as a function of the proximity. A moving 
average trendline was provided for both the high-high (dashed-line) and high-low 
(dotted-line) strategy to highlight the earliest maximal difference in the matched ion 
intensities. 
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Correspondingly, the site of a ΔA=32 Da mass shift, which can correspond to double-
oxidation event or two singly-oxidized alanine residues, was also often found near 
methionine residues. Therefore, the source of the most frequent and abundant SAAPs 
could perhaps be explained away as a “shadow” of the most common sampling 
processing artifact. 
 
Though the presence of a mass shift changes the ion fragmentation pattern of the 
corresponding ions, the fragmentation process is often incomplete. Some mass shifts will 
lead to unique fragmentation patterns, enabling a site to be unambiguously located. On 
the other hand, a mass shift that can occur at adjacent residue sites can introduce 
ambiguity and lead to incorrect localization; the candidate peptide variants will have 
similar theoretical fragmentation patterns and thus similar statistical scores. As the 
distance between the two sites increases, complementary site-determining b- and y-type 
ions together should increase a scoring algorithm’s ability to mitigate the ambiguity 
(Figure 3.11). Therefore, we objectively evaluated how this ambiguity diminishes as the 
adjacency decreases.  
 
The analysis was constrained to ‘DENA’ leaf samples, which contained the highest 
frequency and abundance of ΔA=16 Da mass shifts. Since high mass accuracy of 
fragment ions can help unambiguously annotate fragment ion peaks, a MS run using a 
‘high-high’ strategy, which means full scans (MS) and tandem mass spectra (MS/MS) are 
detected in the Orbitrap analyzer at high resolution and high mass accuracy, was 
simultaneously evaluated with the a MS run that acquired MS/MS scans in the ion trap 
(‘high-low’). The collected spectra were searched by MyriMatch using a directed 
method; only a user-defined mass shift was considered. For both MS runs, two directed 
searches were performed: either a methionine (+16 Da) or an alanine (+16 Da) was 
allowed as a dynamic modification. By searching for the modifications independently, 
the search algorithm interpreted each spectrum, identified the mismatch region containing 
a permissible modification and determined the most probable position of the mass shift 
on either the methionine or alanine. This approach enabled the identification of spectra   
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Figure 3.11. Illustration of site-determining ions. 
Peptide sequence-tagging approaches can readily identify whether a peptide sequence has 
a modification (mass shift), but confident localization of the modified residue still 
remains a challenge. If there are two potential residues that could have modifications, the 
ions between the two sites are the only pieces of information that could provide evidence 
for the modification of one residue over another. Residues that are further away from 
each other within the peptide sequence have more site-determining ions and therefore 
more opportunities for localizing the modification.  
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that were annotated similarly, having the same underlying peptide sequence but differing 
by the location of the mass shift, either on a methionine or a neighboring alanine. For 
discussion purposes, these spectra will be referred as ‘contentious spectra’ (CS). In total, 
the MS searches identified nearly the same number of CS for each analysis strategy – 
37,776 and 38,399 for high-high and high-low, respectively. 
 
As anticipated, the number of CS declined as the distance between the methionine and 
alanine sites increased (Figure 3.10). This observation is the result of an overall increase 
in the number of discriminatory b- and y-ions, which provides a more definitive spectral 
fingerprint. Also shown in this figure, the frequency of CS decreased at a similar rate for 
the two MS strategies. This was expected as both strategies perform collision-induced 
dissociation (CID); the MS/MS spectra will contain the same percentage of backbone 
fragmentation. Interestingly, both MS strategies show a clear inflection point when the 
proximity was ~6 amino acid residues. We suspect that this point represents the distance 
that provides the most discrimination between the two types of mass shifts, 1) those 
belonging to a methionine sulfoxide and 2) those more likely due to a SAAP. For 
distances greater than 6, the mass shift locations likely approach the terminal ends of the 
peptide sequence. In general, mass shifts located near the ends of a peptide sequence tend 
to be assigned less reliably than those near the center, which explains why a level of 
ambiguity remains. These observations are further corroborated by comparing the total 
matched ion intensity (MITs) of the b- and y-ion series for each peptide sequences that 
differed only by the location of a +16 Da mass shift. That is, for each ambiguous 
spectrum, we calculated the difference between the total MIT of the methionine (+16 Da) 
sequence and the total MIT of the alanine (+16 Da) sequence. Figure 3.10 shows the 
distribution of the percent difference between two potential sites for each distance. As 
shown, the maximum difference between the two theoretical mass shift sites occurred 
when the site locations were 6 amino acids apart. Although we suspected a high level of 
uncertainty for proximal sites, we demonstrated the likelihood of precise site localization 
is severely diminished when the number of site-determining b and y ions fall below 12. 
Notably, the vast majority of the CS (68% high-high and 70% high-low) belong to 
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peptides containing two potential possibilities that are less than four amino acids apart. 
Cleary, these spectra have little or no site-determining information for proper site 
placement, which would be necessary for confident SAAP identification. 
 
As others have shown, these observations highlight how precise site localization can be 
challenging for search algorithms when there are few site-determining fragment ions261. 
Presently, additional software is available to calculate the probability of correct 
localization for each site.
115-118
 Though calculating a probability-based score provides a 
measure of certainty, spectra with insufficient site-determining ions (i.e., peptides with 
proximal residue sites and spectra featuring incomplete fragmentation) remain logistical 
problems. In other words, precise site localization in CID fragmentation spectra can be 
difficult when the distance between the two likely sites is less than 6 amino acids apart. 
Nevertheless, an immediate alternative approach is available to provide additional 
information for discriminating between SAAPs and what we suspect is the most common 
chemical modification mistaken for SAAPs: methionine oxidations. 
 
For peptide-sequence tagging, we employed collision induced dissociation (CID), which 
is by far the most frequently used technique in proteomics for peptide sequencing. When 
CID fragmentation techniques are applied, the widely accepted model that describes the 
dissociation process designates b- and y-ion series as the most prevalent types.
119, 120
 The 
primary fragment ions and their contribution to the overall intensity coverage for a single 
CID run are illustrated in Figure 3.12A. In principle, complete coverage of the entire b- 
and y-ion series ions allows full annotation of the amino acid sequence of a peptide. As 
detailed in the section above, this information may be insufficient for definitively 
localizing mass shifts. However, there are alternative fragmentation processes that could 
benefit this task.  
 
Introduced in 2007, higher energy collisional dissociation (HCD) fragmentation became 
available on the Orbitrap platforms.
121
 In a dedicated collision cell, peptide ions are 
subjected to a beam-type fragmentation process, where primary fragment ions retain 
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kinetic energy and are therefore more likely to fragment again. In general, HCD ion types 
are expected to follow the fragmentation rules modeled from CID. Therefore, regular ions 
(b- and y-type ions) derived from backbone fragmentation are expected to be among the 
most abundant types observed. Besides a slightly lower contribution of the b- and y-ion 
series to the total TIC collected in each scan, the observed primary fragment ions and 
their overall intensities in a HCD run are comparable to CID (Figure 3.12B). A prominent 
difference, however, is larger contribution of the a-type ion series, which are derived 
from b-ions by losing CO. Moreover, as a direct consequence of the beam-type 
fragmentation process, the primary fragment ions are subjected to additional 
fragmentation pathways and consequently give rise to various ion types beyond those 
typically observed in CID.
122
 A large portion of such ions are those involving neutral 
losses; the loss of water and ammonia are by far the most frequently observed. Another 
frequently observed class is the neutral loss of an amino acid side chain. In fact, the side 
chain of methionine sulfoxide is prone to cleavage,
123
 producing ions with a specific 
neutral fragment loss (NFL). Since search algorithms only consider backbone 
fragmentation (i.e., a-, b-, and y- ions) and some of their neutral losses (NH3 and H2O), a 
large percentage of the content in HCD spectra remain unassigned. Though many of these 
peaks belong to internal fragment ions and immonium ions, there are peaks which can be 
unambiguously assigned as neutral losses from methionine sulfoxide, based on the 
knowledge of how they fragment and the calculation of their fragment masses. Therefore, 
we exploited HCD fragmentation to identify the presence and precise location of 
methionine oxidations.  
 
Again, the analysis was constrained to ‘DENA’ leaf samples and measurements were 
collected by the LTQ Orbitrap Pro mass spectrometer, which features improved 
sensitivity and HCD capability compared to its predecessors. HCD fragmentation was 
performed in the dedicated octopole collision cell and fragment ions were detected in the 
Orbitrap. To test the suitability of this approach, the collected spectra were searched by 
MyriMatch using a directed method: alanine (+16 Da) was considered as the only 
dynamic modification. With this approach, the search algorithm considers the location of 
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the mass shift irrespective of a neighboring methionine sites. Methionine was 
intentionally neglected during the peptide-spectrum matching process to eliminate the 
MyriMatch scoring system from the discrimination process. HCD spectra that matched a 
peptide sequence containing a modified alanine (+16 Da) and at least one methionine 
were further interpreted. This step restricted the analysis to 4,943 spectra, which matched 
to 1,175 peptides. When annotating HCD peptide-spectrum matches, we looked for the 
presence of the characteristic neutral loss ions from the primary fragment ions (a, b, and 
y) of a peptide containing methionine sulfoxide (Figure 3.12A). As mentioned 
previously, the loss of water and ammonia from primary fragment ions are frequently 
observed. Therefore, these additional small molecule losses were taken into consideration 
when applicable.  
 
For each spectrum, we calculated the percent gain in matched ion intensity when 
considering peaks attributable to the cleavage of a methionine sulfoxide side chain. 
Figure 3.12 depicts their overall contribution for each ion series: 96% of the spectra and 
81% of the peptides exhibit at least one neutral loss from a methionine sulfoxide residue. 
With only a slight increase in the relative abundance of b-ions, the trends observed for 
each ion series (Figure 3.12C) agree with their expected contribution in a typical HCD 
run (Figure 3.12B). The most prominent fragmentation process observed was the neutral 
loss of methane sulfenic acid (CH4SO). This chemical species exhibited a higher 
percentage of side change cleavage relative to the frequencies of the other fragment ions 
and could be observed in 83% of all MS/MS spectra exhibiting side chain loss. Despite 
only occurring when a fragment ion contains a methionine sulfoxide residue, i.e., CH4SO, 
C3H6SO and C3H8SO, the three species could be found relatively abundant in the spectra, 
3%, 1%, and 1% respectively. While their mean contribution to the overall intensity 
coverage was 5%, the maximum additional coverage achievable was 31% (Figure 
3.12D). The gain in spectral information is promising: if searching algorithms could 
consider these characteristic permutations during the identification process, the false 
localization rate of oxidation events would be minimized. It should be noted, that the 
HCD fragmentation process is not only beneficial for the localization of methionine  
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Figure 3.12. Fragmentations statistics of CID and HCD spectra. 
a- (purple), b- (green), and y- (yellow) series were plotted. For each CID spectrum (A) and HCD spectrum (B), the percentage of 
the total ion current (TIC) attributable to a particular fragment ion series was plotted. (C) If a spectrum contained peaks that could 
unambiguously assigned as neutral losses from methionine sulfoxide, the additional intensity coverage for ambiguous spectra was 
calculated. (D) As an example, the HCD spectrum with the maximum additional coverage achievable (31%) was provided. Here, 
only the top 20 most abundant fragment ions were highlighted.  
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 oxidations, but also for other modification events that have characteristic neutral losses, 
such as phosphorylations.  
 
In summary, the identifications of amino acid polymorphisms remains a huge challenge 
in shotgun proteomic experiments. New methods have been developed that allow 
researchers to identify unexpected variants, which improves the speed and throughput of 
these analyses, but the false discovery rate for these identifications is not quite at an 
acceptable level. For many of these analyses, one would more likely prefer fewer false 
positives in order to be very conservative about claiming sequence variants as an amino 
acid change. Using matched ion intensities, however, one can focus on the site 
determining ions surrounding the modified residue and compare quantitative values for 
the evidence supporting that mass shift’s position. An advantage that this project’s 
method affords over other similar algorithms is the inclusion of parameterizable ion 
values, such as the neutral fragment losses from a methionine oxidation measured in 
HCD. By including the intensities of these additional ions, we can more confidently 
support the identification of a common chemical modification (methionine oxidation) 
over the unlikely co-occurrence of a nearby mass shift identifying a mutation from the 
reference genome. 
3.3 Conclusions 
 
These studies directly compared the behavior and advantages of spectral counts and 
matched ion intensities in peptide identification, concluding that using matched ion 
intensities for qualitative and quantitative purposes avoids many of the biases exhibited 
by spectral counts. Most notably, matched ion intensities are more sensitive to their 
chromatographic neighborhood, weighting identifications made in low-complexity 
regions of the chromatogram less than those identifications made in the rich regions of 
the chromatogram. Spectral counts, on the other hand, may be biased in over-representing 
or under-counting identifications in the varying contexts. Matched ion intensities paired 
with peptide sequence tagging affords a finer level of detail in discriminating the correct 
localization of mass shifts along a peptide sequence. In fact, matched ion intensities 
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collected from HCD analysis of peptide-sequence-tagging results refined false positive 
identifications and suggested that the most abundant mutation identified may in fact be a 
known chemical modification. 
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CHAPTER 4:  Peptide to Protein Mapping 
 
 
All of the data presented in Section 4.1.1 and 4.2.1 has been adapted from the 
following journal article: 
 
Paul Abraham,* Rachel Adams,* Richard Giannone, Udaya Kalluri, Priya Ranjan, Brian 
Erickson, Manesh Shah, Gerald Tuskan, Robert Hettich. “Defining the Boundaries and 
Characterizing the Landscape of Functional Genome Expression in Vascular Tissues of 
Populus using Shotgun Proteomics.” Journal of Proteome Research 2012 11(1): 449-460. 
*Authors contributed equally to this work. Sample preparation and mass spectrometry 
experiments were performed by Paul Abraham. The bioinformatic workflow for protein 
grouping was developed by Paul Abraham, Rachel Adams, and Richard Giannone. The 
in-house scripts for protein grouping were created by Rachel Adams. Biological data 
analysis was performed by Paul Abraham. 
 
All of the data presented in Section 4.1.2 has been adapted from the following 
journal article in preparation for submission: 
 
Rachel M. Adams, Richard J. Giannone, Paul Abraham, Robert L. Hettich. “Using 
Cluster-Unique Sequences in Proteomes (CUSPs) to Enhance Confidence in Protein 
Inferences from Shotgun Proteomics Studies of Organisms with Complex Genomes.” 
The bioinformatic workflow for protein grouping was developed by Rachel Adams, Paul 
Abraham, and Richard Giannone. Data analysis was performed by Rachel M. Adams. 
 
All of the data presented in Section 4.1.3 has been adapted from the following 
journal article in review: 
 
Jacque C. Young, Chongle Pan, Rachel Adams, Brandon Brooks, Jillian F. Banfield, 
Michael J. Morowitz, Robert L. Hettich. ”Metaproteomics Reveals Functional Shifts of 
Microbial and Human Proteins in Infant Gut Colonization.” Submitted to Molecular 
Systems Biology. Sample preparation, mass spectrometry experiments were performed by 
Jacque Young. Database searching and reanotation of protein identifications performed 
by Rachel Adams. Biological data analysis was performed by Chongle Pan. 
 
4.1 Using Cluster-Unique Sequences in Proteomes (CUSPs) to 
Enhance Confidence in Protein Inferences 
 
4.1.1. Outlining Existing Solutions to the Protein Inference Problem 
As a property of evolution, genetic redundancy is rampant across the eukaryotic 
kingdom. In fact, many eukaryotic organism genomes have been duplicated more than 
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once in their evolutionary past. As a result, the majority of genetic redundancy observed 
is between gene homologues. Immediately after gene duplication, these genes (i.e., 
proteins) are believed to be functionally redundant. It is generally assumed that one of the 
redundant genes is initially free of all selective pressure, allowing the gene to acquire 
advantageous (i.e., neofunctionalization) that may lead to a new function. Consequently, 
the function of some duplicated genes may only be partially redundant. 
 
Redundancy in the genomes, and therefore proteomes, of the samples under investigation 
often results in a single peptide mapping to multiple proteins. The protein inference 
problem acknowledges the ambiguity in asserting the presence of a protein whose 
peptides are shared among other proteins
74, 97, 124
. There are two traditional approaches to 
counting protein identifications in light of the protein inference problem: 1.) maximal 
lists ignore the ambiguity and count all proteins that are implicated by at least one 
detected peptide, or 2.) minimal lists avoid the ambiguity and count only proteins that are 
implicated by at least one database-unique peptide.
125
  Depending on the proportion of 
unique peptides detected within an MS sample, a single dataset can be interpreted to have 
two wildly different protein identification counts. For higher eukaryotes that have a high 
degree of proteomic redundancy due to large protein families, multiple gene duplications, 
and different gene models, there is a need for an intermediate protein identification list 
that is flexible enough to accommodate these ambiguities without leading to over-
inflation. 
 
A recent nomenclature developed by Yang et al in 2004 has been used to classify proteins 
according to their number of unique peptides.
88
 This parsimonious naming system 
consists of three main classes of proteins: indistinguishable proteins are those identified 
without any unique peptides detected, differentiable proteins are those identified by 
detection of some unique and some non-unique peptides, and distinct proteins are those 
identified by detection of only unique peptides.
88
 While classifying proteins based on 
their degree of uniqueness highlights which proteins have more definitive or ambiguous 
peptide evidence than others, the naming convention does not provide means to handle 
  114 
differentiable proteins. Although the most common approach to addressing the protein 
inference problem is to apply Occam’s Razor (minimal lists) using this parsimony 
nomenclature, the number of confident protein identifications (i.e., proteins with at least 
one distinct peptide) is severely reduced in eukaryotic organisms because of the 
prevalence of shared peptides.
75
 Therefore, objectives of this study encompass 
developing a bioinformatic workflow that reflects our ability to analytically and 
biologically distinguish identifications of closely-related proteins. 
 
Since genes (i.e., proteins) with extensive sequence similarity have a high likelihood of 
performing similar biological roles in a cell, they can be collapsed together by sequence 
homology algorithms. By grouping homologous proteins together, this consolidates 
indistinguishable proteins into a meaningful report, while preserving biological 
information. The research presented in this dissertation has demonstrated that this 
provides a means to alleviate the majority of ambiguity associated with shared peptides. 
Similar to a peptide being unique to a protein within the database, many shared peptides 
are found to be unique to a particular protein group. Although in some cases it may not be 
clear as to which member of a protein group is actually present in a given sample, the 
identification of peptides belonging to a particular protein group likely indicates the 
presence of a shared functional process. Despite sacrificing some level of protein 
resolution, this approach accurately resolves protein ambiguity as a result genetic 
redundancy. 
 
4.1.2. Choosing Appropriate Identity Thresholds 
 
In order to provide a means of identifying and grouping proteins that share a large portion 
of their constituent peptides, proteins that shared a high degree of sequence similarity 
were clustered into protein groups. The software UClust v4.0 sorted the protein database 
by descending length and performed a pairwise comparison of each protein’s sequence to 
the running list of “seed” proteins. If a protein shared a high degree of sequence 
similarity with a seed, the protein was considered a “hit” and joined the protein group. If 
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a protein did not pass the minimal sequence similarity threshold with any of the existing 
seeds, it became a new seed against which subsequent proteins could be compared. The 
final seeds provided a simplified representative list of proteins that were referenced for 
further downstream analysis including quantitative and functional annotation. 
 
The shared peptide problem is essentially when a single peptide can map to multiple 
proteins. This problem is exacerbated if multiple peptides are identified which each may 
infer the presence of several proteins or worse yet, if the majority of the proteins can only 
be described by shared peptides. Before any measurements are collected, one can predict 
the number of unique peptides within a database and calculate how many of the proteins 
are likely to be detected by a unique peptide. It may be the case that only a few peptides 
are shared by many proteins or a few proteins are shared by many peptides, in which 
case, the relative small number of ambiguous assignments may minimally impact the 
collected data. Graphs in the right half of Figure 4.1 illustrate the number of unique 
peptides per protein across the proteomes of E. coli, Mus musculus, Arabidopsis thaliana, 
and Populus trichocarpa. Zea mays and Oriza sativa were also analyzed, but are not 
featured in this figure. Red dashed lines along the diagonal represent where the data 
points would fall if all of the peptides within a protein were unique (100% distinct 
peptides per protein), while black dotted lines indicate linear regressions of the observed 
data. Of the proteomes considered, the Zea mays proteome contains the most redundancy. 
The data’s large deviation from the diagonal (R2 = 0.02) indicates that many of its 
proteins had dissimilar proportions of unique peptides, but more notably, over 75% of its 
proteins had >95% shared peptides. In other words, only a quarter of the proteome was 
theoretically not in danger of suffering an ambiguous assignment due to shared peptides. 
Among the plant proteomes, Arabidopsis seemed to be the least affected by shared 
peptides, although 25% of its proteins had more than 95% shared peptides. This may be 
due to the fact that Arabidopsis is very well-characterized and/or because it is a diploid 
that underwent a whole genome duplication event much further ago than the other plants 
considered in this analysis. Interestingly, the length of the protein has very little 
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correlation with the number of shared peptides, so proteins with few or many peptides are 
equally likely to be affected by the shared peptide problem. 
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E. coli 
4,286 total proteins  
  
Figure A: 
Highly redundant: 78 (1.82%) 
 
Figure B: 
Expect to detect: 2,522 (58.84%) 
Expect to detect & highly redundant: 38 (0.89%) 
Mus musculus 
43,895 total proteins 
  
Figure C: 
Highly redundant: 6,724 (15.33%) 
 
Figure D: 
Expect to detect: 25,098 (54.97%) 
Expect to detect & highly redundant: 14,470 
(33.01%) 
 
 
(continued on next page…) 
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Arabidopsis thaliana: 
35,360 total proteins 
  
Figure E: 
Highly redundant: 8.860 (25.06%) 
 
Figure F: 
Expect to detect: 22,154 (62.65%) 
Expect to detect & highly redundant: 9,197 
(26.01%) 
Populus trichocarpa: 
73,014 total proteins 
  
Figure G: 
Highly redundant: 32,185 (44.10%) 
 
Figure H: 
Expect to detect: 46,992 (64.39%) 
Expect to detect & highly redundant: 33,736 
(46.22%) 
 
(continued on next page…) 
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Figure 4.1. Increased redundancy in higher eukaryotes decreases the potential of 
detecting unique regions within individual proteins. 
Graphs in the right half of this figure (ACEG) illustrate the number of distinct peptides 
per protein across the proteomes of E. coli, Mus musculus, Arabidopsi thaliana, and 
Populus trichocarpa. Black dotted lines indicate linear regressions. Protein redundancy is 
evaluated by the percentage of distinct peptides per protein (“highly redundant” proteins 
have less than 5% of their peptides distinct within the proteome). Graphs in the left half 
of Figure 4.1 (B, D, F, H) illustrate the number of distinct peptides per protein that are 
likely to be detected by an ESI-MUDPIT experiment (p > 0.9), according to 
PeptideSieve. 
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Optimistically, we hypothesized that many of the shared peptides may not be MS-
friendly, and due to their minimal probability of detection, might alleviate the severity of 
the shared peptide problem among these proteomes. After running the proteomes through 
PeptideSieve,
102
 software that calculates the likelihood of peptide detection by ESI-
MudPIT analysis, graphs of unique peptides per protein were constructed in the same 
format as before, but this time, with only those peptides that were likely to be detected (p-
value > 0.9). From this analysis we were looking for 2 metrics: how many of the proteins 
did we expect to detect (at least one peptide with p-value > 0.9), and of those proteins, 
how many were highly-redundant (>95% shared peptides). In general, the trends across 
proteomes were about the same as the previous analysis. Interestingly, the proteome with 
the highest percentage of detectable proteins was Populus (64%), which had 46% of its 
detectable proteins designated as highly redundant. In comparison, Arabidopsis had 63% 
detectable proteins, but only 26% of these proteins were highly-redundant. Zea, on the 
other hand, had very few proteins expected to detect, but of those detectable proteins, 
80% were highly redundant. Therefore, while Populus and Zea show different 
manifestations of a shared peptide problem, they will both have difficulty with protein 
inference. 
 
The goal of clustering a database by the protein sequence identity is to anticipate the 
prevalence of shared peptides within the proteome and to alleviate ambiguous protein 
inferences by grouping together proteins that we are unlikely to analytically distinguish 
under standard conditions. However, in the process of collapsing multiple protein 
identifications into one representative, it is just as important to ensure that whatever 
distinguishable evidence was initially available can still be used to confidently identify as 
many individual proteins as possible. Lowering the threshold of sequence similarity for 
clustering proteins together results in larger, fewer protein groups in the proteome and 
may potentially result in loss of noteworthy distinctions among protein identifications 
and abundances. Therefore, it’s important to analyze the tradeoff between lowering a 
threshold of sequence similarity and the reducing the number of representative proteins.  
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Figure 4.2. Graphs of the percent of unique peptides per protein as a function of sequence similarity thresholds applied to E. coli, 
Mus musculus, Arabidopsis thaliana, Populus trichocarpa, and Zea mays (by row). 
The columns represent the proteomes clustered at 100%, 95%, and 85%.  
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To determine the impact of clustering on the number of unique identifications within a 
proteome, the percent of unique identifications compared to the total number of 
identifications was graphed across a range of identity thresholds (Figure 4.2). Four 
proteomes were clustered at conservative thresholds (100%, 95%, 90%, 85%, and 80%) 
and the resulting percent of unique peptide (y-axis) were graphed according to each 
protein group’s number of total peptides (x-axis). For the purposes of the remainder of 
this discussion, we will refer to the identity thresholds as their fractional values (id = 1, 
0.95, 0.9, 0.85, and 0.8). These graphs help visually compare how the unique peptides are 
distributed among protein groups at each identity threshold, but the goal of this exercise 
was to pinpoint at which threshold the majority of the protein groups were characterized 
by 80% unique peptides. For E. coli, id = 1 clustering was sufficient to achieve this 
characteristic, but for the eukaryotic organisms surveyed, the thresholds varied slightly. 
Clustering Arabidopsis at id = .95 resulted in 89% of the proteins >80% unique peptides. 
In fact there was very little difference in the number of proteins >80% unique peptides 
when the proteome was clustered at 90% (74%) and 85% (78%). Clustered at id = 1, the 
Populus proteome almost looked like an inversion of the Arabidopsis graph at id = 1. 
That is, in the Populus proteome, there were two main distributions of proteins: those that 
had 0-20% unique peptides (representing the majority of the protein groups) and those 
that had 80-100% unique peptides. Based on the number of protein groups with >80% 
unique peptides, the Populus proteome could be clustered at either id = 0.85 or id = 0.9. 
The differences between these annotations (76% of protein groups clustered at id = 0.9 or 
80% of protein groups clustered at id = 0.85) are quite small, suggesting that one should 
probably choose the more conservative threshold (id = 0.9). Oriza also demonstrated little 
gains, but its contentious thresholds were id = 0.8 and id = 0.75. At these clustering 
levels, the Oriza proteome generated 74% and 78% protein groups with mostly unique 
peptides. Again, to be as conservative as possible, the id = 0.8 was suggested to be the 
identity threshold that would be most appropriate. Zea, however, behaved unlike all of 
the other proteomes considered. Even at id = 0.85, it had only 60% of its protein groups 
having >80% unique peptides. Once the threshold was lowered to id = 0.75, 70% of its 
protein groups had predominately unique peptides. In summary, each of the genomes 
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considered suggested different identity thresholds in their assessment of the number of 
unique identifications. These recommended values are not meant to be exact rules, but 
merely guidelines based on what is most likely analytically distinguishable under 
theoretical conditions. Had we encountered a proteome that was still exceedingly 
redundant and lacked unique identifiers even after clustering at id = 0.5, we would 
suggest that clustering based on such low values may substantially lose biological 
meaning. Under such circumstances, in addition to the assumed critical evaluation of a 
clustering threshold selected during routine analyses, it is more important that a 
researcher’s discretion should be relied upon to inspect and validate the chosen clustering 
threshold.  
 
4.1.3. Rescuing Identifications that Would Otherwise be Lost 
 
One method of evaluating the application of a certain threshold is to consider the number 
of proteins identified in a mass spectrometry run that would have been thrown away due 
to their lack of database-unique peptides, but that are rescued by evidence of cluster-
unique peptides. Whereas the previous section focused on the theoretical distribution of 
peptides that could be generated from a proteome and their unique status, assessing the 
impact of clustering on a real dataset of Populus trichocarpa proved to be particularly 
helpful in validating the guidelines we had chosen. Figure 3 graphs proteins that were 
thrown out of a search using the 1 unique peptide rule, but were rescued after the results 
were reannotated into protein groups. The x-axis marks the range of identity thresholds 
that we tested, while the y-axis indicates how many proteins were rescued. The figure 
suggests that our recommendation of id = 0.85 or 0.9 match the inflexion points where 
the number of proteins rescued quickly diminishes as the threshold becomes more 
conservative.  
 
Numbers of peptides, proteins, and protein groups observed in one MS run were 
compared using the two traditional ways to count proteins and the suggested clustering 
method. In one MS run from the Populus dataset, 10,154 non-redundant peptides were 
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identified. After clustering the database by 90% sequence similarity, the number of 
protein groups identified (2,312) was between the counts tallied by the traditional 
approaches: maximal (3,968 proteins) and minimal (1,880 proteins). Of these 2,312 
protein groups identified, there were 2,055 that had at least one cluster-unique peptide. 
 
The degree of confidence in protein identification is directly related to the number of 
unique peptides assigned to a protein, but the overall unique status of a protein can be 
more specifically classified by a widely-used nomenclature, as mentioned previously. 
After clustering the database by 90% sequence similarity, the percentage of non-unique 
protein groups identified (11%) was far greater than the percentages tallied by the 
traditional approaches (52%). Overall, the percentage of protein groups identified as 
cluster-unique was approximately the same as the percentage of all protein groups 
identified, demonstrating increased confidence in the identifications assigned by the 
clustering method. The percentage of distinct proteins for clustered data (66%) was 
higher than the combined percentages of differentiable (37%) and distinct (26%) proteins 
for unclustered data. The shift in the percentage of distinct protein groups increases 
confidence in protein group identifications. Therefore, we feel confident in the use of id = 
0.9 for the Populus proteome after assessment of its behavior theoretically and in a real 
dataset.  
 
4.1.4. Spectral Balancing to Distribute Abundance Measurements 
 
Typically, a protein’s spectral count is the sum of its peptides’ spectral counts but 
clustering proteins into protein groups necessitated methods of assigning spectral counts 
to the representatives of the protein groups. After an MS dataset was searched against an 
unclustered database, the protein identifications were reannotated to their representative 
seed protein names. For peptides that were shared by multiple protein groups, there are 
several ways we could have assigned spectral counts, but they generally fell into one of 
two categories: adding the peptide’s full spectral count to each of its proteins, or adding a 
partial spectral count to each of the peptide’s proteins (Figure 4.3 below). 
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Figure 4.3. Possible ways to assign spectral counts when a peptide is shared among 
multiple proteins. 
 
 
Spectral balancing, one of the more effective methods to calculate what portion of a 
spectral count is added to a particular protein, involves a weighting system determined by 
each protein’s number of unique peptides (Figure 4.3, Eq. 2). The algorithm collects all 
of the proteins that share the peptide and sums the total number of unique peptides found 
within those proteins. Then, it calculates the proportion of unique peptides contributed by 
each protein and divides the shared peptide’s spectral count accordingly. Ultimately, the 
proteins with the greater proportion of unique peptides get a greater share of the shared 
peptide’s spectral counts. In order to apply this method into a clustered dataset, all of the 
peptides that once belonged to the individual proteins were added to the seed proteins and 
their uniqueness was reassessed. The seed proteins’ spectral counts were re-calculated 
using a spectral balancing method based on cluster-unique peptides.  
 
4.1.5. Preserving Functional Annotations 
 
Clustering proteins based on shared sequence similarity was primarily motivated to 
improve confidence in reporting protein identifications as well as protein abundance 
measurements, but the take home message from most comparative proteomic analyses 
primarily revolve around tethering identifications and abundances to functions. What is 
  128 
this protein or group of proteins doing differently in this condition compared to that 
condition? Ultimately, then, clustering has a huge impact in terms of what and how many 
functional components are observed within a sample. Therefore, we were wanted to 
determine whether applying the clustering method changed the overall distribution of 
functional categories in the Populus proteome. The distribution of KOG categories within 
the Populus proteome were compared based on the percentages of identifications and 
spectral counts of unclustered and clustered data. First, a “theoretical” comparison was 
made using the entire list of identifications in the unclustered proteome and the clustered 
proteome (id = 0.9). Interestingly, the theoretical KOG category distribution of proteins 
within a proteome does not change significantly when the identifications come from the 
unclustered database (including all proteins from the proteome) versus the clustered 
database (using only representatives from each protein group). This suggests that each 
functional category benefits equally from the clustering threshold set at 90% and that 
each representative protein in fact captures the same general information of its members. 
From this observation, we feel confident that this clustering method preserves qualitative 
information. The second graph in Figure 4 compares the quantitative observations from a 
single representative MS analysis of Populus leaf. The detected KOG category 
distributions of proteins from two different samples maintain integrity whether the 
spectral count comparison is generated from an unclustered or clustered database. The 
ratios of spectral counts between samples are kept intact for each KOG category, 
suggesting clustering preserves quantitative information as well. 
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4.2 Applying CUSPs to Large-Scale Proteomic Datasets 
4.2.1. Applying Clustering: Defining the Boundaries of Functional Genome 
Expression in Populus using Bottom-up Proteomics. 
 
In this study, current experimental and computational approaches were employed to 
obtain a broad proteome profile of Populus vascular tissue. The experimental context 
includes 1) a large Populus sample set consisting of two genotypes grown under normal 
and tension stress conditions182, 2) bioinformatics clustering to effectively handle gene 
duplication, and 3) an informatics approach to track and identify single amino acid 
polymorphisms. Together, the integration of deep proteome measurement on an extensive 
sample set with protein clustering and characterization of peptide sequence variants has 
provided a level of proteome characterization for Populus that has not yet been observed. 
 
To generate a high-coverage proteome profile, we performed bottom-up proteomics on a 
large sample set consisting of subcellular fractions (soluble, pellet) of two tissue types 
(xylem, phloem) from two Populus species: P. deltoides and P. tremula x alba. Using 
the most recent Populus genome draft (v2.0, 
http://www.phytozome.net/cgi-bin/gbrowse/poplar/), tandem mass spectra from 60 
Populus proteome measurements collectively identified 7,505 total proteins and 33,233 
tryptic peptide sequences with an overall false discovery rate of <1% at the protein level. 
Combining the proteome measurements together provided a global view of protein 
expression involved in vascular tissue development, resulting in protein assignments for 
~17% of the predicted Populus proteome. Approximately 40% of all detected proteins 
belonged to three specific functional categories based on 24 EuKaryotic Orthologous 
Groups (KOGs): 1) unknown function, 2) post-translational modification and turnover, 
and 3) signal transduction. The remaining identified proteins are scattered across the 
other functional categories. 
 
Shotgun proteomics employs a peptide-centric approach that relies on the ability to 
accurately assemble and assign thousands of measured peptides to reference proteins in 
biological samples. Although this is the conventional method for identifying proteins in 
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large-scale studies, this approach presents several challenges when assigning peptides to 
proteins in higher eukaryotes. The most common issue deals with inferring a protein’s 
existence through the identification of peptides that constitute its primary structure. 
Protein inference becomes problematic when two or more proteins share peptides.
75, 97, 124
 
Shared or degenerate peptides are natural occurrences that originate from protein 
homology, conserved protein domains among various proteins, splice variants, and 
redundant entries due to gene duplication events, all of which are common in plants184-
185. Compared to A. thaliana, the Populus genome is highly genetically redundant, such 
that two-thirds of protein-coding genes share sequence similarity greater than 90% 
(Figure 3.2A-B). After performing an in silico digest of the A. thaliana protein reference 
database, there were ~4.3 million fully tryptic peptides in the database. Out of those, 
~320,000 peptides are shared between two or more proteins. After completing an in silico 
digest of the P. trichocarpa reference protein database, ~6.3 million fully tryptic peptides 
were present and, of those, ~2 million are shared between two or more proteins. Clearly, 
the level of genetic sequence redundancy is extensive in the Populus proteome. 
Therefore, within these large data sets emphasis must be placed on accurate identification 
and validation of proteins, accounting for highly conserved, shared peptides. 
 
In previous studies, the categorical nomenclature of Yang et al. (2005) has been adapted 
to rationally organize the peptide data from each LC-MS/MS experiment.
88
 Several 
research groups have shown that this nomenclature can be coupled with Occam’s razor 
constraints to provide a minimal list of proteins to explain all observed peptides.
75
 Using 
this classification method, we consolidated protein assignments by their level of 
uniqueness. Proteins that consist of only uniquely identified peptides were classified as 
distinct proteins. Proteins were classified as differentiable when they contain at least one 
peptide that is unique to that locus, as well as one or more peptides that map elsewhere in 
the proteome. The indistinguishable proteins consisted of only measured non-unique 
peptides that map elsewhere in the data set. Within our entire data set, only 50% of the 
tryptic peptides identified were classified as unique to the database. Therefore, out of the 
7,505 total protein identifications in the present study, 3,510 proteins were uniquely 
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identified (classified as distinct or differentiable) and 3,995 proteins were categorized as 
non-unique or indistinguishable (Figure: 3.2C-D). 
 
 
Using the nomenclature above, we generated a minimal list of proteins that were 
conclusively determined to be present within the data set. However, due to the inherent 
ambiguity of the Populus proteome, less than 50% of the proteins categorized by the 
above-mentioned criteria could be used for biological interpretation. In addition, due to 
the extensive homology within the database, a vast majority of the proteins were 
classified as indistinguishable. As most of the proteins in this category contain no unique 
peptides, it was difficult to determine which specific proteins were present in the sample 
using an MS-based approach. As shown in other studies, one approach for proteins that 
cannot be distinguished on the basis of identified peptides is to collapse these into protein 
groups to provide a more accurate and informative data set.
126, 127
 In an attempt to 
reconcile this problem, a bioinformatics workflow was incorporated to better handle 
proteins sharing high sequence homology (90%) to increase qualitative accuracy by 
avoiding the over- and under-identification of homologous proteins. 
 
Briefly, proteins sharing 90% or more sequence identity were clustered into groups by 
UCLUST, a clustering algorithm functionally equivalent to BLASTP.
128
 Each protein 
group was defined by a representative protein sequence called a seed, where each seed 
shares >90% sequence identity to each protein in that cluster. By applying the clustering 
algorithm to the Populus database, the number of protein entries decreased from 64,689 
proteins to a total of 43,069 protein groups. Implementation of clustering to the data set 
reduced the 7,505 observed proteins to a total of 4,226 protein groups (see Methods), in 
which 2,016 were singletons (i.e., a one-member group). This reduction implies that 
~50% of the observed proteins were clustered into groups that shared extensive sequence 
homology. Therefore, this approach effectively consolidates indistinguishable proteins 
into a meaningful report. Although grouping proteins by high sequence similarity 
undoubtedly sacrifices some level of protein resolution, it is reasonable to assume that 
proteins with this level of sequence homology share similar biological functions. 
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Furthermore, integrating the clustering approach with the initial SEQUEST analysis 
provided a means to categorize which members of a protein group were unique. 
 
Due to the peptide-centric nature of shotgun proteomics, it was imperative to report 
peptides in the context of proteins groups. As expected, clustering proteins into groups 
alleviated some of the ambiguity associated with shared peptides. Similar to a peptide 
being unique to a protein within the database, we found many peptides were unique to a 
particular protein group within the clustered database. In fact, 68% of previously shared 
peptides that were classified as non-unique to the Populus database were reclassified as 
unique to the clustered database. Moreover, the bioinformatics workflow generated a data 
set where 84% of the detected peptides were classified as unique. Therefore, rather than 
disregarding these peptides from the analysis, they were rescued and used for biological 
insight. While it may not be clear as to which member of a protein group is actually 
present in a given sample, the identification of peptides belonging to a particular protein 
group likely indicates the presence of a shared functional process, especially considering 
the relatively stringent similarity cut-off (90%) applied to the protein database.
129
 
 
Here, we investigate the growth and development of the tree vascular network, which 
involves a complex system that integrates both molecular signaling components and 
regulation of protein expression. In higher plants, this elaborate network exists in two 
vascular tissues, phloem and xylem. Spanning the entire length of plants, these extensive 
vascular networks are responsible for the distribution of water and essential nutrients 
across long distances to vital locations. A recent study used bottom-up proteomics to 
examine proteins expressed during xylem development.
130
 This approach demonstrated 
an ability to robustly characterize xylem tissue in Populus by vastly increasing the 
number of proteins identified and characterized relative to previous Populus proteome 
studies.
131
 In the current study, a similar experimental approach was applied to identify 
and contrast the relationship and dissimilarities between the xylem and phloem 
proteomes. A “core” proteome was extracted from the entire data set, consisting of 2,627 
protein groups that were confidently identified in both xylem and phloem. The core 
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proteome, encompassing 59% of the total proteins identified in the Populus data set, 
includes proteins representing each KOG category. The core metabolic signature is 
consistent with other studies that show an overrepresentation of proteins that are involved 
in energy production and translation.
132
 Moreover, a similar quantitative distribution 
profile was also observed during xylem development.
130, 133
 In addition, these functionally 
and spatially separate vascular networks contain tissue-specific proteins: 606 unique 
xylem proteins-groups and 461 unique phloem protein groups, each having a distinct 
metabolic profile. 
 
4.2.2. Applying Clustering: Putting the Pieces Together: High-performance 
LC-MS/MS Provides Network-, Pathway-, and Protein-level 
Perspectives in Populus 
 
In an effort to generate a high-density proteomic atlas that accurately captures the 
predicted Populus proteome, individual proteome maps of the four major organ-types 
were integrated. In total, we performed multiple (5-6 each) LTQ Velos ion-trap mass 
spectrometry measurements on proteome extracts from root, stem and both mature (fully 
expanded, leaf plastichronic index (LPI) 10-12) and young leaf (LPI 4-6) samples. The 
resulting tandem mass spectra (MS/MS) were searched (SEQUEST) against the most 
recent protein database of P. trichocarpa, containing 45,778 predicted proteins and 
supplemented with the chloroplast and mitochondrial proteomes. 
 
In plants, the task of assigning identified peptides to their respective proteins is not 
trivial. Due to the peptide-centric nature of shotgun proteomics, peptides that map to 
multiple proteins in a reference database can lead to ambiguous identifications. Within 
higher eukaryotes, this imposes a considerable challenge because shared or degenerate 
peptides, which result from segmental duplications, homologous proteins or splicing 
variants and comprise a large fraction of total extracted peptide library.
134-136
 To date, 
there are different methods for aggregating MS evidence for protein assembly.
97
 As 
discussed in Chapter 3, the most advantageous framework to classify and validate protein 
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identifications in higher eukaryotes should include the following: 1) a means to report the 
minimum of proteins implicated by at least one unique peptide and 2) the ability to 
account for database redundancies by clustering similar proteins into groups by sequence 
homology. 
 
Using the principle of parsimony with Occam’s razor constraints, 7,720 Populus proteins 
were confidently identified (classified as distinct or differentiable), and 4,520 proteins 
were categorized as indistinguishable. Although widely used, the guidelines in the 
suggested nomenclature make data interpretation more complicated and less accurate, 
especially in highly redundant proteome databases like Populus. 
 
For this reason, we proposed a strategy that incorporates additional supporting 
information (i.e., sequence homology) to better infer the existence of proteins. While this 
approach can be applied to bottom-up proteomic studies of plants in general, it confers 
demonstrable advantages for Populus specifically. Proteins sharing 90% or more 
sequence identity within the Populus database were clustered into groups. Each protein 
group was defined by a single representative protein sequence called a seed, where each 
seed shares ≥90% sequence identity with all other members of that group. Observed 
peptides from the originally searched protein entries were then directly referenced back to 
the clustered database. For the current data set that included 63,056 tryptic peptides, 
~25% were previously shared within the original Populus database (non- 
unique/degenerate) but were reclassified as unique to a particular protein group in the 
newly constructed database. This illustrates the advantage of implementing a “protein 
group-centric” approach, such that including information about sequence homology 
allows the interpreter to readily assess the relatedness between shared peptides of 
indistinguishable proteins derived from gene duplication and splice variants. Moreover, 
as clustered proteins are ≥90% similar to one another, members of a particular group 
likely exhibit similar functional roles which, when applied to semi-quantitative 
proteomics, allows for a more robust analysis of functional signatures across conditions, 
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time points or organ types. In other words, this strategy effectively reduces the 
complexity of the functional analysis and biological interpretation of plant data. 
 
Based on this approach, a total of 11,692 protein assignments across all organ- types were 
reduced into 7,538 protein groups at an average false-discovery rates of <1% at the 
peptide level. Protein groups were populated by as many as 21 members, with one- 
membered groups (i.e., singletons) representing only 36% of the total. In total, we were 
able to measure 25% of the predicted proteins for Populus. Generating complete 
proteome maps of higher organisms is a difficult task as it is unlikely the entire ensemble 
of polypeptide species encoded by a genome will be expressed at any given time. 
Nevertheless, this integrated data set provides an “information backbone” that captures 
baseline protein expression across spatially and functionally distinct pathways. This 
holistic view of plant-wide protein expression will provide a better understanding of the 
detected components (i.e., proteins, pathways, etc.) in the context of relationships 
between organs. 
 
4.2.3. Applying Clustering: Metaproteomics Reveals Functional Shifts of 
Microbial and Human Proteins in Infant Gut Colonization 
 
Microbial colonization of the human gastrointestinal tract plays an important role in 
establishing health and homeostasis. However, the time-dependent functional signatures 
of microbial and human proteins during early colonization of the gut have yet to be 
determined. Thus, we employed shotgun proteomics to simultaneously monitor microbial 
and human proteins in fecal samples from a healthy preterm infant during the first month 
of life. Microbial community complexity and functions increased over time, with 
compositional changes that were consistent with previous metagenomic and rRNA gene 
data indicating three distinct colonization phases. Overall microbial community functions 
were established relatively early in development and remained stable. Detected human 
proteins included those responsible for epithelial barrier function and antimicrobial 
activity. Some neutrophil-derived proteins increased in abundance early in the study 
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period, suggesting activation of the innate immune system. Likewise, abundances of 
cytoskeletal and mucin proteins increased later in the time course, suggestive of 
subsequent adjustment to the increased microbial load. This study provides the first 
snapshot of coordinated human and microbial protein expression in the infant gut during 
early development. 
 
A search database was generated from the predicted protein sequences of dominant 
members reconstructed from metagenomic sequences collected on days 10, 16, 18, and 
21 from matched samples. These included a Serratia species UC1SER, two closely 
related Citrobacter strains, UC1i and UC1ii, an Enterococcus species UC1ENC, and 
associated virus and plasmids UC1ENCp, UC1ENCv, and UC1CITp. Since samples from 
early time points were not represented in the metagenomic sequences, the following 
additional isolate sequences, selected based on 16S rRNA data, were also included in the 
database: Arcobacter butzleri RM4018, Acinetobacter junii SH205, Bacteroides fragilis 
NCTC 9343, Bifidobacterium adolescentis ATCC 15703, Bifidobacterium longum 
infantis ATCC 15697, Campylobacter concisus 13826, Clostridium sporogenes ATCC 
15579, Enterobacter cancerogenus ATCC 35316, Escherichia coli K12 DH10B, 
Eubacterium rectale ATCC 33656, Fusobacterium sp. 1_1_41FAA, Klebsiella sp. 
1_1_55, Lactococcus lactis subsp. lactis KF147, Lactobacillus reuteri 100-23, 
Leuconostoc mesenteroides cremoris ATCC 19254, Pseudomonas aeruginosa PAO1, 
Staphylococcus aureus 04-02981, Streptococcus sp. 2_1_36FAA, Weissella 
paramesenteroides ATCC 33313 (acquired from JGI: http://www.hmpdacc-
resources.org/cgi- bin/img_hmp/main.cgi in January of 2011 ).  
 
Since mass spectrometry based proteomics identifies proteins by their corresponding 
peptide sequences, data analysis must take into consideration the high levels of protein 
redundancy within and between species to avoid inflating the total number of proteins 
identified or misinterpretation of the biological conclusions by over- representing 
proteins with the same function. Therefore, we applied a bioinformatic clustering 
algorithm to the database in order improve confidence in protein identification and 
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quantification. Different similarity thresholds were chosen to reflect the higher level of 
redundancy in the human genome due to gene duplications, splice variants, and multiple 
protein isoforms. Microbial proteins were clustered using more stringent criteria in order 
to preserve species information and distinguish functional contributions of different 
community members. Specifically, using the publically-available software, USEARCH 
v.5.0,
128
 microbial proteins were clustered into a protein group if they shared 100% 
amino acid identity, and human proteins were clustered into a protein group if they 
contained ≥90% amino acid similarity. These differing similarity thresholds were chosen 
based on the higher numbers of paralogous proteins present within the human genome, 
and were supported by plotting similarity thresholds ranging from 0.5-1 against the 
percent proteome reduction via clustering. In fact, the clustered microbial metaproteome 
had 0.5% of its protein groups with more than one member and the clustered human 
proteome had 36% of its protein groups characterized by multiple members. Spectral 
counts were assigned, balanced, normalized, and adjusted according to methods 
previously described, yielding adjusted NSAF values.
103, 137, 138
 In total, 4,413 microbial 
and 3,062 human protein groups were detected across the dataset. Protein groups range 
from singletons to groups that contain multiple protein isoforms. 
 
By measuring both microbial and human proteins simultaneously in each run, we 
observed an increased complexity of the microbial composition and a decrease in the 
ratio of total human/microbial proteins with time (Figure 4.4). At the earliest time point, 
when the initial microbial communities were being established, human proteins 
comprised ~96% of all proteins identified (day 7). The low microbial load may be a 
consequence of antibiotic administration during the first week of life for this particular 
infant. Human proteins comprised ~72% of the identified protein dataset on day 13, and 
by day 15 the percent of human proteins decreased to ~30%, with a concomitant increase 
in the number of microbial proteins detected. The ratio of human to microbial proteins 
remained at this level for the remainder of the times measured, with the exception of day 
20, when an unexpected rise in human proteins was detected. Microbial proteins detected 
in this time course study are consistent with metagenomic inference of three distinct  
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Figure 4.4. Graph of the ratio of total human/microbial proteins with time. 
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 colonization phases with vastly different species composition. Despite temporal changes 
in microbial community composition, the overall functions of the community increase in 
complexity with time, stabilize relatively early, and remain remarkably conserved 
thereafter. Thus, this study provides detailed information about the microbial and human 
proteins in fecal samples from a newborn premature infant during the first month of life, 
and reveals the complex-but-synergistic interplay of host adaptation to microbiome 
establishment.  
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4.3 Conclusions 
 
In this project, we developed a potential solution to the protein inference problem: 
clustering protein databases by sequence similarity groups together proteins that we are 
unlikely to analytically distinguish while also taking into consideration shared biological 
functions. While other existing approaches group proteins based on the observed peptides 
detected within a run or experiment, our approach, Clustering Unique Sequences in 
Proteomes (CUSPs), provides more stable grouping that only changes with the database- 
not with observed data. In addition, by comparing entire protein sequences rather than 
partial sequences, we are more confident that the proteins are grouped based on similar 
biological function (i.e., multiple domains and motifs). We suggest using two approaches 
to identify an appropriate clustering threshold: the reduction of proteome size as a result 
of clustering and the number of distinguishable identifications from the clustered 
database. While lowering the threshold for grouping proteins will create more groups, it 
is also possible to lose unique information that could be helpful in confidently 
pinpointing which proteins are identified within the sample. We considered these 
tradeoffs for a number of complex proteomes, including Mus muculus, Populus 
trichocarpa, Oriza sativa, and Zea mays. In total, we suggest that each proteome has 
different properties that would recommend different identity thresholds, so future studies 
would need to adopt this methodology to find the most appropriate identity for grouping 
the proteome of interest. Case studies of Populus trichocarpa and the infant gut 
microbiome demonstrated successful implementation of CUSPs to gain crucial insight 
into the identification and quantification of proteins that would have otherwise been 
excluded from their analyses. Therefore, CUSPs not only removes ambiguity from 
protein reports, but also rescues and strengthens the confidence in the protein 
identifications and abundances measured in complex proteomic studies. 
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CHAPTER 5:  Protein Quantification 
 
Data presented in Section 5.2 has been adapted from the following journal article ready 
for submission to the Journal of Proteome Research: 
 
Rachel M. Adams,* Richard J. Giannone,* Paul Abraham, Robert L. Hettich. “Protease-
Optimized Spectral Indexing Enhances Protein Identification and Quantification in 
Shotgun Proteomics Datasets.” * Authors contributed equally to this work. Sample 
preparation and mass spectrometry experiments were performed by Richard J. Giannone. 
Data analysis was performed by Rachel M. Adams. 
 
Data presented in Section 5.3 has been adapted from the following journal articles: 
 
Zhou Li,* Rachel M. Adams,* Karuna Chourey, Gregory B. Hurst,  Robert L. Hettich, and 
Chongle Pan. “Systematic Comparison of Label-Free, Metabolic Labeling, and Isobaric 
Chemical Labeling for Quantitative Proteomics on LTQ Orbitrap Velos”. Journal of 
Proteome Research 2012 11(3):1582-90. * Authors contributed equally to this work. 
Sample preparation, mass spectrometry experiments, and manuscript preparation were 
lead by Zhou Li and Chongle Pan. In-house scripts for comparison of HCD with dual 
HCD/CID identifications and iTRAQ and TMT intensity summarization were written by 
Rachel Adams. 
 
 
5.1 Using a Poisson Bootstrapping Method to Test Differential 
Protein Expression Based on Spectral Counts 
 
Recently the traditional quantitative MS methods using isotopic labeling have received 
criticism for being biologically and computationally cumbersome. In light of these 
drawbacks, our endeavors have been focused on pursuing label-free quantitative analysis 
of MS data. Strong cases have been made for running each sample separately and 
considering inherent characteristics of the measured data, primarily spectral count (SpC), 
in order to compare protein abundances.
139-141
 By counting the number of times each 
protein is detected with respect to the other proteins in a sample, a relative abundance can 
be calculated. Likewise, a relative abundance can be calculated by comparing the spectral 
count of a protein between samples. Appropriate normalization and consideration of 
statistical guidelines for determining differences between groups of values, spectral 
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counts in this case, are left to the discretion of biostatisticians with the implicit 
understanding that the methods implemented should be biologically and analytically 
defendable. 
 
The normalized spectral abundance factor (NSAF) is a widely-used normalization 
method for spectral counts that takes into consideration protein length and the run’s 
overall total spectra collected.
138
 This normalization method assumes that longer proteins 
are more likely to have more peptides and therefore higher spectral counts than shorter 
proteins. While protein length is an important consideration when comparing two 
proteins within a sample, it becomes irrelevant when comparing the same protein 
between two conditions. Normalizing total spectral counts between runs, however, is 
exceedingly important; depending on any number of instrumental or experimental 
factors, two runs may have quite different total spectral counts. Due to their prevalence in 
label-free shotgun proteomic studies, NSAFs are benchmark measures against which any 
newly-proposed label-free measures or normalization methods are compared. In fact, 
NSAF is the prominent label-free measure that has pushed spectral counts as the 
forerunner among label-free features, including spectral intensities, peak area or peak 
height, or a combination of these features. It is therefore beneficial to compare the 
descriptive behavior of any normalized label-free measure to NSAFs. An objective of this 
research will be to properly employ a normalized label-free measure to determine and 
compare relative protein abundance between samples. 
 
Alongside the debates over the most effective label-free features to be used for measuring 
protein abundance, many studies have suggested that certain statistical methods are more 
appropriate for detecting and assessing changes in protein abundances. Most proposed 
algorithms, such as the t-test and G-test, assume normally-distributed data and can only 
handle pairwise comparisons,
142
 which can become computationally cumbersome for 
experiments involving multiple conditions. Pooling replicates’ data into a single 
representative value is an additional limitation characteristic of several algorithms 
previously implemented in label-free quantification. An additional aim of this study is to 
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optimize a statistical test that best determines whether two spectral counts are 
significantly different from each other. 
 
One of the most straightforward approaches to normalization is to transform all of the 
run’s total assigned spectra counts to the same amounts, much like a percentage but with 
the sum being a number that is more representative of the spectral counts assigned. To 
achieve this method, one first divides each protein’s raw SpC by the total SpC for that 
run. Then the normalized SpC is divided by the sum of the protein’s normalized SpC and 
multiplied by the sum of the protein’s raw SpC. For validation, the sum of each protein’s 
normalized SpC’s should equal the sum of the protein’s raw SpC. 
 
A second approach, normalization by means, ensures that each run’s average SpC is the 
same. For this method, the average spectral count of each run needs to be identified as 
well as the average spectral count of the entire dataset. Next, each run’s total spectral 
count is multiplied by an adjustment factor (the run’s spectral count divided by the 
average spectral count for the entire data set). This method may be preferable over the 
normalization by totals only if one is confident that the variation between runs is 
approximately the same. 
 
Before developing an improved method for determining differential expression in 
spectral counts, we wanted to get a sense of the overall behavior and characteristics of 
raw spectral count (SpC) measurements. Looking at non-normalized SpCs allowed us to 
inspect the distribution of unaltered measurements without any presuppositions about 
how the data should look. To ensure that our sampling space was large and reproducible 
enough to make unbiased observations, 10 samples of R. palustris were prepared with 
identical protocols and measured using an LTQ. A total of 3,114 proteins were identified 
in these 10 runs. Our first, most general inquiry sought to ascertain basic descriptive 
statistics about the entire dataset’s proteins and spectral counts. Each run identified 
2,005-2,329 proteins, and each run assigned 47,985-64,623 SpC. 44% of the proteins 
were identified in all 10 runs compared to the 12% of proteins that were unique to a 
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single run, highlighting the high-degree of reproducibility between these technical 
replicates. The plots in Figure 5.1A illustrate that the 1500 proteins found in all 10 runs 
have a similar SpC distribution as the entire dataset, so those highly reproducible proteins 
can be used to represent the dataset for later analyses. Additional validation of the 
reproducibility of the dataset was measured by calculating the standard deviations and 
variances for each protein’s spectral counts across the 10 runs compared to that protein’s 
overall mean spectral count.  
 
From these basic measurements of means, standard deviations, and variances, we were 
able to start exploring the overall distribution of spectral counts. Figure 5.1B graphs the 
relationship between the means and variances for each of the 3,114 proteins. The 
strikingly linear relationship between the means and variances (R
2
 = 0.89) with a slope 
close to 1 (1.09) suggests that for the majority of the proteins in this study, the mean 
spectral count equals the variance. In other words, the more abundant proteins (those with 
larger spectral counts) have a larger standard deviation than the less abundant proteins 
(proteins with smaller spectral counts). While this observation seems intuitive, it has very 
significant implications in supporting the data’s Poisson-like distribution. Poisson 
distributions are characterized by a single variable: the mean (lambda, λ), which is equal 
to the variance and therefore the only degree of freedom. Normal distributions, on the 
other hand, are characterized by 2 variables: the mean and standard deviation. If the data 
had followed a normal distribution, the standard deviation (and therefore the variance) 
would have been approximately constant for all proteins, regardless of their means. 
Figure 5.1’s demonstration of the mean dictating the variance suggests raw spectral count 
data follows a Poisson-like distribution.  
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Figure 5.1. High degree of reproducibility between 10 technical runs of R. palustris. 
(A) Means and standard deviations of 1500 proteins found in all 10 technical replicates. 
(B) Means versus Log2(Variances) of all 3,114 proteins found in the 10 runs.  
  
(A) 
(B) 
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While the linear correlation between mean and variance was very strong for the raw 
spectral counts, it was not known whether the data behaved the same way after 
normalization. The same dataset of 10 runs was transformed by NSAF, an in-house 
normalization, and additional modifications, including log and square-root 
transformations, to see whether the correlation between average and standard deviations 
improved (i.e, whether the data became more Poisson-like after normalizations were 
applied). There is a highly linear correlation (R
2
 = 0.94) between the averages and 
standard deviations for NSAF values, but the in-house normalization method produces a 
stronger correlation coefficient (R
2 = 0.95) between spectral counts’ averages and 
variances. There is also a strong linear correlation (R
2
 = 0.95) between the average and 
the relative standard deviation of normalized spectral counts. The correlation coefficient 
for the square-root transformation (R
2
 = 0.92) is less than that of the logarithmic 
transformation (R
2
 = 0.9435). In total, all of these strong linear correlations between the 
average and standard deviations of spectral counts suggest the data follows a Poisson 
distribution. However, the additional transformations and normalizations do not greatly 
improve the raw correlation between means and variances (R
2
 = 0.95) and therefore they 
do not greatly impact the fit of a Poisson-like distribution. 
 
In fact, goodness of fit (GOF) tests showed the majority of the proteins in the dataset 
were consistently a Poisson-like distribution when the datasets were raw and normalized 
by means. Since comparisons of multiple datasets increases the sparseness of the data (by 
generating more data points produced by proteins found in only one or a few 
experimental runs), additional GOF tests were performed to determine if the number of 
runs in which a protein was identified affects whether that protein follows a Poisson-like 
distribution. As Table 5.1 displays, although the percentage of proteins that followed a 
Poisson-like distribution did not vary much according to the number of replicates 
identifying a protein, the highest number of proteins following a Poisson distribution 
were those found in all 10 runs. Of the 1368 proteins found in all 10 runs, 85% of these 
proteins passed a Poisson GOF test (p < 0.05). Similar results were found for normalizing 
the proteins by the means. These proteins found in all 10 runs are most likely our more
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Table 5.1. Results for maximum likelihood goodness of fit test to Poisson distribution 
using protein SpCs from 10 replicates of R. palustris. 
 
# Exact Reps # Proteins % Proteins 
p < 0.05 
# Proteins 
p < 0.05 
% Proteins 
3 173 5.56% 128 73.99% 
4 124 3.98% 109 87.90% 
5 138 4.43% 108 78.26% 
6 135 4.34% 94 69.63% 
7 165 5.30% 110 66.67% 
8 160 5.14% 104 65.00% 
9 221 7.10% 161 72.85% 
10 1368 43.93% 1207 88.23% 
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confident identifications; therefore, their GOF tests further enhance our assertion of the 
Poisson distribution. 
 
To demonstrate whether ratios of spectral counts can approximate known relative protein 
abundances, a dataset was analyzed from a standard mixture of metabolically-labeled 
proteins in which R. pal was grown in normal (
14
N) minimal media and heavy (
15
N) 
minimal media and then mixed in ratios of 1:1, 1:5, 1:10, 5:1, and 10:1. The graphs in 
Figure 5.2 demonstrate that ratios of 
14
N:
15
N spectral counts can approximate differences 
in known relative protein abundances whether those differences span an order of 
magnitude (1:10 or 10:1) or whether the differences are negligible (1:1). Some of the 
proteins were found in only one of the conditions, so their ratios could not be calculated 
and therefore are displayed separately. The histograms of 3,115 proteins distribute around 
the expected 
14
N:
15
N spectral count ratios, indicated by the thick red lines. 
 
Confident that not only are spectral counts valid measurements of protein abundances and 
that they tend to follow a Poisson distribution, we propose a novel parametric 
bootstrapping method of normalization. For the explanation of this method, we assume 
that there are at least two technical replicates for two biological conditions. For each 
condition, a single random measurement (SpC) selected from either replicate is chosen. 
For each measurement, 1000 bootstrapped values are then randomly generated from a 
Poisson distribution described by λ = the value of the random sample. A random pair of 
bootstrapped values are chosen to represent each condition. The ratio of the two values is 
calculated, followed by calculating the p-value. 
 
To benchmark the performance of other existing significance analysis tests, we compared 
QSpec
90
 and BetaBinomial
91
 tests on our R. pal standard mixture datasets in addition to 
the PBS method. In Figure 5.3, ROC curves of the false positive rate (FPR) against the 
true positive rate (TPR) provide a visual representation of the tradeoffs between 
significance and power for each algorithm. Area-under-the-curve (AUC) calculations 
confirm that the PBS method outperforms the other methods on the R. palustris labeled 
  149 
standard mixture datasets. However, the power of the algorithms at 95% significance was 
a more practical measure of assessing the algorithm’s performance at a typical p-value 
cutoff (p < 0.05).  
 
Figure 5.3B illustrates that the power of our Poisson Bootstapping (PBS) method (63%) 
far surpasses that of QSpec (>1%) and BetaBinomial (33%) at 95% significance. In fact, 
even with exceedingly stringent cutoff criteria (p < 0.001), PBS can discriminate 
numerous differences in protein expression where the other methods cannot detect any 
changes in abundance at all. 
 
Of the 1647 proteins compared, 845 were considered differentially expressed by at least 
one method at p < 0.05. PBS identified 670 (80%) of these proteins, and 104 proteins 
were found to be identified by PBS only. To determine how our method was improving 
over the other methods, we sought to classify the types of abundances being compared 
(Figure 5.4). Each protein abundance was categorized as “high” (SpC > 50), “medium” (5 
< SpC < 50), “low” (2 < SpC < 5), or “zero” (0 SpC) so the comparison of a protein in 
condition A and condition B would be considered a “high-high” abundance comparison 
or “high-low” or “medium-low” or “medium-zero”, etc… For each of these 
classifications, PBS identified 78-97% of all significant proteins except for “low-zero” 
proteins, which are the least confident identifications. In comparison, QSpec identified at 
least 92% of the “high-high,” “high-medium,” “medium-medium,” and “medium-low” 
proteins but missed a majority of the “medium-zero” and “low-zero” proteins. 
BetaBinomial, on the other hand, identified 93% of the “low-zero” proteins and 29-69% 
of the other proteins. While QSpec emphasized significance in high abundant-proteins 
and BB emphasized significance in low-abundance proteins, PBS identified the largest 
overlap and unique set of proteins across the entire dynamic range. Therefore, the 
significance analysis achieved by PBS excels in correctness, lack of bias, and 
comprehensiveness compared to other existing approaches. 
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Figure 5.2. Validation of the use of SpC for estimating relative protein abundance. 
Standard mixtures of R. palustris grown in labeled (
15
N) and unlabeled (
14
N) media were 
mixed in 1:1,1:5, 5:1, 1:10, and 10:1 ratios before MS analysis. The ratios of SpC 
between the 
14
N and 
15
N proteins can approximate the known relative protein 
abundances.  
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Figure 5.3. ROC Curves for BetaBinomial (BB), Poisson Bootstrapping (PBS), and 
QSpec tests of differential protein expression between the standard mixture datasets. 
 (A) Full ROC Curve analysis (up to 100% FPR) for these three methods illustrate quite 
different powers of significance testing. (B) An inset analysis (up to 10% FPR) of the 
same results highlights the discrimination of PBS over the other two methods.  
(A) 
(B) 
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An additional feature of the PBS method is that we are able to calculate confidence 
intervals for the ratios between the two measurements. As a complementary figure to 
Figure 5.2, we generated the 95% confidence interval for each protein in the standard 
mixture dataset (Figure 5.5). We expected to see the confidence intervals of bootstrapped 
ratios coincide with the pre-determined 1:1, 5:1, and 10:1 ratios. As evidenced in this 
figure, the proteins compared in the 1:1 dataset are in fact centered on 1. Furthermore, the 
proteins in the 5:1 dataset and 10:1 dataset have fairly tight distributions around 5 and 10, 
respectively, without elongating the range of bootstrapped values and therefore changing 
the kurtosis of expected data point distributions.  
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Proteins Significant in  
Only One Test 
Proteins Significant in  
Two Tests 
Proteins Significant in  
At Least One Test 
Proteins Significant in  
All Tests 
Significance Tests BB PBS Q-Spec BB & PBS 
BB &  
Q-Spec 
PBS & Q-
Spec > BB > PBS > Q-Spec BB, PBS, & Q-Spec 
Comparison Types 
          high-high 0.00% 0.00% 0.00% 0.00% 7.69% 46.15% 53.85% 92.31% 100.00% 46.15% 
high-med 0.00% 0.00% 0.00% 0.00% 2.99% 61.19% 38.81% 97.01% 100.00% 35.82% 
med-med 1.20% 0.00% 10.24% 0.00% 4.82% 60.24% 29.52% 83.73% 98.80% 23.49% 
med-low 2.40% 5.29% 12.50% 0.00% 5.77% 39.90% 41.83% 78.85% 92.31% 33.65% 
med-zero 6.35% 28.57% 1.27% 43.17% 0.32% 0.63% 69.52% 92.06% 21.90% 19.68% 
low-zero 82.22% 4.44% 2.22% 0.00% 8.89% 0.00% 93.33% 6.67% 13.33% 2.22% 
  
Figure 5.4. Comparison of abundance ratios considered significant by each significance test. 
The BetaBinomial (BB), Poisson Bootstrapping (PBS), and Q-Spec tests often disagreed on whether a protein was significantly 
different or not. BB uniquely identified many low abundance proteins to be significantly different, while the PBS test agreed with 
the medium-low abundance differences detected by BB and the high-high, high-medium, medium-medium, and medium-low 
differences detected by QSpec.
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Figure 5.5. Calculated Log2 ratios (right column) and their confidence intervals (left 
column) using the PBS Method. 
Proteins that were determined to be significantly different (p < 0.05 are colored in red) 
and those without enough evidence of difference are in blue. Each row represents a 
different dataset (1:1, 5:1, and 10:1, respectively).  
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5.2 Protease-Optimized Spectral Indexing for Relative Protein 
Abundances in Label-free Approaches 
 
5.2.1. Using Matched Ion Intensities for POSI 
 
As described in Chapter 3, matching all fragment ion intensities within an MS/MS scan 
provides reproducible results for peptides measured across technical replicates. In 
addition, comparing the sum of matched fragment ion intensities for an entire run can 
serve as an indicator of the relative difference in two loading amounts. Whereas the 
previous discussion focused on how the matched ion intensities correspond to the 
peptide-level measurements, it is equally important to give thoughtful consideration to 
the method of aggregating PSM-level matched ion intensities into protein-level 
measurements. Therefore, many of the same metrics that were discussed previously 
(distribution of measurements, reproducibility, and comparison across loading amounts) 
will be revisited from a protein perspective. 
 
One of the touted strengths of matched ion intensities is that they capture an extra 
dimension of information for each spectrum collected. Each fragment m/z value is 
quantified by the number of electrons measured by the detector as a measure of quantify 
the analyte’s abundance observed at that given time.140, 143 Therefore, by summing the 
intensity value of each m/z from each scan for each peptide, one is actually accumulating 
a distribution of intensity data with thousands of data points for each peptide and millions 
to billions of data points for a given protein. One would suspect that if the random 
sampling of mass spectrometry instruments is truly random, and if all of the spectra are 
representatives of the protein’s relative abundance within a run, then the distribution of 
these data points would most likely follow a normal distribution. Indeed, previous studies 
have demonstrated that spectral counts tend to follow a log-normal distribution,
138
 but it 
has not been previously asserted whether the additional information provided by matched 
ion intensities supports or rejects this hypothesis.  
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Using a single run as an example, we tested the null hypothesis that each protein’sPSM 
matched ion intensities came from a normally distributed population (after the log 10 of 
each intensity measurement was taken). Using the Shapiro-Wilk’s test, in which smaller 
p-values indicate less probability of a normal distribution, 89% of the 1190 C. 
thermocellum proteins were not normally-distributed (p < 0.05). We suspected that closer 
examination would demonstrate that the remaining 11% of the proteins would be the 
most abundant proteins (by SpC and MIT), because their increased measurements would 
be more representative of the “truer” (more normal) distribution. However, we found that 
the proteins that initially passed the Shapiro-Wilks test were proteins of “medium” 
abundance (50-100 SpC). As depicted in Figure 5.6, the test was actually more sensitive 
to samples that had more data points, so the test asserted that there was sufficient 
evidence to say matched ion intensities from proteins that had more than 100 SpC were 
highly unlikely to come from a normal distribution.  
 
While only 25% of the dataset had proteins > 100 SpC, the majority of the dataset was 
plagued by a different problem. Scans that were assigned to multiple peptide sequences, 
either due to an isobaric sequence (isoleucine or leucine ambiguity) or lack of evidence 
for confident charge state identification, were strongly shaping the intensity distributions 
of the low-abundant proteins. In a second normality test, these ambiguous scans were 
removed from each protein and their distributions re-evaluated. This time, the number of 
proteins that were not normally-distributed diminished considerably (30% of the 1190 
proteins, p <0.05). A third normality test was performed in attempt to also address the 
problem of high-abundant proteins. For each protein > 120 SpC, we selected 120 
measurements from the protein and ran the normality test. This selection of 120 
measurements was repeated 1000 times for each protein in order to achieve representative 
sampling of the protein. Their average p-value after 1000 of these “bootstrapped” 
samples was considered for their assessment of normality. After this method was applied, 
21% of all proteins had sufficient evidence to say they did not follow a normal 
distribution (p < 0.05). When applied to other datasets, averages between 80-90% of the 
proteins failed to reject the null hypothesis that their measurements came from a log-
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normal distribution. These findings were instrumental in the path of considering various 
methods of normalizing protein abundances, as discussed in 5.2.2. Unique, unambiguous 
peptide intensities have long since been the metrics of choice for representing protein 
abundances in labeling methods, such as TMT and iTRAQ, which depend on the 
intensity of a specific tag for relative or even absolute quantitative comparisons. If similar 
performance could be achieved without the labeling process, that method may be a more 
attractive and economical approach for routine MS analyses. 
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Figure 5.6. Normal distribution of protein-level measurements. 
 (A) Original normality test of all scans, graphed by SpC and their p-value. (B) 
Ambiguous scans were removed and the normality tests were rerun. (C) Insert of p-values 
from first normality test, limited to proteins with >100 SpC. (D) Normality test results for 
high abundance proteins after bootstrapping method was applied.  
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Table 5.2. Definitions of protease-optimized protein lengths. 
 
Effective Protein Length  Description  
Coverage  Number of amino acids “covered” by a peptide  
PeptideSum  Sum of (non-redundant) peptide lengths  
NumPeptide  Number of non-redundant peptides 
*Note: Valid peptides must be between 5 and 50 amino acids long and have a mass between 
400 and 6000 Da  
 
 
 
  160 
 
 
 
 
Figure 5.7. Illustration of the different effective lengths suggested by POSI.
 
     
Protein Length: 92 
Effective Protein Lengths: 
Coverage: 89 (16+16+16+41) 
PeptideSum: 57 (16+41) 
NumPeptide: 2 (16, 41) 
16 16 16 41 3 
protein 
peptides 
peptide 
lengths 
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5.2.2. POSI: Comparing Samples Digested by Different Proteases 
 
Instead of normalizing proteins by their lengths, we propose that proteins should be 
normalized by protease-optimized effective protein lengths (Table 5.2, Figure 5.7). 
Protease-optimized effective lengths take into consideration the number, length, and 
redundancy of peptides generated by specific proteases on each protein.  
 
The first effective protein length is the number of amino acids covered by a proteotypic 
peptide (“coverage length”), or the sum of the redundant peptide lengths. This 
measurement will most likely look very similar to the original protein length, but it could 
be slightly shorter due to long stretches of hydrophilic amino acids without a cut site. In 
other words, if a region of a protein does not have a cut site and therefore doesn’t 
contribute to peptide identification, this first effective protein length will not consider 
those amino acids as part of the protein length. For the purposes of this calculation, no 
missed cleavages were allowed and a peptide had to fall within 5 to 50 amino acids in 
length. In the C. thermocellum proteome, 12% of the proteins have at least one 40-amino 
acid stretch that is not MS-compatible under a tryptic digestion and 5% of the proteins 
are “invisible” to the MS instruments for more than half of their amino acids. Figure 3A 
shows an example of a protein that has a reduced coverage length when it is digested with 
each protease. This protein, Clo1313_2479, has 2300 amino acids but under a tryptic 
digestion, it will only generate peptides that account for 1629 amino acids (70% of the 
original size). Even more staggering, when this protein is digested with chymotrypsin, it 
will generate an effective coverage length of 47 amino acids (just 2% of the original 
protein size). This protein under a digestion with chymotrypsin under a digestion will 
produce 137 amino acids that will be amenable to MS analysis, accounting for 6% of the 
original size. Figure 3B illustrates, however, that these differences are not typical for any 
given protein. Their “coverage” lengths do not significantly affect most proteins, but 
those that respond generally have extreme reductions in size. Overall, the average protein 
length reduction by coverage is 93% with trypsin, 98% with chymotrypsin, and 75% with 
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glu-C. Based on a comparison of the traditional protein length and the calculated 
coverage length, 266 proteins in the database are expected to be affected by their trypsin 
differences, 59 proteins could be affected by their chymotrypsin differences, and 961 
proteins could be affected by their glu-C length differences (based on those with >25% 
length differences). 
 
The second effective protein length is the number of non-redundant peptides generated by 
the specific protease. This measurement is particularly aimed at addressing questions 
raised by researchers interested in proteins that have large regions of repeated domains 
within a protein. For example, in a recent dataset analyzing the C. thermocellum 
proteome, many of the peptides in Clo1313_2479 occur multiple times throughout the 
protein. In fact, one of its peptide has 7 separate locations. Thus, the protein’s full length 
could be said to be “inflated” by internal redundancy. If these regions are MS-compatible 
and ionize well, these repeated peptides could make the protein look far more abundant, 
simply because it has a surplus of advantageous peptides. On the other hand, if redundant 
proteins do not have many cut sites or are not MS-friendly, then the protein will be 
unduly penalized by its longer length and reduced opportunities for detection. This 
attempt to resolve whether a protein “putting all of its eggs in one basket” is more likely 
to be rewarded or penalized for its high degree of internal redundancy may give 
conflicting results for different proteins, but we are interested in whether there are trends 
that suggest this is a valid alternative for true protein length. Within a tryptic digestion, 
2784 proteins are predicted to have more than 25% of their cut sites lead to redundant or 
otherwise inadmissible peptides. The calculated number of peptides after a gluC digestion 
of the C. thermocellum proteome suggests that 1814 proteins will have >25% of their cut 
sites fail to generate a novel peptide. Interestingly, only 59 proteins are predicted to be 
affected by this effective protein length after a chymotrypsin digestion. 
 
The third effective protein length is the sum of the non-redundant peptide lengths. This 
measure is a hybrid of the first and second effective protein lengths. Unlike the first 
effective protein length that summed the length of each instance of a peptide but like the 
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second effective length that only considered non-redundant peptides, this method of 
calculating a protein’s length reduces the plurality of identical peptides. This method 
rewards those peptides that have longer sequences and gives advantage to proteins that 
have more distinct peptides. The more distinct peptides a protein generates, the closer this 
length will look like the first “coverage” length. Conversely, the more redundant peptides 
generated by a protein, the more this length will resemble the second effective protein 
length. For our example protein Clo1313_2479 digested under trypsin, its coverage 
length was reduced by 70% due to incompatible peptides and 22 of its 90 peptides 
occurred more than once within the protein, resulting in a final “sum” length of 1256 
(55% of the original length and 77% of the coverage length). Similar to the other 
protease-optimized lengths, this effective length is not predicted to affect the majority of 
the proteins (226 in trypsin, 60 in chymotrypsin, and 862 in gluC), but the emphasis of 
this study is not to affect the overall distribution of protein lengths expected in an MS 
analysis; rather, we anticipate that these minor deviations will be extremely helpful to a 
few proteins and not harm the remainder of the identifications. 
 
To observe whether varying proteolytic enzymes within the digestion step of a shotgun 
proteomic experiment affects the relative protein abundances of its complex protein 
mixture, a sample of C. thermocellum was digested by three proteases (trypsin, 
chymotrypsin, and glu-C) and examined by three replicate measurements for each 
digestion. While each individual run identified between 1120 and 1388 proteins, 1543 
proteins were identified collectively (representing 45% of the proteome). Moreover, 1231 
proteins were identified within all 3 replicates of at least one digestion type, suggesting 
there is a high degree of consistency between each technical replicate. As further 
validation of the reproducibility within this data set, the Pearson correlation between 
replicates is greater than 97% and the Pearson correlation among digestion types is 
greater than 80%. In other words, there is a substantial overlap in the protein 
identifications between each type of digestion. 
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Confident in this high correlation of protein identifications between datasets, we then 
considered the reproducibility of the protein abundances assigned across protease sets. 
Across all of the runs, the raw totals of assigned spectra varied by nearly 3-fold 
differences in abundances (from 8,3496 to 213,898 SpC per run), but the assigned 
intensities spanned multiple orders of magnitude (from 1.5e11 to 5.34e15). After the 
traditional NSAF approach was applied to apportion protein abundances according to the 
protein length and total abundances assigned in the run, 37% of the proteins demonstrated 
significant variation (ANOVA, p <0.05) between their SpC abundances under different 
protease conditions. Using MIT as the metric for protein abundance, 69% of the proteins 
demonstrated significant variation between the proteases. Interestingly, when we applied 
the POSI normalization methods, the number of proteins identified as significantly 
different between the datasets increased. One of the unforeseen implications of our 
dataset was that the tight reproducibility of technical replicates allowed each digestion 
series to be distinguishable. Those proteins that had larger standard deviations in their 
measurements were those that the ANOVA analysis calculated to be significantly 
different. In fact, the behavior of proteins across protease sets appeared far more similar 
when the relative rank of each protein was compared. For NSAF MIT measurements, the 
Pearson correlations between the average ranks within the different protease datasets 
were between R2 = 0.82 and R2 = 0.84 with a slope around 0.9. For the POSI MIT 
measurements, the correlation values were between 0.6 and 0.74, still suggesting slightly 
different protein abundances between the enzymatic digestions. From this data, we can 
surmise that the peptide-spectrum match abundances are differently distributed among 
proteins depending on the protease used in the experimental protocol. If a study wanted 
to compare its relative protein abundances to that of another study whose data was 
collected using a different enzymatic digestion method, the two datasets could not be 
assumed to be comparable. Rather, the individual ionizability of each peptide in the 
biological sample and the stochastic, random sampling of MS instruments create 
substantially different subpopulations of measurements for each protein and each group 
of proteins. For the time being, relative protein quantitation is most suitable for 
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comparing protein A to protein A between two samples collected under different 
biological conditions (but assuming their experimental/analytical protocol is the same). 
 
When the proteins’ NSAF ranks were compared to each of the POSI ranks, the majority 
of the proteins followed the same trend in both types of normalization methods (R2 = 
0.98 for coverage and NSAF, R
2
 = 0.89 for sum and NSAF, R
2
 = 0.78 for num). There 
were a few proteins, however, that were dramatically different in their ranks between 
normalization methods. For example, Clo1313_2540 was ranked 698 out of 856 proteins 
in the tryptic digestions when normalized with NSAF, whereas it was ranked 305 when 
normalized with the coverage length. This protein, which has an original size of 749 
amino acids, was reduced to a calculated effective coverage length of 99 in a simulated 
trypsin digestion, causing the protein to appear in the bottom 10% of protein lengths 
rather than the top 90%. Clearly this magnitude of a discrepancy would affect relative 
abundance measurements dependent on apportioning values based on expected protein 
lengths. The ranks between proteins normalized by coverage lengths and (non-redundant) 
sum lengths were overwhelmingly similar (only 3 of 856 proteins differed by more than 
10 positions). Consistent with our previous discussion in anticipating differences among 
the protease-optimized normalization methods, Clo1313_2479 not only demonstrated 
cause for different positions in its NSAF and coverage normalized ranks (627 and 572), 
but it moved to position 519 once it was normalized by the sum effective length. 
Clo1313_1021, a large protein (7955 amino acids) that was calculated to only generate 48 
non-redundant peptides out of the 711 tryptic cut sites, was by far the least consistent 
between its tryptic NSAF rank and rank of values normalized by the proteins’ numbers of 
peptides was. Its jump from ranks 529 (normalized by NSAF) to 123 (normalized by 
number of peptides) reflected a large reward for the protease-optimized protein length, 
supporting the expected implication that it far fewer opportunities to be measured than its 
original size would suggest. In contrast, when the same ranks are compared for this 
protein’s behavior in the chymotrypsin runs, the ranks are far more similar (only 19 
away) because the predicted number of peptides under a chymotryptic digestion (687) 
aligns more with the large original size of the protein. Interestingly, some proteins that 
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were expected to be greatly affected by protease-optimized lengths did not show much 
difference from their NSAF values, especially for the highly abundant proteins. 
Clo1313_0627, for example, has an original size of 1352 amino acids but because it is a 
membrane protein with large, repetitive hydrophilic regions, its expected number of 
contributing peptides is 56 (approximately 40% fewer than other proteins of the same 
size). However, it was consistently identified as one of the top 3 most abundant proteins, 
regardless of normalization method. In total, the results generated from the comparisons 
of protease datasets highlight the impact of enzymes on a sample, creating truly different 
populations of peptides that can be detected and measured for protein identification and 
relative quantification. The protease-optimized normalization methods do not standardize 
the relative abundance measurements across proteolytic digestions, but rather more 
sensitively apportion measurements within the dynamic context of their analytical 
backgrounds. 
 
5.2.3. POSI: Comparing Samples Loaded in Different Concentration 
Amounts 
 
While matched ion intensities provide more accurate information than spectral counts and 
the normalization methods adjust the measurements to account for biases in instrumental 
detection and analytical viability, protease-optimized spectral indexes are still a relative 
quantitative measure- not an absolute one. In other words, the normalization methods 
help compare the measured expression of one protein in a sample against the measured 
expression of another protein in the same sample relative to all proteins identified in the 
sample, but comparing the absolute abundance of one protein with respect to another is 
still beyond the scope of label-free measurements. However, given the improvements in 
accuracy and robustness of multidimensional measures like intensity information, one 
can consistently observe fold-changes between groups of proteins measured within the 
same sample as well as fold-changes between proteins identified in a sample loaded onto 
the LC column in two different amounts.  
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To determine the level of sensitivity of the protease-optimized spectral indexing method, 
a standard mixture of 48 proteins was analyzed following a tryptic digestion amidst a 
proteomic background and their intensities were compared against the expected 6 orders 
of magnitude differences. 15 of the 16 proteins within the top two tiers of the standard 
mixture (“tier 1”: 8 proteins at initial concentrations of 50000 fmoles and “tier 2”: 7 
proteins at 5000 fmoles) were consistently identified across all 3 replicates of two sample 
sets (25 μg and 67 μg loads) and were therefore the focus of this specific investigation. 
For both sample loads, pairwise comparisons of the abundances in tier 1 proteins versus 
tier 2 proteins yielded fairly disparate results, regardless of whether the measurements 
were calculated (spectral counts or intensities) or normalized (raw, nsaf, coverage, sum, 
or num). Although the average intensity ratio of tier1 to tier 2 abundances was around 10 
(sd 15) for the 25 μg load, the average was closer to 15 (stdev 15) for the 67 μg load. 
Similarly, the average spectral count ratio of tier1 to tier2 was 7.3 (stdev 7) in the 25 μg 
load and a little higher (8.75 avg and stdev 12.31) in the 67 μg load. In an effort to 
remove individual protein-dependent biases in the measurements, we then considered 
how the tiers behaved as a whole. When the ratio of the sums of intensities between tier 1 
and tier 2 were calculated, the averages were between 7.65 and 13.82 with a standard 
deviation of 2.13 for the 25 μg load. The improvement by grouping proteins was less 
noticeable for the 67 μg load, moving the average to 10.35-17.34 (standard deviation of 
2.56). Interestingly, the raw summed intensities had the smallest deviations and the 
closest ratio to 10 when compared to the normalized summed intensities in both samples 
(Figure 5). Visual inspection of the standard proteins separated by tiers highlights how 
one protein in particular (gold) does not seem to follow the trend of the other proteins in 
its group. UPS_P0131 had an initial concentration that places it in the tier 1 group, but it 
behaved more similarly to the tier 2 group in every run. This protein is extremely small 
(74 amino acids) compared to the other tier 1 proteins, which average 200 amino acids in 
length, and is the least affected by the protease-optimized lengths. The differences 
observed here support the claim that peptide ionizability strongly affects our ability to 
collect absolute quantitative measurements at the protein level and that comparisons 
between protein A and protein B within the same run is not very reliable. 
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On the other hand, comparison of protein abundances between the two runs that only 
differ by their loading amounts demonstrate extreme consistency in their run-level, 
protein-level, and even peptide-level fold-changes. The total raw matched ion intensities 
collected for the 3 technical replicates in which 67 μg was loaded summed to an average 
of 6.87e10, whereas the 3 technical replicates in which 25 μg was loaded summed to an 
average of 1.49e11. Ratios of the raw summed matched ion intensities were between 2.01 
and 2.29, very similar to the concentration ratio (67/25 = 2.68). In fact, measurements of 
the flow-through (the material that was loaded but not analyzed by MS) revealed that an 
average of 80% of the 67 μg material was presented to the instrument and an average of 
90% of the 25 μg material. Therefore, a closer value for the loaded concentration ratio is 
2.38, which is even more similar to the observed intensity ratios. Pairwise comparison of 
each protein identified in all of the 67 μg and 25 μg runs (850 proteins) revealed that the 
average ratio of a protein’s intensity between the 67 μg and 25 μg runs was 2.58 (with a 
standard deviation of 1.58). Among the standard mixture proteins in particular, their 
average intensity ratio was 2.42 with a standard deviation of 1. Even more interesting, 
one of the most abundant peptides (TLTVELGVSSLNEGTYK, +2) from one of the most 
abundant proteins, Clo1313_3011, had a SpC of 729 in the 67 μg rep 1 and 643 SpC in 
25 μg rep 1 (a ratio of 1.13), but its matched ion intensities demonstrated the same overall 
fold-change as the ratio between the runs (6.32e8 from 67 μg and 2.45e8 from 25 μg 
resulting in a ratio of 2.58). These results support the use of matched ion intensities 
instead of spectral counts in order to detect relative abundance differences between runs 
overall, the same protein between two runs, and even abundant peptides detected in two 
runs. 
 
5.1. Using Reporter Ion Intensities for Relative Protein 
Abundances in Labeled Measurements 
 
Quantitative proteomics measures abundance changes of many proteins among multiple 
samples in a high-throughput manner.
144
 Results from such measurements provide 
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information on how biological systems respond to environmental perturbations at a 
genomic scale. A number of methods have been developed for quantitative proteomics to 
obtain high proteome coverage, accurate quantification, and wide applicability to 
different types of samples.
145
 In proteomics analysis based on 2-dimensional gel 
electrophoresis (2D-GE),
37
 quantification is achieved by measuring staining intensities of 
protein spots. To eliminate gel-to-gel variability, proteomes under comparison can be 
labeled separately using different fluorescent cyanine dyes (Cy2, Cy3, and Cy5) and then 
combined for 2D-GE analysis.
146
 However, both identification and quantification are 
difficult for gel spots containing multiple comigrating proteins.
147
 Only one of those co-
migrating proteins may be identified in such a gel spot, and that protein may not be the 
one responsible for the differential expression. In addition, the capability of 2D-GE 
proteomics is also limited by the number of quantifiable proteins in a gel, a bias against 
membrane proteins, and a low sample throughput.
144
 
 
In the shotgun proteomics approach, proteins are typically digested using proteases into 
peptides, which are then analyzed using liquid chromatography coupled with tandem 
mass spectrometry (LC−MS/MS).48 Without using any isotopic or chemical modification 
of proteins or peptides, label-free quantification can be achieved by correlating protein 
abundance with either mass spectrometric signal intensities of peptides
148
 or the number 
of MS/MS spectra matched to peptides and proteins (spectral counting).
138
 Label-free 
quantification is widely used because it allows simultaneous identification and 
quantification of proteins without a laborious and costly process of introducing stable 
isotopes into samples, and this approach is applicable to samples from any source. 
However, because samples to be quantified are prepared and measured separately, label-
free approaches have limited quantification performance in terms of accuracy, precision, 
and reproducibility. To improve quantification performance, many approaches were 
developed on the basis of stable isotope labeling, including metabolic labeling,
149
 
enzymatic labeling,
150
 and chemical labeling.
69
 In metabolic labeling, stable heavy 
isotopes are incorporated into proteins by growing cells in controlled media containing an 
15N-enriched nitrogen source
151
 (15N labeling) or isotopically labeled essential amino 
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acids (stable isotope labeling by amino acids in cell culture or SILAC
70
). Metabolic 
labeling allows samples grown in different states to be combined at the cell level. 
Therefore, any bias in the downstream sample preparation and measurement would alter 
protein abundances from different samples to the same extent, making their ratios 
relatively unchanged. However, many biological systems are not amenable to efficient 
metabolic labeling, such as natural microbial communities.
152
 To overcome this, chemical 
or enzymatic methods have been developed to label proteins or peptides using different 
isotopic tags. For example, after cell lysis, extracted proteins can be labeled using 
isotope-coded affinity tags (ICAT).
69
 After protein digestion, peptides can be labeled 
enzymatically at the C-terminus using H2
18
O.
151
 Peptides can also be labeled on the 
primary amine group at the N-terminus and lysine side chain using reductive 
dimethylation (ReDi).
153
 In proteomics measurements based on these stable-isotope 
labeling strategies, the abundance ratios of mass-different isotopic variants of peptides 
are determined using their signal intensities in full parent ion scans of the LC− MS/MS 
analysis. Abundance ratios of peptides are then used to infer abundance ratios of their 
parent proteins.  
 
Recently, two similar isobaric chemical labeling methods, isobaric tag for relative and 
absolute quantification (iTRAQ)
68
 and tandem mass tag (TMT),
67
 have become 
increasingly popular for quantitative proteomics. After proteolysis, samples are labeled 
separately with different isotopic variants of iTRAQ or TMT and are then combined for 
LC−MS/MS analysis. Both iTRAQ and TMT tags contain three functional parts: a 
reporter ion group, a mass normalization group, and an amine-reactive group. The amine-
reactive group specifically reacts with N-terminal amine groups and epsilon-amine 
groups of lysine residues to attach the tags to peptides. The mass normalization groups 
balance the mass difference among the reporter ion groups such that different isotopic 
variants of the tag have the same mass. Peptides labeled with different variants of the tag 
are indistinguishable in full scans, which prevents increasing the full-scan complexity 
after mixing multiple samples. In MS/MS scans, reporter ions of different masses are 
dissociated from isolated peptide species. The mass of a reporter ion is associated with a 
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specific variant of the tag,
154
 and the relative intensity of the reporter ions measures the 
relative abundance of the peptide labeled with that specific tag variant. 6-Plex TMT
155
 
and 8-plex iTRAQ
156
 allow comparing up to 6 and 8 samples in a single LC−MS/MS 
analysis, respectively. Multiplexing is a unique capability of iTRAQ and TMT in 
comparison to the other labeling techniques.  
 
Each of the described methods has its advantages and disadvantages for quantitative 
proteomics. A comparison of SILAC and spectral counting showed that spectral counting 
provided less precise quantification to proteins with low spectral counts.
157
 A comparison 
of 14N/15N metabolic labeling with spectral counting showed that spectral counting was 
less sensitive to detecting small fold changes.
158
 iTRAQ was also compared to a label-
free quantification method based on normalized chromatographic peak intensity.
159
 While 
the number of identified proteins and reproducibility were comparable between these two 
methods, proteome coverage was significantly higher in the label-free method. To date, 
no study has systematically compared label-free, metabolic labeling, and isobaric 
chemical labeling with iTRAQ or TMT using the same analytical platform. In this study, 
performances of spectral counting, 14N/15N metabolic labeling, iTRAQ, and TMT were 
benchmarked using standard proteome samples prepared from a model microorganism, 
Pseudomonas putida F1.
160
 P. putida F1 is a gram-negative soil microbe, known for its 
diverse metabolism and ability to degrade aromatic hydrocarbons. Its unique 
bioremediation potential is frequently exploited for remedying contaminated soils. 
Measurements for all four methods were performed using the LTQ Orbitrap Velos.
161
 
The higher-energy collisional dissociation (HCD) capability and the improved ion 
extraction efficiency of LTQ Orbitrap Velos enabled excellent measurement of iTRAQ- 
or TMT-labeled samples.  
 
For iTRAQ and TMT analysis, every full scan was followed by four CID-HCD dual MS2 
scans, in which a selected parent ion was first fragmented by CID for peptide 
identification and then by HCD for quantification. HCD offers higher fragmentation 
efficiency and lower minimum m/z detection limit than CID, which enables measurement 
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of reporter ions in Orbitrap analyzer with high signal-to-noise ratio. However, because of 
the extra time needed for HCD analysis, the duty cycle of MS2 acquisition was 
significantly lower in the CID-HCD dual-scan configuration than the CID-only 
configuration used for the other analyses. Furthermore, previous studies have shown that 
the presence of fragment ions as a result of losing isobaric tags from precursor ions 
complicates the interpretation of spectra by database searching algorithms.
162
 Therefore, 
fewer peptides and fewer proteins were identified in isobaric chemical labeling than in 
label-free and metabolic labeling. Similar protein identification results were observed 
between iTRAQ and TMT. 1473 unique proteins were detected from the iTRAQ-labeled 
sample (FDR = 2%) and 1404 in the TMT-labeled sample (FDR = 3%). 73% of proteins 
were identified reproducibly between duplicate runs in iTRAQ and 76% in TMT. 
 
Because HCD spectra can be used for both peptide identification and quantification, 
TMT and iTRAQ samples can be analyzed using only HCD.
163
 We found that less than 
30% of identified spectra were from HCD fragmentation. Less than 10% of those 
identified HCD spectra have a paired CID spectrum that did not identify a peptide, 
whereas approximately 60% of identified CID spectra have a paired HCD spectrum that 
did not identify a peptide. This indicates the value of CID for peptide identification. The 
duty cycle of the CID-HCD configuration was not significantly lower than the HCD-only 
configuration because the acquisition time for CID coupled with ion-trap detection is 
only a fraction of the acquisition time for HCD coupled with Orbitrap detection in the 
dual scan.  
 
Isobaric mass tags were chemically linked to N-terminus amine groups and the epsilon-
amine group of lysine. In one database search, derivatization of the N-terminus was set as 
a static modification and dynamic modification was set at lysine residue. >98% of lysine 
residues in the identified peptides were labeled, indicating high labeling efficiency of 
lysine in sample preparation. A separate search for peptides with an unmodified N-
terminus using dynamic modification at lysine identified only a few hundred peptides 
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with a greater than 50% FDR, which suggests a high labeling efficiency of the N-
terminus by iTRAQ and TMT.  
 
Ross et al. observed that the ratio of Lys-terminated peptides to Arg-terminated peptides 
(Lys/Arg peptide ratio) increased from 0.79 in an unlabeled sample to 0.98 in an iTRAQ 
labeled sample.
68
 However, in this study, the Lys/Arg peptide ratios from TMT and 
iTRAQ were not significantly higher than those from label-free or metabolic labeling. An 
expected Lys/Arg peptide ratio of 0.50 (170,662 Lys-ending peptides and 342,497 Arg-
ending peptides.) was calculated based on in silico digestion34 of the P. putida F1 
proteome. The observed Lys/Arg peptide ratios in all runs were higher than the expected 
ratio. 
 
All MS/MS spectra were searched using SEQUEST
63
 against the P. putida F1 genome 
database containing in FASTA format a total of 5251 predicted proteins and 44 common 
contaminants (trypsin, keratin, etc.). The reversed sequences of all proteins were 
appended into the database for calculation of false discovery rate (FDR).
164
 The 
SEQUEST searches for label-free samples and 14N/15N-labeled samples were performed 
as described previously.
160
 Two SEQUEST searches were performed for each iTRAQ 
and TMT run. The first search used static modification at the N-terminus and dynamic 
modification at the lysine residue by the labeling reagents. The second search used only 
dynamic modification at the lysine residue. The output data files were then filtered and 
sorted using the DTASelect v1.2
71
 algorithm as described previously.
160
 Perl scripts were 
developed to process iTRAQ and TMT data sets for protein quantification. 
 
In the CID/HCD dual scan configuration, peptide identification can be obtained from the 
CID scan, the linked HCD scan, or both. Reporter ions for all peptide identifications were 
extracted from small windows (±0.02 Da) around their expected m/z in the HCD scan. If 
multiple peaks were found within the accepted m/z window of a reporter ion, the one 
with the highest intensity was considered to represent the reporter ion. The total intensity 
at a reporter ion channel for a protein was calculated as the sum of this reporter ion’s 
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intensities from all constituent unique peptides from this protein.
165
 The abundance ratio 
of a protein was estimated using the ratio between the protein’s total intensities in 
different reporter ion channels.  
 
More specifically, all LC−MS/MS data sets from iTRAQ and TMT experiments were 
converted from the Xcalibur Raw file format to the MS2 flat file format using the 
Raxport
166
 program freely available at http://code.google.com/p/raxport/. This tab-
delimited data format contains 3 types of information lines: 1) the header lines contain 
scan id, its precursor scan, the precursor mass, 2) the peak header lines contain the parent 
scan number, and 3) the peak information lines contain the fragment m/z value and its 
intensity. For the dual HCD/CID runs, there is not any information that explicitly 
identifies which scans are “siblings,” except by their reference to the same parent scan 
and mass. Due to the random nature of the scanning process, one could not quickly index 
all MS2 scans based on their scanned order. An additional complication was that the 
parent scan reported was not the survey scan id; it was an enumerated precursor scan id 
that restarted from 1 with every survey scan. Similarly, the parent mass reported for each 
fragment scan was in fact the m/z value acquired during the survey scan, and not the 
exact m/z selected for the subsequent 4 fragment scans. In other words, each sibling 
MS/MS scans was reported with a slightly different parent m/z value. Therefore, a 1 ppm 
window was used to find sibling HCD and CID fragment scans. A window of +/- 0.02 Da 
from the TMT or iTRAQ reporter ion mass was searched within each precursor scan’s 
fragment peaks and the reporter ion with the highest intensity was selected as the 
representative for that precursor mass and fragmentation method. These intensities and 
their mass errors were then added to the DTASelect file so that peptide sequencing and 
protein assembly information could be more readily evaluated. Each peptide in the 
DTASelect file was assigned a reporter ion intensity if the tag was identified (in both CID 
and HCD fragmentation for the dual scan configuration), but only the HCD 
fragmentation was used for quantitative purposes. Since SEQUEST searches were 
performed both with and without consideration of a dynamic lysine terminus, there was 
an expectation that there would be valuable unique and overlapping information in the 
  175 
comparison of the identifications from both searches. Therefore, all of the peptide-
spectrum matches from both searches were merged into one file and of the scans that 
were assigned to sequences in both files, only the PSM with the best xcorr score was 
retained. Then, for each reporter tag, peptide intensities were summed into protein 
intensities only if the peptide sequence was unique to that protein. The abundance ratio of 
a protein was estimated using the ratio between the protein’s total intensities in different 
reporter ion channels. 
 
A total of 1980 unique proteins were identified using the label-free method (on average 
approximately 1600 non-redundant proteins from a run, FDR = 2%). 79% of all identified 
proteins in the duplicate runs of a sample were identified reproducibly in both duplicate 
runs. A total of 1606 unique proteins were identified using the metabolic labeling method 
with 77% identification reproducibility between duplicate runs (FDR = 3%). 1473 unique 
proteins were detected from the iTRAQ-labeled sample (FDR = 2%) and 1404 in the 
TMT-labeled sample (FDR = 3%). 73% of proteins were identified reproducibly between 
duplicate runs in iTRAQ and 76% in TMT. This shows that the label-free method had the 
highest number of protein identifications and provided the deepest coverage of the 
genome (∼30%). Identification reproducibility between duplicates was similar among all 
four methods. 
 
In label-free quantification, each sample of interest must be prepared and analyzed by 
LC−MS/MS separately. The semi-random sampling nature of the peptide identification 
process in a shotgun proteomics run also contributes to the variability of spectral 
counting for protein quantification. Therefore, relatively poor quantification results were 
observed with the spectral counting method. Several alternative MS/MS acquisition 
methods have been developed, which could overcome this limitation. Venable et al. 
introduced a data independent acquisition method based on sequential isolation and 
fragmentation of a series of predetermined precursor windows.39Carvalho et al. extended 
this method and developed an algorithm to identify multiplexed spectra acquired with 
CID and electron transfer dissociation.
167
 In the MSE approach, a quadrupole time-of-
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flight mass spectrometer was used to fragment all precursor ions in an elevated-energy 
mode.
168
 These data-independent methods will probably increase the reproducibility of 
label-free quantification. Alternative data analysis methods have also been developed to 
improve labelfree quantification. For example, chromatographic peak areas of peptides, 
instead of spectral counts, can be used as the measure of protein abundance for 
quantification.
169
 The normalized spectral index (SIN) method estimates protein 
abundance by combining spectral counts and total ion intensity of MS/MS spectra.
143
 In 
contrast to label-free quantification in terms of sample preparation, metabolic labeling 
allows the mixing of samples at the very beginning of preparation. Samples representing 
two states are prepared and measured together, which minimizes potential bias in these 
processes. The relative abundance ratio of a protein between samples is maintained. 
Thus, accurate and reproducible quantification results can be obtained from metabolic 
labeling. In iTRAQ and TMT analysis, samples from different conditions are processed 
separately until peptides are generated and labeled with different tags. After that, these 
samples are pooled for subsequent LC−MS/MS measurement. HCD provides efficient 
ion extraction and fragmentation for generation of reporter ions, allowing detection of 
reporter ions with high signal-to-noise ratio in Orbitrap analyzer. In comparison to 
metabolic labeling, MS detection of reporter ions in an Orbitrap MS2 scan may be better 
for quantifying a peptide than detection of precursor ions in a series of Orbitrap MS1 
scans. Thus, although TMT and iTRAQ require samples to be mixed at a later sample 
preparation stage than metabolic labeling, they produced better overall quantification 
results. The comparison results provided guidance for choosing an appropriate approach 
for a proteomics experiment. The label-free method has the largest dynamic range for 
protein identification; however, high spectral counts are required for reliable 
quantification. In addition, special care is necessary to minimize sample-to-sample 
variability during sample preparation and measurement. Both metabolic labeling and 
isobaric chemical labeling provide accurate, precise, and reproducible quantification for 
many proteins, but each has advantages and disadvantages. Metabolic labeling is ideal for 
samples that need to undergo extensive preparation steps at the protein level, such as 
fractionation and enrichment, which may introduce a significant amount of error without 
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pooling samples together. However, metabolic labeling is feasible only for selected 
microorganisms and cell cultures. The unique advantage of TRAQ and TMT is the 
capability to multiplex more than two samples in a measurement. This not only saves 
instrument time but also simplifies experimental design. However, iTRAQ and TMT 
require advanced MS instruments, such as Q-TOF and LTQ Orbitrap Velos. 
 
In this study, four quantitative proteomic approaches, label-free, metabolic labeling, and 
isobaric chemical labeling by iTRAQ or TMT, were compared using an LTQ Orbitrap 
Velos mass spectrometer for protein identification and quantification. Our results indicate 
that the label-free method provides the deepest proteome coverage. However, the 
quantification is not as efficient as in the labeling-based approaches, especially for low-
abundance proteins. Metabolic labeling and isobaric chemical labeling have improved 
quantification accuracy, precision, and reproducibility. iTRAQ and TMT have similar 
performance in all aspects. 
 
5.3 Conclusions 
 
This project explored the use of the most common metrics for relative protein abundance: 
spectral counts (SpCs) and matched ion intensities (MITs). We looked at the behaviors 
and distributions of both measures, concluding that SpCs most closely followed a 
Poisson-like distribution and that MITs followed a normal distribution at the protein 
level. These studies also looked at the most appropriate ways to normalize these measures 
within and between MS runs. Surprisingly, both metrics performed rather well in 
discriminating known differences in protein abundances without normalization. However, 
normalizations were applied to adjust for run-to-run variation in total SpC and MITs 
assigned. For MITs, we also considered slight deviations from the traditional NSAF 
normalization, which uses the protein’s length as a second dimension for normalization. 
POSI (Protease-Optimized Spectral Indexing) assumes that each protein will generate 
different peptides, depending on the enzymatic digestion used, thereby changing the 
number of opportunities for each protein to be detected and analyzed by MS. Since 
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different peptides ionize differently and the observed intensity measurements are largely 
dependent on the competition between co-eluting peptides, it is more accurate to use the 
length of the protein as it is presented to the instrument after digestion. The suggested 
POSI normalizations confirmed that each protein appeared to have a different ranked 
relative abundance in the same sample digested by three different proteases. Comparison 
of the spectral indexes (sums of the peptide MITs) were also able to identify fold-changes 
in loading amounts when the same sample was loaded using 25 μg and 67 μg. The normal 
distribution of matched ion intensities supports the use of ANOVA for determining 
differences between relative abundance measurements. For SpC, however, we developed 
a new method for assessing whether two proteins are differentially expressed using the 
Poisson Bootstrapping Method (PBS). The PBS method seemed to give superior 
performance and lack of bias compared to other existing methods of testing significance.  
 
As an alternative to label-free matched ion intensities, labeled ion intensities use a 
reporter ion (one with a very specific, known mass) to act as the representative peak for 
that peptide’s intensity. This study found that label-free methods afford better 
representation of protein identifications but labeling methods achieve more accurate, 
reproducible quantification measurements.    
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CHAPTER 6:  Integrating Novel and Existing Tools into a 
Seamless Bioinformatic Workflow for Analyzing Shotgun 
Proteomic Datasets 
 
6.1 Logistics of Developing a Bioinformatics Workflow 
 
Shotgun proteomic experiments provide qualitative and quantitative analytical 
information from biological samples ranging in complexity from simple bacterial isolates 
to higher eukaryotes such as plants and humans and even to communities of microbial 
organisms. Improvements to instrument performance, sample preparation, and informatic 
tools are increasing the scope and volume of data that can be analyzed by mass 
spectrometry (MS). To accommodate for these advances, it is becoming increasingly 
essential to choose and/or create tools that can not only scale well but also those that 
make more informed decisions using additional features within the data. Incorporating 
novel and existing tools into a scalable, modular workflow not only provides more 
accurate, contextualized perspectives of processed data, but it also generates detailed, 
standardized outputs that can be used for future studies dedicated to mining general 
analytical or biological trends.  
 
Tightly coupled to the advancements in sample preparation and instrument technology, 
there is an increasing demand for software improvements to make sense of and report the 
collected data in a meaningful way. Each new parameter that can be adjusted in the 
experimental protocol or tuning of the instrument adds to the opportunity for an 
optimized combination of settings that provide the best-case scenario for deep, accurate 
measurements. Therefore, data is collected on instrument statistics (voltage, % salt, DE 
window, etc) as well as spectral-level statistics (elution time, precursor ion selection, 
spectral counts, measured MS1 peak intensity, calculated peak area, etc). Once the data 
has been collected, interpreting the data requires algorithms to perform peptide to spectra 
matching (PSM scores/likelihoods) and protein to peptide matching (FDRs). The existing 
algorithms that provide scores and suggest assignments have a mixture of competing and 
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complementary benefits and disadvantages, so it is conceivable one may want to compare 
the results of multiple software algorithms in order to come up with the most 
comprehensive understanding of the components collected in the biological sample. 
Several software programs use index-based information retrieval so that one isn’t always 
moving every piece of data with each analysis. For example, protein assembly software 
generally does not maintain information about individual ion series distributions for each 
PSM; the data is usually linked in some way so that the user can explore to his or her 
desired level of detail, or the data’s represented by an aggregate measure. However, with 
a centralized repository of raw input data as well as processed results, it is a much more 
straightforward task to provide means of easily extracting cross-referenced information, 
transforming or filtering it, and sharing it with others. Some of the most beneficial steps 
taken by other research groups along the way include standardizing their input and output 
formats for informatics software. Making data results portable not only increases the 
speed and efficiency at which a new tool can be evaluated and adopted into an existing 
workflow, but it helps standardize vocabularies, establish quality control, and move the 
community closer to diagnostic and deterministic assessments of datasets’ behaviors. 
Therefore, in our implementation of a bioinformatic workflow, TORPEDO (Tools and 
Omnibus of Resources for Proteomic Experimental Datasets Online), we have 
endeavored to receive and generate the common standardized outputs. 
 
With so many tasks to accomplish, and for occupation by multiple users at a time, such a 
workflow requires support by adequate hardware infrastructure. Successfully integrating 
this workflow within the existing computing architectures was not possible. The distinct 
computational resources currently available require multiple data transfers between users, 
adaptation of analysis scripts to accommodate different operating systems, numerous 
transformations of the data into various input and output file formats, and non-linear 
documentation of analyses performed on the data. Therefore, we proposed developing 
cyber-infrastructure that would allow a user to seamlessly run multiple analyses, store the 
results, and share processed data with other users.  
 
  181 
Specifically, we built a web-based front-end to facilitate data exploration. Users have to 
sign in with an account to run analyses, but they can choose to make their results 
available to the public or private. In addition, users can opt to upload data for one-time 
analyses, or users can create a persistent project with longer-term data storage and invite 
other users to view their results. In short, this project offers an easy-to-use interface for 
running multiple proteomics analyses tools backed by sizable computing resources and a 
platform for sharing data with other researchers for enriched collaborations.  
 
The alternative hardware solutions we explored involved complicated communication 
between two existing resources: a host computer and a compute cluster. For this setup to 
work, the host computer handled user interactions and constantly pinged the remote 
compute cluster for notifications of completed jobs and retrieving the results. Checks had 
to be made both at the user- and processing-end to ensure all parameters were in place, 
even though the software only resided on the compute cluster. Security requirements also 
provided a significant hurdle to protect the computing cluster from attacks originating 
through our website.  
 
Simplifying this architecture into one machine minimized redundant validation steps, 
mitigated communication errors, allowed real-time job status updates, and simplified the 
overall design concept to create truly modular program development. By building a 
computer system that can handle both responsibilities of hosting and computing 
processes, computing tasks can later be distributed onto other machines as infrastructure 
expands. Thus, in the future the single computer will not become obsolete, but instead 
can easily be repurposed as a login node facilitating load balancing and job execution on 
compute nodes.  
 
This proposed solution is not just for large labs on the cutting-edge of large-scale data-
centric experiments; it also provides a gateway for small labs doing one-off experiments 
that do not necessitate a dedicated informatics solution. This solution fits well with the 
NSF-recognized need for national cyber-infrastructure for research and provides a 
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starting framework for future projects to expand capabilities. Specifically, we will 
leverage this project to apply for the Annual Research Cluster Grant from Silicon 
Mechanics. By providing centralized pre-built options for analysis, we engage an 
audience that otherwise may not participate in data-centric biological experiments and 
provide a functional education for best-practices in experimental design and data 
analyses.  
   
To ensure the usability, performance, and integrity of the data in these analyses, it is 
critical to have efficient ways to store, access, and interpret information. These needs 
translate into tangible computational specifications. For example, current state-of-the-art 
mass spectrometry instruments are generating twice as many spectra as their 
predecessors, which means algorithms that are optimized for multi-threading and MPI 
communication are becoming increasingly essential to efficiently deconvoluting spectra 
into protein identifications. In addition, filtering true protein identifications is far more 
effective when a user can dynamically score matches, but re-evaluating the large amount 
of multidimensional data is a highly memory-intensive, user-interactive process. Once the 
data is properly filtered, it is common to normalize datasets against technical and 
biological replicates and compare the results between biological conditions or 
experimental methods. Since each experiment can easily scale to 10-20 GB, having 
adequate data storage is especially important to obtaining proper perspectives on the 
analytical quality and biological significance of these proteomics experiments.  
 
While it is important for informatic tools to be able to handle large datasets, it is 
becoming increasingly crucial for tools to also handle the biological complexity 
associated with more intricate experimental designs. The overwhelming volume and 
complexity of these experiments requires that the new and existing tools are not only 
optimized for speed and interpretation, but they also necessitate seamless communication 
with each other in an integrated workflow. By constructing a workflow that allows high-
throughput processing of massive datasets, data collected within the past decade can be 
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standardized and updated with the most recent analyses. Once these analyses are 
complete, meta-analyses can identify global analytical and biological trends.  
 
6.2 Improving an Existing Workflow 
 
When attempting to overhaul an existing workflow, it is important to consider what the 
major functionality of the workflow needs to be, as well as who is going to be using it. 
For researchers within our lab, we identified 3 major tasks that this architecture would 
provide: 1) search raw data against a protein database, 2) apply normalization methods in 
preparation for differential expression tests, and 3) store and access raw and processed 
data. With these three chief aims in mind, we set out to evaluate existing software and 
decide what would be most appropriate for the scale and quality of the proteomic 
analyses currently underway as well as anticipated computational bottlenecks of future 
projects. 
 
One of the most immediate informatic needs that aligned with the objectives of the new 
workflow was the adoption of a new search algorithm. Whereas local projects were 
analyzed by SEQUEST for the last decade, the version that was most commonly used 
was out of date and no longer sufficiently fast or reliable for large-scale experiments that 
include highly complex organisms and metaproteomes of bacterial communities. 
Myrimatch, a database searching platform released in 2007, not only has multi-threaded 
MPI compatibility for optimized speed performance but also highly customizable search 
parameters that allow the researcher to specifically define what he is looking for. Another 
appealing feature about Myrimatch is that it can run on a personal desktop or it can be 
run on a more powerful Linux computer for batch submissions and high-throughput 
analyses. 
 
Myrimatch takes standardized input files that merely need to be converted from the direct 
output from the instrument (.RAW files) and run through a freely-available conversion 
software, MSConvert, into .mzML or .mzXML files. These XML files compress well and 
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can be used for other searching software, should one want to compare their 
identifications. The structure of these files accommodates quite a bit of data and lends 
itself to quick parsing by PERL or Python scripts. Pure data collection information can 
easily be retrieved and graphically displayed, such as the total ion current (TIC) 
compared to the number of peaks collected in each MS2 scan (Figure 3.3). This ability, 
while a feature, reinforced the decision to adopt Myrimatch as the default search engine. 
 
While it is becoming more common to move away from the reference genome and look 
for dynamic modifications and sequence variants that may be mutations, it was also 
necessary to include searching algorithms that could handle flexible search parameters 
for unexpected or multiple modifications. Complementary programs, DirectTag and 
TagRecon, which were written by the same research group, were natural choices for their 
shared vocabularies and options with Myrimatch, as well as their demonstrated 
performance in large-scale studies. Therefore, Myrimatch, DirecTag, and TagRecon were 
implemented into the TORPEDO workflow. 
 
While these database searching algorithms are very comprehensive, their outputs are 
pepXML files containing all possible peptide-spectrum matches between the collected 
scans and the specified protein database. Another program is required to filter the 
peptide-spectrum matches and retain only the high-scoring peptide sequences.  Generally 
this program also assembles the peptide sequences into proteins as well. IDPicker is the 
recommended protein assembly and filtering tool for pepXML files, but it is a Windows-
only GUI program that does not lend itself to batch submissions or Linux web hosts. 
Therefore, a current limitation in this workflow is that it requires offline filtering by the 
user and submission of a filtered list of identifications. Until a comparable program has 
been identified or developed, temporary scripts were written to extract the information 
from the (filtered and assembled) IDPicker output files and recast them into tab-delimited 
files that associated peptide-spectrum matches with protein identifications.  
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In order to integrate the CUSPs method we developed, which clusters protein databases 
based on a degree of sequence similarity, we added an option for the users to select that 
will reannotate the IDPicker results in terms of protein groups. In fact, there is a program 
that generates pictures of the reduction in proteome size as a result of clustering at a 
range of identity thresholds (id = 0.5 to id = 1) so that the user can make an informed 
decision about how to group the protein sequences. Peptide uniqueness and redistribution 
of protein abundance measurements are automatically calculated upon selection of a 
clustering threshold. 
 
From these filtered files, whether they are clustered or not, we aimed to implement the 
second goal: normalize and quantify protein abundances. TORPEDO houses and runs 
scripts that apply NSAF and/or Protease-Optimized Spectral Indexing (POSI) 
normalizations on either spectral counts (SpC) or matched ion intensities (MITs). Users 
can compare the results of any of these methods and a preliminary ANOVA p-value is 
performed to highlight which proteins are ranked differently for each normalization 
method. The POSI method requires the mzML file to be uploaded as it contains the 
original scan information with the collected m/z values and their intensities. One feature 
of choosing the POSI method is that it generates a mzIdentML file with the matching 
ions and their intensity information so that individuals can easily lookup and/or parse the 
information that was used to generate the protein abundances. Especially since most 
peptide-spectrum matching algorithms do not explicitly reveal which fragment ions were 
identified, this listing is particularly useful for those who desire detailed inspection of the 
identifications. In general, the output can be exported as a tab-delimited file that can be 
easily introduced to JMP Genomics or another software program that performs 
significance tests. 
 
The third goal of this project, a resource to store and access data, is perhaps one of the 
most appealing aspects of this infrastructure. The web-based front-end of this project 
allows users to easily upload raw or processed files into a project or user-specific 
directory. This feature allows the researchers to have control over what data is shared 
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with collaborators or kept private. Due to the increasing number of projects a researcher 
may be working on, it is becoming increasingly impractical to keep all raw, processed, 
and analyzed data for all projects on a person’s personal computer. Therefore, terabytes 
of storage were purchased and added to the storage on TORPEDO in order to free users 
from worrying about crowding their computers with data files. Each file kept on 
TORPEDO has an export or download option (if the user has permission), so that data 
can be easily retrieved as necessary. In addition, the system was RAIDed in order to 
backup the data kept on the system to help protect the computer from unintentionally 
losing user data.   
 
Some of the more novel aspects of this architecture are the availability of streamlined 
analyses that have been developed in-house for individual projects or intended for 
widespread adoption within the group. This architecture allows researchers to pick and 
choose at which level he would like to analyze his data: in silico digestions or 
fragmentations, peptide-spectrum matching, peptide to protein assembly, or quantitative 
comparisons. Specifically, tools such as a viewer for sequence coverage viewer, a 
summarizer for matched ion intensity, a modified residue locator that uses matched ion 
intensities to support site localization, and an extracted ion chromatogram of MS2 
intensities among many others. Many of these tools can be used in tandem for predictive 
studies, such as the in silico digestion tool followed by the sequence coverage viewer, in 
order to have a preliminary snapshot of what peptides are expected to be generated for a 
given protein and visualization for how these peptides could affect their POSI effective 
lengths (Figure 6.1). More commonly, the tools can be used in concert to identify 
peptides and proteins within or across technical replicates, such as viewing the gains 
afforded by additional runs or the discrepancy between proteins abundances measured 
under different biological conditions. 
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Figure 6.1. Illustrations of visualization tools provided by TORPEDO. 
The sequence coverage tool in TORPEDO can highlight regions of proteins that were 
identified by multiple runs, regions that are predicted to be identified by an in silico 
digest, regions that vary by observed abundances, and regions that occur multiple times 
within a protein. Collected data can also be interactively explored using a dynamic 
MS1/MS2 viewer.  
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6.3 Conclusions 
 
 
In total, the TORPEDO platform has been designed to be a user-friendly bioinformatic 
workflow that meets the immediate computational needs of researchers performing large-
scale proteomic analyses, as well as includes a few unique features that set it apart from 
other comparable tools. Users can upload their data straight from the instrument, 
sequence peptides, quantify the identifications, and query their results with a number of 
visualization tools designed to further investigations and evoke new questions to be 
explored. Housing all of the informatic components in a single repository also makes the 
tools easier to disseminate, update, and access. The intentionally modular design also 
allows users to pick and choose their analyses for a customized experience that facilitates 
quality scientific research. 
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CHAPTER 7:  Propelling a Dynamic, Iterative Feedback Loop 
between Biology and Technology: Future Outlook, Remaining 
Challenges, and Conclusions 
 
7.1 Overview 
 
As the adoption of mass spectrometry analyses becomes more routine analyses for large-
scale proteomic analyses, the potential opportunities that lay ahead appear infinite. A 
large part of its current success is due to the field’s general receptiveness and outright 
eagerness in collaborating across disciplines to pair biochemical sample preparation with 
exquisitely purposeful manipulation of molecular physics in order to develop high-
throughput, high-resolution analytical platforms that continue to outperform their 
previous depths, breadths, and accuracies of complex protein mixtures. As the 
instrumentation and analyses continue to progress and there are even more questions to 
ask and investigate, one also discovers new challenges that have not been encountered 
before. The informatics components to shotgun proteomic experiments, in particular, are 
experiencing a roller coaster ride of accomplishments and new hurdles that makes for an 
exhilarating non-stop journey of high-velocity loops, unexpected turns, and generally 
obscured views of the path ahead. That being said, there are a number of key mechanics 
along the bioinformatic workflow that are crucial to delivering biologically meaningful 
pieces of information from raw instrumental values. This dissertation particularly focused 
on preparing a virtual vehicle (TORPEDO, Chapter 6) to customize and optimize the 
informatics processes of peptide-spectrum matching (Chapter 3), peptide to protein 
assembly (Chapter 4), and protein quantitation (Chapter 5).  
 
First, the principles underlying peptide-sequence matching were examined. Due to their 
sensitivity to their chromatographic neighborhood, matching fragment ion intensities 
demonstrated to be useful in discriminating which MS2 scans were over-inflating spectral 
count identifications and suggesting which peptides may have been under-represented 
based on their spectral counts. Matched ion intensities were also helpful in refining 
ambiguous scan identifications as well as improving site localization for modified 
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peptides. In fact, matched ion intensities from HCD data discriminated false positive 
identifications of single amino acid polymorphisms and provided evidence for a new 
attestation rule for calling sequence variants: modified sequences that are within close 
proximity of a known chemical modification should make use of additional information 
to confidently localize the modification or else be discounted as an ambiguous 
identification. For the confident peptide identifications, a notoriously contentious 
challenge was addressed: the protein inference problem. Peptides that map to multiple 
proteins add layers of ambiguity to the affected protein identifications and 
quantifications. We proposed clustering the protein database by sequence similarity in 
order to form groups of identifications whose members we would most likely not be able 
to analytically distinguish. Using the CUSPs (Clustering Unique Sequences in 
Proteomes) framework, sequence identity thresholds are recommended by analyzing the 
tradeoffs of the clustered proteome’s reduction in size from the original database as well 
as the clustered proteome’s number of unique identifications that can still be teased apart. 
This approach not only allows researchers to rescue up to 50% of their data that would 
have otherwise been lost, but also improves confidence in the identifications in total. The 
clustering method also has provisions for accurately distributing measurements among 
protein groups so that quantitative analyses can follow. While this study considered the 
use of spectral counts and matched ion intensities for quantitative purposes, matched ion 
intensities demonstrated a number of advantages, particularly with respect to their ability 
to reflect expected fold-changes at the run, protein, and peptide level when different 
amounts of sample was loaded. Additionally, a number of POSI (Protease-Optimized 
Spectral Indexing) normalization methods were explored on the same sample digested by 
3 protease sets. From this study, we propose that the peptide distributions generated by 
each protease are very specific to the enzyme and that it may not be reasonable to expect 
protein A’s relative abundance in a run digested with trypsin to be the same as protein 
A’s relative abundance in a run digested with gluC.  
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7.2 Status and Remaining Challenges of Peptide-Spectrum 
Matching 
 
One of the most controversial topics in proteome informatics is the derivitization and 
application of a false discovery rate on a dataset. Some firmly believe that the FDR 
should be calculated with respect to all other candidates within the database, whereas 
others seek to capture the likelihood of an identification with respect to all possible 
sequences. Where the FDR should be applied (PSM, peptide, or protein level) as well as 
at what amount of error (1%, 2%, 5%, or even 10%) are also contested. Unfortunately, 
regardless of what approach one chooses, there are biases in letting only one FDR dictate 
a dataset’s filtering criteria. PSM-level and peptide-level FDRs have instrument biases 
and protein-level FDRs have proteome biases. Changing one slight setting on the 
instrument could have quite large ramifications that propagate through to the final 
analysis. There are also a number of arguments against the protein FDRs (how do protein 
lengths, proteome redundancy and size affect FDR calculations?), but in summary, 
collectively resolving how protein data sets should be filtered is a major need in the 
proteomics field. There may not be one standard approach that becomes the only rule to 
adopt, but FDRs are exceedingly crucial to keep in mind as one draws biological 
conclusions from analytical data that has a certain probability of being due to error. 
 
In addition, an area of improvement that has become more evident by the analyses 
addressed in Chapter 3 is the confident identification of modified residues. Although 
genomes can be sequenced at much higher rates and with better accuracies than even 5 
years ago, the proteomes of all organisms cannot wait for their sequencing. Despite the 
use of reference genomes, the variability from one genus to the next can be just as 
different as one species to the next, depending on the complexity of the organism. It is 
therefore imperative that database-searching software include flexibility in determining 
mutations or unexpected sequence variants from the given protein database. Such 
inclusion would ideally also extend to the conclusive identification of post-translational 
modifications, which considerably impact amino acid masses, and therefore impact 
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peptide-spectrum matching. The key to many biological questions being explored with 
proteomic experiments may not be found in the primary sequence; post-translational 
modifications such as glycosylations, acetylations, and phosphorylations may be the most 
interesting nuances present in the sample. Of the modifications that are specifically 
searched for within a dataset, there is a high level of ambiguity in site localization, as 
suggested in Chapter 3. Instrumentation or algorithms in the near future will surely be 
able to confidently select which residue contains the mass shift, but at the present, it is in 
large part, a guessing game. Despite the probabilistic calculations, these identifications 
also factor into the murky controversies over false discovery rates and complicate the 
standards even further. 
 
7.3 Status and Remaining Challenges of Protein Inference 
 
There are a number of solutions available that tout that they have the best way to handle 
the protein inference problem. However, most of them rely on data-dependent 
observations and are therefore volatile in which proteins may be grouped together in one 
run compared to another. The proposed clustering method, CUSPs, is able to group 
analytically ambiguous identifications that also most likely have shared biological 
function. However, this method is more beneficial for single, complex organisms and 
must be carefully applied to metaproteomes.  Metaproteomes, which may contain several 
closely-related organisms or several distinct organisms that are most likely present in the 
same sample, could cause a similar issue to the volatility observed in the data-dependent 
clustering methods. Depending on which databases are combined into a metaproteome, it 
may make more sense for some proteins to be collapsed into a single representative, or it 
may be more useful to keep them as separate identifications. The methods recommended 
for identifying an appropriate clustering threshold take the entire database into 
consideration; it does not make any delineations for species or genus.  For example, the 
infant gut microbiome discussed in Chapter 4 contained both human and bacterial 
proteomes. The human proteomes were clustered at id=0.9, while the microbial 
proteomes were clustered as a group at id=1.0.  The applicability of this method on other 
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metaproteomic datasets has yet to be explored, but there is currently not a standard 
approach that meets this informatic need and maintains biological integrity and 
consistency. 
 
7.4 Status and Remaining Challenges of Protein Quantitation 
 
Perhaps the most natural next step after the discussion in Chapter 5 is the investigation 
and improvement of peak-picking algorithms for determining the area-under-the-curve 
for label-free relative protein quantitation. While spectral counts (SpC) provide “width” 
information about how many times the peptide was sampled across a run, and matched 
ion intensity (MIT) provides a “height” metric indicating the abundance of the analyte 
measured at the time of fragmentation, the true behavior of the peptide is an elution peak 
and is best described by the integration of the SpC and MIT. However, all peptides are 
not constantly sampled at every time point, so there needs to be some method of inferring 
where the peptide would have been measured if its precursor had been selected for 
fragmentation. Currently, the ionizability of a peptide cannot be directly computed 
among the complicated background of all peptides generated in a proteomic digestion. 
Changing the instrument’s data acquisition settings can greatly affect whether each 
peptide is sampled once (optimized for proteome breadth) or sampled many times 
(optimized for proteome depth). Whereas label-free methods generally allow for the 
identification of more peptides, labeling methods are more accurate and consistent for 
quantification purposes. Therefore, for large-scale proteomic studies, one must choose 
upfront qualitative or quantitative data, understanding the limitations and biases of the 
selected approach. 
 
7.5 Status and Remaining Challenges of Proteome Informatic 
Workflows 
 
 
Despite the abundance of proteome informatics workflows available, there is one 
common issue that cannot be escaped: with each new algorithm or approach that is 
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suggested, a substantial amount of work is required to implement and integrate the tool 
into an existing series of analyses. Software packages that try to be too comprehensive 
lack the flexibility and versatility of many smaller tools that have been individually 
developed. Finding a program that performs a desired function and has an easy to use 
input and output format can sometimes be quite difficult, especially for specialized tools 
that were designed for a specific purpose. The turnover for such tools is quite high, many 
of which are the culmination of a graduate student’s thesis, implemented on a specific 
platform and not easily maintained (if at all) by the original research group. Many labs 
are pushing towards open source development, allowing researchers to peer inside the 
inner-workings of algorithms and prompting “transparency” in each process, which helps 
computational biologists apply existing tools to meet his or her specific needs. However, 
for those researchers that do not have the time or skill set to make modifications, it can be 
somewhat overwhelming to study the nitty-gritty details of each algorithm. Integrating 
computer scientists in biological workspaces, allowing each expert to become more 
conversational in each other’s language, would greatly facilitate the communication and 
adoption of informatics workflows.  
7.6 Concluding Perspective 
 
An increasingly popular mentality among the scientific community is an adaptation of the 
Central Limit Theorem: as one collects more data points, you are more likely to be 
looking at the data’s “true” distribution, from which you can make more accurate 
interpretations and estimations about its behavior. If we were trying to describe the 
characteristics of a single variable in a 2 dimensional space, simply collecting more data 
points might be sufficient. But the growing trend of pursuing “systems biology”- 
integrating complementary bioscience information across the entire scale of biological 
interrogations- redefines the process, rationale, and personnel involved in collecting 
“more data points.”  In fact, it leads to a growing dichotomy of holism versus 
reductionism, and an ever-increasing gap between scientific integration and 
specialization. With each new discovery, there is an overwhelming amount of associated 
vocabulary, hidden implications, and revolutionizing truths that may not be immediately 
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apparent. Computational scientists are tasked with not only trying to mine significance 
out of yesterday’s answers in hopes of evoking new questions, but also trying to 
implement architectures that can use and anticipate today’s technology with tomorrow’s 
questions. Proteomics experiments using mass spectrometry are continuing to push the 
envelope on what it means to produce more accurate, precise, and comprehensive protein 
identifications and quantifications. Improvements to sample preparation, instrument 
capabilities, and informatic reconstruction and interpretation are creating new, higher 
standards with each study. But it is not the protocols, the instruments, nor the algorithms 
that are moving the field forward- it is the people. The greatest successes arise out of 
collaborative efforts by analytical chemists, molecular physicists, bioinformaticians, and 
biologists. It is becoming increasingly impossible for every student of life sciences to be 
an expert in all fields of research, and therefore ever more necessary for young 
researchers to be conversant with other advanced and specialized scientists.  The ability 
to immerse oneself in the current vocabularies, struggles, and discoveries of other 
relevant fields is not only a way to enrich one’s academic repertoire, but also provides a 
cultural appreciation for the differences and commonalities of the contributions made in 
pursuit of scientific truths. If one is provided the tools that allow one to collaborate with 
others while maintaining personal excellence in his study, then investigating biological 
drivers with analytical technologies that are processed by computational resources and 
assessed by statistical tests will assuredly propel the scientific process into an exciting 
new era of successful integration. 
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